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Reactive oxygen species (ROS) are associated with a variety of human diseases 
and toxicities mediated by redox-active chemicals and/or their metabolites. One such 
redox active chemical, hydroquinone (HQ), is both a nephrotoxicant and a 
nephrocarcinogen. Sequential oxidation of HQ and addition of glutathione (GSH) leads to 
the formation of 2,3,5-tris-(glutathion-S-yl)hydroquinone (TGHQ). TGHQ maintains 
HQ’s ability to redox-cycle and generate ROS, and to covalently bind to cellular 
molecules. Thus, TGHQ induces ROS-dependent DNA damage and cell death in renal 
proximal tubule epithelial cells (LLC-PK1). It is not clear how ROS generated by redox-
active chemicals induce renal cell death. The molecular mechanisms of quinone-mediated 
nephrotoxicity therefore invite further investigation. We used TGHQ to study ROS-
mediated renal cell death, and have found that TGHQ induces oncotic rather than 
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apoptotic cell death in LLC-PK1 cells. MAPKs are quickly and robustly activated by 
TGHQ in a ROS-dependent manner. Pharmacological inhibition of either extracelluar 
signal regulated kinase (ERK) or p38 MAPK pathways attenuates TGHQ-induced cell 
death in LLC-PK1 cells. TGHQ also induces ROS-dependent histone H3 phosphorylation 
in LLC-PK1 cells, which leads to premature chromatin condensation (PCC) and mitotic 
catastrophe. Our studies show that TGHQ induces epidermal growth factor receptor 
(EGFR) phosphorylation at multiple tyrosine residues, leading to the EGFR-dependent 
activation of the ERK cascade. TGHQ also induces EGFR-independent activation of the 
p38 MAPK cascade. Both ERK and p38 MAPK inhibition attenuates TGHQ-induced 
histone H3 phosphorylation in LLC-PK1 cells, indicating both ERK and p38 MAPK are 
associated with ROS-mediated histone H3 phosphorylation. Additionally, proteomics 
analysis revealed changes in the overall expression and post-translational modification of 
several proteins in TGHQ-treated LLC-PK1 cells. The identified proteins can be grouped 
according to function, as follows; antioxidants and cytoskeleton stabilizing proteins 
(peroxiredoxin II, peroxiredoxin III, Hsp27), membrane fusion (annexin I), nuclear 
shuttling (nucleophosmin/B23), and calcium binding and chaperoning (calreticulin, 
Hsp27, peroxiredoxins). The changes are largely due to post-translational modifications, 
such as phosphorylation (Hsp27) and oxidation (peroxiredoxin). These modifications 
likely determine cell fate. Finally, we found that in Eker rats, TGHQ induces a time-
dependent increase in ERK1/2 and histone H3 phosphorylation within the outer stripe of 
outer medulla (OSOM) in the kidneys, confirming our findings in LLC-PK1 cells. The 
high constitutive in vivo phosphorylation of p38 MAPK obscured any changes induced 
by TGHQ within the OSOM. These early molecular changes likely lead to nephrotoxicity 
followed by excessive proliferation and amplification of genomic instability in Eker rats, 
and contribute to subsequent nephrocarcinogenicity. This dissertation contributes to the 
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understanding of the molecular mechanisms of TGHQ/ROS-induced renal cell 
death/nephrotoxicity. I am also of the view that this work will contribute to the future 
development of therapeutic strategies designed to alleviate acute renal diseases associated 
with ROS generation. 
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Chapter 1: INTRODUCTION 
I. GENERAL COMMENTS 
The quality of life for human beings has been greatly improved since the 
industrial revolution of the eighteenth century, during which the production of chemicals 
has roared to an exceptional level. Nevertheless, adverse effects of these chemicals have 
raised many concerns and have been the subject of many studies. Scientists endeavor to 
protect the health of human beings by identifying toxicants, studying their properties, 
observing dose-response relationships, and investigating the underlying mechanisms of 
the toxic effects. With the rapid development of advanced molecular and cellular 
technologies, toxicological studies have accelerated in the past several decades. 
Molecular and cellular toxicology arose from traditional toxicology, and has become an 
innovative area of study in recent years, with some significant successes. Utilizing 
molecular and cellular toxicological methods, toxicologists now have a better 
understanding of mechanisms of toxicity than has been previously achieved. New drugs 
with less adverse effects are therefore being produced, prevention of diseases achieved, 
and human safety improved. 
A lot of drugs and chemicals have adverse effects on the kidney, with a number of 
chemicals inducing renal diseases by generating toxic metabolites of oxygen, reactive 
oxygen species (ROS). Prevention and treatment of these diseases necessitates a 
theoretical understanding of the problem. The goal of the work described in this 
dissertation is to discover key mechanisms of ROS-induced nephrotoxicity and 





Quinones are named according to the parent compounds from which they are 
derived. Thus, benzoquinone is the simplest form of a quinone, and is named after 
benzene, while anthraquinones are named after anthracene. Quinones are prevalent in the 
environment and are ubiquitously present in the life of human beings. For example, 
quinones are components of a variety of natural products, endogenous biochemicals, and 
manufacturing intermediates (Bolton et al. 2000). Data on the concentration of 
hydroquinone in the environment are not available, but hydroquinone production in the 
world was 35,000 tonnes in 1992, with 16,000 tonnes produced in the USA (IPCS 1996). 
Benzene, which is metabolized to hydroquinone by CYP450 in the liver, is found in 
crude petroleum at a concentration of 4 g/l, and is produced at 14 million tonnes 
worldwide (IPCS 1993). Therefore, the prevalence and abundance of quinones and their 
derivatives assure that human beings will be exposured to quinones.  
Indeed, quinones are widely used by humans. Humans first used quinones as 
pigments and as drugs. For example, the principal active constituents of Chinese herbal 
medicine rhubarb are anthroquinones. Use of the senna plant originated in the Arab 
world, and pigments from henna and madder were used in cosmetics, and contained 
derivatives of 1,4-naphthoquinone and anthraquinone. Quinones are currently used as 
chemical intermediates, polymerization inhibitors, antioxidizing agents, photographic 
chemicals, tanning agents, and as chemical reagents (IPCS 1996). Hydroquinone is also 
used as a food preservative, as a skin-lightening agent in cosmetics, in hair dyes, and in 
medicines. Occupational exposure to quinones mainly include the dyes, textile, chemical, 
tanning, and cosmetic industries. Quinones may also be inhaled from tobacco smoke 
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(IARC 1977), and automobile exhaust (Schuetzle 1983; Schuetzle et al. 1981). As such, 
hydroquinone is present in the mainstream smoke from non-filtered cigarettes, with the 
amount from 110-300 µg/cigarette, whereas occupational exposure to hydroquinone in 
manufacturing industry has been reported to be 0.13 to 0.79 mg/m3. In addition, 
hydroquinone has also been found to be naturally present in many food products, such as 
brewed coffee, and teas. Therefore, humans may be exposed to quinones through 
consumption of foods, by using cosmetics, smoking, inhalation of polluted air, taking 
medicines, or occupationally. Fortunately, hydroquinone does not bioaccumulate in the 
environment, due to its rapid degradation by both photochemical and biological processes 
(IPCS 1996). However, exposure to quinones may cause severe adverse effects. For 
example, acute exposure to quinones causes irritation to the eyes, dermatitis in humans, 
and renal toxicity in animal studies (IPCS 1996). Chronic human exposure to quinones in 
human results in skin irritation and visual disturbance. More and more data support that 
many quinones can contribute to cancer. The toxicity and carcinogenicity of quinones are 
somehow dependent on their metabolism, which will be explained in the next section. 
 
B. Metabolism 
The simplest quinol/quinone, hydroquinone, is rapidly absorbed through ingestion 
and inhalation by animals, and is absorbed slower via dermal absorption. Hydroquinone 
is found in a wide range of tissues after administration, and it is oxidized to p-
benzoquinone as well as other oxidized products. Hydroquinone and its oxidized 
metabolites are subsequently detoxified by glucuronidation and sulfation, but their 
toxicitiy can be enhanced by conjugation with glutathione (GSH) (Monks et al. 1985). 
Hydroquinone and its metabolites are excreted rapidly via the urine. In an acute study, 
after a single dose of hydroquinone in male Fischer-344 rats, the metabolites of 
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hydroquinone were principally found in the urine, including 21% as a glucuronide 
conjugate, 15% as a sulfate conjugate, and 13% as mercapturate conjugates (Lau et al. 
1996). The metabolites of hydroquinone vary by species, route of administration, and 
duration of administration (Divincenzo et al. 1984; Hill et al. 1993; Lau et al. 1996; 
Nerland and Pierce 1990). 
Hydroquinone is subject to oxidation by different isoforms of cytochrome P450 
(1A1, 2E1, 3A4) (Hill et al. 1993; Lau 1997), or other enzymes such as myeloperoxidase 
(Subrahmanyam et al. 1990), and prostaglandin H synthase (Lau and Monks 1987). 
Benzoquinone, the oxidized form of hydroquinone, undergoes nucleophilic addition of 
GSH to form GSH-conjugated hydroquinone. The process of oxidation and GSH addition 
is repeated, leading eventually to 2,3,5-tris-conjugated hydroquinone, 2,3,5-tris-
(glutathion-S-yl)hydroquinone (TGHQ) (Lau et al. 1988). This sequential oxidation and 
GSH addition is summarized in Figure 1-1. GSH conjugation was long thought of as a 
detoxication pathway, but GSH conjugation to a number of polyphenols, resulting in 
polyphenolic GSH conjugates, are actually nephrotoxicants in various animal models 
(Bai et al. 2001; Bolton et al. 2000; Butterworth et al. 1998; Lau et al. 1988; Monks et al. 
1988; Monks et al. 2004; Monks and Lau 1997, 1998; Monks et al. 1985; Peters et al. 
1996). This is because GSH conjugation to quinones frequently increases their ability to 
generate reactive oxygen species (ROS), which damage the cells, and also target the 
conjugates to specific organs (Monks and Lau 1994). Moreover, quinone-GSH 
conjugates maintain their electrophilicity and can covalently bind to macromolecules. 
These biological activities of polyphenolic GSH conjugates will be discussed in detail in 
the following section. After GSH conjugation, quinones are subject to futher metabolism 
via the mercapturic acid pathway, the first step being catalyzed by γ-glutamyl 
transpeptidase (γ-GT), to form cysteinyl-glycine conjugates of quinones. A second 
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enzyme, dipeptidase, further metabolizes the cysteinyl-glycine conjugates to the 
corresponding cysteinyl conjugates. Renal proximal tubule epithelial cells express high 
activity of both γ-GT and dipeptidase. The subsequent formation of N-acetylcysteine 
conjugates is the last step in the mercapturic acid pathway (Monks and Lau 1997, 1998). 
Each of the metabolites in the mercapturic acid pathway is highly reactive, and can 
generate ROS, as well as alkylate tissue macromolecules. Therefore, high activities of the 
enzymes of the mercapturic acid pathway in renal proximal tubule epithelial cells 






















































C. Biological and Pharmacological Properties of Quinones and their Derivatives 
As summarized in the preceding section, quinones exhibit dual characteristics: 
they are both redox-active and electrophilic, and these two activities are closely 
associated (Monks and Lau 1997). Quinones may undergo either enzymatic or 
nonenzymatic redox cycling to generate superoxide radicals. The one-electron reduced 
form of a quinone, the semiquinone, may undergo oxidation to regenerate the quinone, 
during which an oxygen molecule gains an electron to form superoxide (O2·-) (Monks and 
Lau 1997). O2·- subsequently generates hydrogen peroxide (H2O2) via spontaneous or 
enzyme-driven dismutation. Additionally, hydroxyl radical (HO·) is generated via 
reaction with Fe2+ and H2O2. HO·- is thought to be the ROS principally responsible for the 
damage induced by quinones and quinone-derivatives (Monks and Lau 1997). These 
highly active oxygen derivatives are all called ROS, reactive oxygen species, and include 
O2·-, H2O2, and HO·- (Figure 1.2). Small amounts of ROS generated under physiological 
conditions may function as signaling factors, whereas large amount of ROS generated 
exogenously by chemicals or irradiation, for instance, cause deleterious effects to cellular 
contents. The two-electron reduction of quinones is catalyzed by NAD(P)H 
quinone:oxidoreductase (DT-diaphorase), and is considered a detoxication mechanism. 
However, due to hydroquinone’s ability to redox cycle and generate semiquinone radicals 
and subsequent ROS, this enzyme can actually potentiate the toxicity of hydroquinone. 
Quinones are also Michael acceptors and may covalently bind to a variety of 
cellular nucleophiles (Bolton et al. 2000). GSH represents the major non-protein 
sulfhydryl in cells, and GSH readily binds to quinones to form mono-, and multi-GSH 
conjugates, also known as quinone-thioethers. As noted, the addition of GSH to quinones 
is generally considered cytoprotective, because GSH functions as a ‘sacrificial’ 
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nucleophile to prevent binding of quinones to essential cellular proteins. But GSH 
addition to quinones can also increase quinone-mediated toxicity in certain target organs. 
This is because the conjugates maintain the properties of the parent compounds to redox 
cycle and to alkylate macromolecules (Monks and Lau 1997). Moreover, γ-GT and 
dipeptidases contribute to the formation of cysteinyl conjugates of quinones, which may 
enter cells by L-amino acid transporters (Monks and Lau 1997). Renal proximal tubule 
epithelial cells express high levels of γ-GT and dipeptidase, and are therefore targets for 
GSH-conjugated quinones. In summary, due to the two highly active biological 
properties of quinones and their derivatives, quinones and quinone-GSH conjugates may 
influence the essential functions of normal cells. For example, oxidation of cysteine 
residues of essential proteins may result in changes in their structure and function. 
Oxidation of lipids leads to the formation of lipid peroxide-derived malondialdehyde 
DNA adducts (Marnett 1999). Formation of 8-oxo-2’-deoxyguanosine is a sign of DNA 
oxidation and damage (Shigenaga and Ames 1991), and occurs in TGHQ-treated Eker 
rats (Habib et al. 2003). Proteins alkylated by TGHQ have been found in TGHQ-treated 
rats, and are localized to the S3 segment of the proximal tubule, the target of TGHQ-
induced toxicity (Kleiner et al. 1998a). Therefore, the biological and pharmacological 
properties of quinones and quinone-thioethers likely determine their toxicities in humans 










(1) Dismutation of superoxide anion to hydrogen peroxide 
 
SOD 
2O2·-  + 2H+             H2O2 + O2 
 
 
(2) The Harber-Weiss reaction 
 
Fe3+ + O2·-                    Fe2+  + O2 
Fe2+ + H2O2·-                    Fe3+  + HO· + HO- 
(3) Degradation of hydrogen peroxide 
 
         catalase 
2 H2O2               H2O + O2 
 
Figure 1.2. ROS generation and degradation. 
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D. Toxicity of Quinones and Quinone-thioethers 
The metabolism and biological and pharmacological properties of quinones and 
quinone-thioethers underlie their toxicological effects. The following discussion will 
focus on the various toxicities of hydroquinone as described in the literature to provide a 
panoramic view of hydroquinone-mediated adverse effects. Nephrotoxicity, the focus of 
this thesis, will be described in substantial detail, and other toxicities will also be 
mentioned to compare and contrast with hydroquinone-induced nephrotoxicity thereby 
providing a generic understanding of quinone-mediated toxicity. 
1. General Toxicities of Hydroquinone: 
The mammalian toxicity of hydroquinone is well-studied. Oral LD50 values for 
hydroquinone in mammals range from 300-1300 mg/kg body weight, with cats the most 
sensitive (LD50=42-86 mg/kg body weight). Dermal LD50 values in rodents are 
approximate by >3800 mg/kg. Acute exposure to hydroquinone causes central nervous 
system (CNS) toxicity, depigmentation, minor irritation, sensitization, inflammatory 
changes, and thickening of the epidermis in skin test (IPCS 1996). Subchronic oral 
toxicological studies revealed nephropathy and renal cell proliferation, and CNS toxicity 
in Fischer-344 rats and B6C3F1 mice (IPCS 1996). Weight loss and CNS signs of 
toxicity were also observed in Sprague-Dawley rats after 13-week exposure to 
hydroquinone at 200 mg/kg body weight (IPCS 1996). Reproductive and developmental 
toxicities of hydroquinone were also observed (IPCS 1996). Genetic toxicities revealed 
numerical and structural changes to chromosomes, gene mutations, sister-chromatid 
exchange, and DNA damage. Chronic ingestion of hydroquinone caused dose-dependent 
renal tubule cell adenomas in male Fischer-344 rats, and hepatocellular adenomas in 
female Fisher-344 rats and male mice (Kari et al. 1992). The incidence of squamous cell 
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hyperplasia in the forestomach epithelium also increased significantly in rats. 
Hydroquinone demonstrates both in vitro and in vivo cytotoxic effects manifested by 
reduced cell counts in bone marrow and spleen, and subsequent immunosuppressive 
potential. 
Toxicity after oral ingestion of hydroquinone by humans in the photographic 
industry was reported. Signs of toxicity included dark urine, vomiting, abdominal pain, 
brachycardia, CNS effects, coma, and even death. Ingestion of 300-500 mg hydroquinone 
daily for 3-5 months by a human did not induce pathological changes in blood or urine 
(IPCS 1996). Epidemiological studies suggest that skin creams containing hydroquinone 
produce leukoderma and ochronosis, irritation, and allergic contact dermatitis. Exposure 
to hydroquinone in the air causes eye irritation, sensitivity to light, and eye damage. 
2. Nephrotoxicity 
As noted earlier, GSH conjugates of polyphenols (quinone-thioethers) are 
nephrotoxic in Sprague Dawley and Fischer-344 rats (Bolton et al. 2000), and TGHQ is 
nephrocarcinogenic in the Eker rat (Lau et al. 2001a). The nephrocarcinogenicity induced 
by quinone-thioethers will be discussed in Section II.E. The nephrotoxicity of GSH 
conjugates of polyphenols is due to the relatively high activity of γ-GT and dipeptidase 
present in the brush border membrane of the kidney proximal tubule epithelial cells. The 
activity of these two enzymes leads to the formation of cysteinyl conjugates of 
polyphenols, which may be transported into renal cells via the L-amino acid transporter 
system (Monks and Lau 1997, 1998). Thus, inhibition of γ-GT activity by acivicin (AT-
125) blocks quinone-thioether induced nephrotoxicity (Lau et al. 1988; Monks et al. 
1988; Monks and Lau 1997, 1998). In essence, the metabolism of the GSH conjugates of 
polyphenols determines target-organ oriented toxicity in the kidney. Typical 
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nephrotoxicity by 2-bromo-bis-(glutathion-S-yl)hydroquinone in Fischer-344 rats is 
characterized by loss of the brush border membrane integrity (release of γ-GT and 
alkaline phosphatase into urine), margination of heterochromatin, loss of chromatin 
staining, reorganization of the endoplasmic reticulum into discrete aggregates, loss of 
cellular contents (glutathione-S-transferase [GST] in urine), karyorrhexis and karyolysis, 
DNA fragmentation, and renal cell necrosis (Monks and Lau 1998; Peters et al. 1997; 
Rivera et al. 1994). DNA damage induced by TGHQ in Eker rat kidneys was manifest by 
an increase in the 8-oxo-deoxyguanosine, an oxidized damaged nucleotide (Habib et al. 
2003). DNA damage was found to be specifically localized within the outer stripe of 
outer medulla (OSOM), within the S3 segment of proximal tubule epithelial cells. These 
cells are most sensitive to TGHQ treatment (Monks and Lau 1998). 
To study the mechamisms of polyphenolic GSH conjugate induced 
nephrotoxicity, we utilize an in vitro cell culture model system (LLC-PK1). LLC-PK1 
cells are a porcine renal proximal tubule epithelial cell line, and have relatively high 
expression of γ-GT. GSH conjugates of polyphenols induce cell death in LLC-PK1 cells, 
as determined by neutral red uptake (Mertens et al. 1995). Thus, TGHQ induces oncotic 
cell death in LLC-PK1 cells (Dong et al. 2004; Ramachandiran et al. 2002), and the 
response is both dose- and time-dependent. Polyphenolic GSH conjugate induced 
cytotoxicity is associated with their ability to generate reactive oxygen species (ROS), 
and to cause single strand DNA damage (Jeong et al. 1997a; Jeong et al. 1996; Mertens 
et al. 1995). Cell cycle arrest induced by 2-bromo-bis-(glutathion-S-yl)hydroquinone is 
represented by an increase in gadd153 expression, a growth arrest gene responding to 
DNA damaging agents (Jeong et al. 1997a; Jeong et al. 1996). gadd153 induction by 2-
bromo-bis-(glutathion-S-yl)hydroquinone corresponds to a direct inhibition of DNA 
synthesis, due to the inhibition of the DNA synthesis enzymes. As such, histone mRNAs 
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also decrease upon 2-bromo-bis-(glutathion-S-yl)hydroquinone treatment (Jeong et al. 
1997b; Jeong et al. 1996), preventing chromatin remodeling and cell growth. 
Additionally, TGHQ induced activation of all three subfamilies of the mitogen activated 
protein kinases (MAPKs), extracellular signal-regulated protein kinase (ERK), c-Jun N-
terminal kinases/stress-activated protein kinase (JNK/SAPK), and p38 MAPK 
(Ramachandiran et al. 2002). Pharmacological inhibitors of the ERK (PD-98059) and 
p38 MAPK (SB-202190) pathways, but not JNK (SP-600125) attenuate TGHQ-mediated 
oncotic cell death, yet there was no additive effects with the two inhibitors 
(Ramachandiran et al. 2002). TGHQ also increased the DNA binding activity of AP-1 
and NF-κB, downstream effectors of the MAPKs, and NF-κB is likely involved in the 
cytoprotective effects of PD-98059 (Ramachandiran et al. 2002). Another downstream 
effector of the MAPKs is histone H3, which was phosphorylated after TGHQ treatment. 
Phosphorylation of histone H3 was attenuated by inhibition of the ERK pathway, using 
pharmacological inhibitors (Tikoo et al. 2001). Meanwhile, histone H3 phosphorylation 
by TGHQ is accompanied by an increase in chromatin condensation, and is modulated by 
poly(ADP)ribosylation (Tikoo et al. 2001). Histone H3 phosphorylation induced by DNA 
damage and growth arrest-inducing agents likely mediates a cellular malfunction called 
premature chromatin/chromosomal condensation, and leads to cell death. In summary, 
quinone-thioethers induce DNA damage and growth arrest, MAPKs activation, and 
histone H3 phosphorylation in LLC-PK1 cells, which are all associated with quinone-
thioether induced renal cell death.  
In contrast, cells also possess a number of signaling pathways to prevent and 
recover from stress-induced damage. For example, TGHQ induces early hsp70 
expression (Towndrow et al. 2000), a cell survival signal induced by stress and heat 
shock. DDM-PGE2 pretreated (24 h) or in genetic manipulated post-confluent renal cells 
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(Grp78 antisense), changes of total levels of Hsp27 and the subsequent phosphorylation 
are important in stabilizing actin and yield protective effects (Jia et al. 2004). Whether 
cells die or survive after stress depends on the balance of these death/survival signaling 
pathways within the cells. Theoretically, if the stress level is low, cell survival signals 
overwhelm the death-driven signals to protect or ensure recovery from stress-induced 
damage. If the stress exceeds a certain threshold, cells no longer have the capacity to 
compensate, and cell death signals dominate cell signaling and drive cells to die. 
3. Other Quinone-thioether-mediated Target Organ Toxicities: Similarities and 
Differences to Nephrotoxicity 
Quinones and their derivatives not only target kidneys, but also bone marrow and 
neural systems. For example, benzene causes a decrease in the numbers of circulating 
blood cells in workers occupationally exposed to benzene (Greenburg 1996). Benzene is 
both hematotoxic and leukemogenic in humans, and benzene causes aplastic anemia, 
myelodysplastic syndrome, and acute myelogenous leukemia (Snyder et al. 1993). The 
metabolism of benzene is responsible for its toxicity. Benzene is metabolized in the liver 
by CYP450 2E1 or peroxidase(s) to form phenols, and subsequently hydroquinone and 
catechol, and ultimately various conjugated metabolites. Thus, a number of redox active 
quinol-thioethers were identified in the bone marrow of both Sprague-Dawley rats and 
DBS/2 mice administered a combination of hydroquinone/phenol or benzene (Bratton et 
al. 1997). Mice are more sensitive to benzene-mediated hematotoxicity than rats, partially 
due to different concentrations of quinone-thioethers in bone marrow (Bratton et al. 
1997). TGHQ reproduced benzene erythrotoxicity in vivo (Bratton et al. 1997). 
The molecular mechanisms behind quinone-thioether induced hematopoietic 
effects are due to apoptotic cell death (Bratton et al. 2000), but little is known about the 
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roles of apoptosis in benzene or benzene metabolite-induced hematotoxicity. Therefore, 
studies in our laboratory have attempted to define an apoptotic cell death pathway in HL-
60 cells, and are exploring the mechanism of TGHQ-induced apoptosis (Bratton et al. 
2000). In essence, TGHQ induces a decrease in cellular GSH levels independent of ROS 
generation, and this decrease precedes cell death (Bratton et al. 2000). Decreases in GSH 
levels likely induces apoptosis through the ceramide signaling pathway (Bratton et al. 
2000). Ceramide induces apoptosis through the activation of caspase-3 or phosphatases. 
Sphingomyelin turnover is also increased by TGHQ, together with the induction of the 
ceramide pathway, verifying the responses of cells to decreases in GSH levels. Current 
studies in our laboratory are attempting to decipher the apoptotic signaling pathways 
involved in TGHQ-mediated apoptosis. 
Another target organ of interest is the CNS. The neurotoxicity of quinone-
thioethers is illustrated by the toxic effects of 3,4-(±)methylenedioxyamphetamine 
(MDA) and 3,4-(±)methylenedioxymethamphetamine (MDMA), the latter known as 
ecstasy. Ecstasy is abused in western countries, with mild to severe acute adverse effects 
such as convulsions, hyperthermia, rhabomyolysis, and acute liver and renal failure 
(Henry et al. 1992). The acute toxicity in rats is manifest as damage to serotonergic 
axonal structure and function, and increases the acute release of 5-hydroxytryptamine (5-
HT), followed by a long term depletion of 5-HT in serotonergic nerve terminals, and 
inhibition of tryptophan hydroxylase (Stone et al. 1989). Long-term consumption of 




















Figure 1.3. Metabolism of methylenedioxymethamphetamine (MDMA) and 































































Metabolism again plays a role in MDA and MDMA-mediated neurotoxicity, 
because injection of these two chemicals directly into the brain fails to produce toxic 
effects. CYP450 mediated oxidation and GSH conjugation are required for MDA and 
MDMA induced neurotoxicity. Very similar to hydroquinone metabolism, the 
metabolites of MDA and MDMA, α-MeDA and N-methyl-α-MeDA undergo sequential 
oxidation and addition of GSH to form 5-(glutathion-S-yl)-α-MeDA and 2,5-bis-
(glutathion-S-yl)-α-MeDA (Figure 1.3), which retain the ability to redox cycle (Miller et 
al. 1997). Injection of 2,5-bis-(glutathion-S-yl)-α-MeDA into the brain reproduces 
similar effects as MDA and MDMA, with respect to decreases in 5-HT in the brain 
(Miller et al. 1997). Inhibition of γ-GT by acivicin (AT-125), interestingly, increases the 
uptake of 5-(glutathion-S-yl)-α-MeDA into the brain (Bai et al. 1999), which is in 
contrast to findings in the kidney. This is probably due to the prevalence of intact GSH 
transporters in the brain, which readily transport the GSH-conjugates into the brain. 
Inhibition of γ-GT increases the pool of GSH conjugates, therefore potentiating MDA-
induced neurotoxicity (Bai et al. 2001). This observation is also confirmed in cell culture 
(Carvalho et al. 2002). 
The molecular mechanisms by which metabolites of MDA and MDMA induced 
neurotoxicity are being explored. 5-(Glutathion-S-yl)-α-MeDA, 2,5-bis-(glutathion-S-
yl)-α-MeDA, MDA, and MDMA all induce a concentration and time-dependent increase 
in ROS levels in both human serotonin transporter (hSERT) and human dopamine 
transporter (hDAT)-transfected cells, to a lesser extent with MDA and MDMA treated 
cells (Jones et al. 2004). Dopamine transport into the hSERT-transfected cells by the 
metabolites mentioned above also contributes to the metabolism-dependent neurotoxicity 
(Jones et al. 2004). Interestingly, many investigators consider MDMA-induced 
hyperthermia to be responsible for the enhancement of neurotoxicity, but recent findings 
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from our laboratory indicate that MDMA induced neurotoxicity can be dissociated from 
increases in body temperature (Jones, unpublished data). 
In summary, quinone-thioether-induced nephrotoxicity and other target organ 
toxicities share some common mechanisms of actions including metabolism, ROS 
generation, and dependence on certain molecular mechanisms, but they also exhibit 
differences. For example, TGHQ induces oncotic cell death in renal epithelial cells, 
whereas TGHQ induces apoptotic cell death in bone marrow cells. Inhibition of γ-GT 
attenuates quinone-thioether-induced nephrotoxicity but potentiates neurotoxicity. Other 
quinone-thioethers such as GSH conjugates of 17β-estradiol, tert-butyl-4-hydroxyanisole 
(BHA) and its metabolite tert-butylhydroquinone (TBHQ) are mild nephrotoxic and are 
associated with carcinogencitiy (Monks and Lau 1997).  
E. Nephrocarcinogenicity of Quinone-thioethers 
Hydroquinone is ubiquitously present in natural products and in the environment, 
but relatively little data is available on the carcinogenicity of hydroquinone. Because 
hydroquinone is present in cigarette at high concentrations (155 µg per cigarette), and 
smoking is associated with a higher incidence of renal tumors in men (Randerath and 
Randerath 1993; Tavani and La Vecchia 1997), the National Cancer Institute listed 
hydroquinone for future study on its ability to induce carcinogenicity. The mechanism by 
which cigarette smoke induces carcinogenicity is probably due to the high levels of 
oxidants and free radicals in smoke (Church and Pryor 1985).  
Hydroquinone is generally not considered mutagenic in short-term mutagenicity 
assays (Florin et al. 1980; Sakai et al. 1985), and not mutagenic in mouse cells in vivo 
(Gocke et al. 1983). However, hydroquinone causes base pair changes in the TA1535 
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Salmonella typhimurium test strain (Gocke et al. 1981), is mutagenic in TA104 and 
TA2637 Salmonella test strains (Hakura et al. 1996), and tested positive for mutagenicity 
in several Ames bacterial test strains (Hakura et al. 1995). Hydroquinone also induces 
sister chromatid exchange (Gocke et al. 1981; Kari et al. 1992; Tsutsui et al. 1997) 
catalyzes the formation of 8-oxo-dG (Leanderson and Tagesson 1990), and causes single-
strand DNA breaks in hepatocytes (Walles 1992). Hydroquinone also increases the 
number of tubular cell adenomas in Fischer-344 rats (Kari et al. 1992). Nephrotoxic 
doses of hydroquinone induce renal cell tumors in male rats (Kari et al. 1992; Shibata et 
al. 1991) and mice (Shibata et al. 1991). Hydroquinone not only acts as an initiator by 
causing DNA damage, it can also act as a tumor promoter, depending on the target organ 
and initiation protocol used (Yamaguchi et al. 1989). The mechanism of hydroquinone-
mediated carcinogenicity is not well characterized, and is the focus of studies in our 
laboratory and of others.  
The acute nephrotoxicity of hydroquinone is dependent on the activity of γ-GT, 
which metabolizes the various GSH-conjugated hydroquinones (Lau et al. 1988; Monks 
et al. 1985; Peters et al. 1997). TGHQ is one of these metabolites and is a potent 
nephrotoxicant (Lau et al. 1988; Peters et al. 1997). TGHQ also causes 
nephrocarcinogenicity in Eker rats (Lau et al. 2001a). Eker rats (Eker et al. 1981) are 
derived from the Long-Evans strain, and possess a germline insertion in the tuberous 
sclerosis-2 (Tsc-2) tumor suppressor gene, which predisposes these animals to the 
development of renal cell carcinoma (RCC) (Lau et al. 2001a; Walker et al. 1992; 
Walker 2002; Yoon et al. 2002; Yoon et al. 2001). The Tsc-2 gene has been primarily 
associated with the development of renal cell carcinoma (RCC) in rats, and with higher 
risk of development of renal tumors in humans (Walker 1998). In Eker rats, spontaneous 
preneoplastic lesions start to appear as early as 2-3 months, and nearly 100% of the rats 
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exhibit renal tumors by 1 year of age. Interestingly, these renal tumors arise from the 
proximal tubules (Everitt et al. 1992), which are the target area for TGHQ induced 
toxicity. Exposure to known renal carcinogens increases the incidence of renal tumors in 
Eker rats (Hino et al. 1993; Walker et al. 1992). Loss of the remaining normal allele of 
the Tsc-2 gene underlies the development of RCC in Eker rats (Lau et al. 2001a; Walker 
et al. 1992; Yeung et al. 1995). Therefore, Eker rats provide a good model with which to 
investigate chemical-induced nephrocarcinogenicity.  
Certain chemicals may induce carcinogenicity by first inducing toxicity, followed 
by excessive and sustained regeneration of cells, causing hyperlasia and finally tumor 
formation (Florin et al. 1980; Gocke et al. 1983; Sakai et al. 1985). Since TGHQ is both 
nephrotoxic and genotoxic (Habib et al. 2003; Jeong et al. 1999), and TGHQ induces a 
proliferative response after tissue damage (Peters et al. 1997), it is likely that TGHQ 
could be a carcinogenic chemical. Exposure of the supF gene to TGHQ followed by 
transfection and replication in either human AD293 or bacterial cells increased the 
mutation frequency (Jeong et al. 1999). TGHQ also causes the loss of heterozygosity of 
the Tsc-2 gene (Lau et al. 2001a). Therefore, TGHQ-induced cell proliferation likely 
magnifies the chemical-induced DNA damage and genetic alterations, providing the 
opportunity for tumor initiation and progression. TGHQ or hydroquinone induces an 
increase in the incidence of atypical tubules and atypical hyperplasias following 4-
months of treatment, and a significant increase in the number of carcinomas after 10 
months treatment (Lau et al. 2001b). TGHQ-mediated nephrocarcinogenicity is localized 
to the OSOM of the Eker rat kidneys, where the acute nephrotoxicity occurs. 
The Tsc-2 gene is a tumor suppressor gene that encodes for tuberin, a protein 
involved in limiting tumor development. Loss of the Tsc-2 tumor suppressor gene in 
TGHQ-induced tumors suggests that tuberin also plays a role in chemical-induced 
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nephrocarcinogenesis, but detailed mechanisms by which this gene regulates tumor 
formation are limited. TGHQ treatment significantly increases proliferation within the 
OSOM of Eker rats and the wild-type equivalents, yet only Eker rats develop renal 
tumors, indicating that proliferation is not sufficient for tumor development in rat kidney 
(Yoon et al. 2002). Tuberin expression is lost after long-term TGHQ treatment, and this 
correlates with an increase in ERK activity within the OSOM of Eker rats at 4 months, 
and in TGHQ-induced tumors (Yoon et al. 2002). Reintroduction of Tsc-2 gene in 
tuberin-negative renal cells (QT-RRE) attenuates ERK activity (Yoon et al. 2001). QT-
RRE cells are derived from quinol-thioether transformed primary renal epithelial cells 
from Eker rats (Yoon et al. 2001). In QT-RRE cells, tuberin loss is accompanied by an 
increase in growth signaling in tumors, such as ERK and B-Raf activity. Restoration of 
tuberin, achieved by transfecting Tsc-2 cDNA back into QT-RRE cells accordingly 
decreased ERK and B-Raf activities (Yoon et al. 2001; Yoon et al. 2004). Additionally, 
cDNA microarray analysis of QT-RRE cells and of tumor tissue of Eker rats treated with 
TGHQ revealed alterations in a total of 80 genes, with major functions in 1) signal 
transduction, 2) stress response, tissue remodeling, and DNA repair, and 3) electron 
transport and energy homeostasis (Patel et al. 2003). The annexin I and II proteins were 
further studied, and were found to be upregulated in tumor tissue and in QT-RRE cells, 
which likely play a role in TGHQ-induced nephrocarcinogenicity (Patel et al. 2003). 
Injection of the QT-RRE cells into nude mice generated tumors, providing further 
evidence that these cells are malignantly transformed (Patel et al. 2003). 
In conclusion, TGHQ, a metabolite of hydroquinone, induces both nephrotoxicity 
and nephrocarcinogenicity within the chemical-targeted OSOM region of the Eker rat 
kidney. Nephrotoxicity, with subsequent sustained compensatory proliferation likely 
leads to amplification of DNA damage and enhances genomic instability. For example, 
 22
loss of heterozygosity of the Tsc-2 gene by TGHQ treatment is associated with the 
generation of renal tumors. HQ is not identified in the common mutagenic tests. The 
“nongenotoxic” hydroquinone is therefore identified as a carcinogenetic chemical in 
tumor-susceptible animals following metabolism to cytotoxic and mutagenic metabolites. 
III. ROS AND CELL SIGNALING 
ROS play an essential role in quinone and quinone-thioether mediated renal cell 
death, as evidenced by the fact that catalase totally blockes ROS-induced MAPK 
activation, histone H3 phosphorylation, and renal cell death (unpublished data). 
Understanding ROS mediated signaling is a key to understanding the mechanism of 
quinone and quinone-thioether mediated ROS-dependent renal cell death. ROS comprise 
a variety of highly reactive metabolites of oxygen, including superoxide anions (O.-), 
hydrogen peroxide (H2O2), and hydroxyl radicals (HO.-) (Figure 1.2). ROS are produced 
both endogenously, as a consequence of normal cell function, or from external sources. 
Physiological or sub-physiological levels of ROS play a role in signal transduction as 
second messengers (Forman and Torres 2002; Martindale and Holbrook 2002; Meves et 
al. 2001; Rhee 1999; Torres and Forman 2003). In contrast, the excessive generation of 
ROS are otherwise linked to a number of human diseases, redox-chemical induced 
toxicities (Bolton et al. 2000), and aging (Martindale and Holbrook 2002), possibly by 
causing severe damages to DNA, protein, and lipid.  
In response to ROS-mediated cellular damage, cells possess a number of 
antioxidant defenses (e.g., GSH, SOD, catalase, peroxidases) to counteract ROS-
mediated adverse effects. However, once ROS generation exceeds cellular antioxidant 
capacity, cells become subject to oxidative stress-induced damage. Therefore, cell fate is 
determined by the ability of cells to prevent oxidative stress and to repair cellular 
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damage. These cellular responses to ROS consist of signaling pathways to enhance 
survival and pathways to induce cell death. Additional factors, for example, cell type 
(different pools of signaling expression), combinatorial and/or temporal activation of the 
signaling pathways (Schlessinger 2000) also determine the outcome following exposure 
to ROS. As such, although ROS, at both low and high concentrations, induce MAPK 
activation, ROS induce proliferation at low doses yet cell death at high doses (Martindale 
and Holbrook 2002). Many signaling pathways have been identified to be activated in 
response to ROS, with more and more being discovered. The mechanisms by which these 
pathways contribute to ROS-induced renal cell death are the main focus of the current 
studies. 
Renal proximal tubule epithelial cells are particularly sensitive to oxidative stress 
induced damage. The molecular mechanisms by which ROS cause injury in renal cells 
remain to be investigated. Studies on the initial molecular changes induced by ROS in 
renal cells will help to identify novel targets and therapeutic strategies. TGHQ, a quinol-
thioether metabolite of HQ, contributes to HQ-mediated nephrotoxicity and 
nephrocarcinogenicity (Lau et al. 1988; Lau et al. 2001a; Peters et al. 1997). TGHQ 
maintains the ability to redox-cycle and to generate ROS (Towndrow et al. 2000; Weber 
et al. 2001). Quinol-thioethers induce rapid ROS-dependent DNA damage, growth arrest, 
MAPK activation, histone H3 phosphorylation, and cell death in a well-established in 
vitro model of porcine renal proximal tubule epithelial cells (LLC-PK1) (Jeong et al. 
1997a; Jeong et al. 1997b; Jeong et al. 1996; Mertens et al. 1995; Ramachandiran et al. 
2002). TGHQ also induces ROS-dependent DNA damage (8-oxo-dG) in Eker rats (Habib 
et al. 2003). Subsequently, my research is designed to decipher the various signaling 
pathways that contribute to quinol-thioether-induced renal cell death/nephrotoxicity in 
response to oxidative stress. The findings discussed in the following chapters reveal some 
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of the mechanisms by which ROS induce nephrotoxicity, and provide insights for 
potential therapeutic intervention and prevention of HQ/ROS-mediated kidney disease. 
The following subsections will provide brief introductions on the concept of cell death, 
and cell signaling pathways that are likely involved in ROS-mediated cell death. 
A. Cell Death 
There are two recognized modes of cell death, oncosis and apoptosis (Majno and 
Joris 1995; Trump et al. 1997; Van Cruchten and Van Den Broeck 2002). Oncosis is a 
non-apoptotic cell death pathway, a passive cell death characterized by cell and organelle 
swelling, and loss of membrane integrity in response to various stresses. von 
Recklinghausen first introduced the term oncosis in 1910, derived from a Greek word 
meaning “swelling” (Van Cruchten and Van Den Broeck 2002). This term has 
subsequently been used by increased number of researches (Park et al. 2000; 
Ramachandiran et al. 2002; Tikoo et al. 2001). Oncosis was proposed to describe any 
type of cell death characterized by a marked cell swelling, whereas necrosis was 
proposed to describe post-mortal features (Majno and Joris 1995). Moreover, necrosis 
often occurs more frequently in the adult organism, and is the consequence of a large 
number of injured cells regardless of the pre-lethal changes (Majno and Joris 1995). Cell 
swelling during oncosis is due to damage to the cell membrane and loss of membrane 
integrity. Finally, cells burst and die, releasing a number of enzymes such as 
phospholipases, hydrolases, DNases, and RNases. These enzymes lead to the random 
degradation of protein, DNA and RNA. At the same time, inflammatory factors released 
after the cell membrane bursts cause injury to neighboring cells. Therefore, oncosis is 
usually observed as a zonal area of cell death. Traditionally, programmed cell death is 
used to describe apoptotic cell death, which encompasses active signaling pathways that 
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lead to cell death. However, necrotic/oncotic cell death is also involved in a number of 
signaling pathways, inhibition of which attenuates cell death (Ramachandiran et al. 
2002). Therefore, programmed cell death should not be used as synonyms for either 
apoptosis or oncosis. 
In contrast to oncotic cell death, apoptotic cell death is an active cell death 
pathway, characterized by cell shrinkage, cell membrane budding (while maintaining 
integrity), chromatin margination, and formation of apoptotic body (Trump et al. 1997). 
Various factors, including ROS, heat shock, protein synthesis inhibitors and DNA 
damaging agents can induce apoptosis. Apoptosis was first elaborated by Kerr in 1971 to 
describe a mode of hepatocyte death with morphological changes including decreased 
cell volume, ruffled cell membranes, condensed chromatin, and cell segregation with 
formation of intact vesicles. In early 1971, this mode of cell death was called shrinking 
necrosis, and was changed to apoptosis the next year, which in Greek refers to the falling 
of leaves. In the last stage of apoptotic cell death, apoptotic bodies maintaining an intact 
membrane and encapsulating fragmented DNA and intact organelles are formed. These 
apoptotic bodies are rapidly engulfed by phagocytes, without causing an inflammatory 
response and therefore does not adversely affect neighboring cells. However, not all 
apoptotic cells are recognized by phagocytes. Therefore, under certain conditions 
apoptotic cells can undergo secondary necrosis, or apoptotic necrosis (Majno and Joris 
1995). Cells undergoing secondary necrosis share several features with necrotic cell 
death, with the exception of an inflammatory response. Apoptosis also occurs in normal 
tissues, and is an important process to control tissue development, and to maintain the 
appropriate number of cells within normal tissues to ensure normal tissue function. In 
contrast, inhibition of apoptosis occurs in tumor tissue and autoimmune disease. DNA 
degradation into ~180 base pair fragments, catalyzed by specific cleavage of DNA 
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between nucleosomes, is one of the hallmark characteristics of apoptosis (Hendzel et al. 
1998). Another important feature of apoptosis is caspase activation (Bratton and Cohen 
2001; Shi 2004). Caspases are a family of proteins that are usually present in cells as 
inactive precursors, procaspases. Precaspases become activated by selective and specific 
proteoic splicing, initiating a caspase cascade. Caspases cleave a variety of structural 
proteins and activate caspase-activated DNase. Mechanisms for caspase activation 
include a receptor-ligand binding activation of caspase 8 (Ashkenazi and Dixit 1998; 
Curtin and Cotter 2003; Lee et al. 1997b), a mitochondrial mediated activation of caspase 
9 (Bratton and Cohen 2003; Gross et al. 1999), and an endoplasmic reticulum related 
activation of caspase 12 (Szegezdi et al. 2003). During the final stage of apoptosis 
caspase 3 is activated.  
TGHQ induces apoptosis in hematopoeic cells (Bratton et al. 2000), whereas the 
nature of cell death pathways in acute renal failure caused by ROS-generating chemicals 
such as TGHQ is unknown. Whether TGHQ induces oncotic or apoptotic renal cell death 
will be investigated in Chapter 3. 
B. EGFR 
The epidermal growth factor (EGF) receptor (EGFR) is activated by ROS in 
different cellular systems. The EGFR is one family of the growth factor receptor proteins 
(e.g., EGFR, insulin receptor [IR], platelet derived growth factor [PDGF] receptor). 
These receptors possess intrinsic tyrosine kinase activity, and are thus called receptor 
tyrosine kinases (RTKs). RTKs play an important role in a variety of cellular functions, 
including proliferation/differentiation, migration, metabolism, and survival. The EGFR 
family consists of four RTKs, EGFR, ErbB2, ErbB3, and ErbB4 (Schlessinger 2000). 
EGFR is a 170 kDa protein, and consists of several domains (Jorissen et al. 2003). The 
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N-terminal of the EGFR is the extracelluar portion (ectodomain) that contains the ligand 
binding domain (L1 & L2) rich of glycosylation (IgG like), and the cysteine-rich domain 
(CR1 & CR2). Juxtamembrane domains (JM) are located within the double layer 
membrane. The C-terminal domain (CT) of the EGFR contains tyrosine residues that are 
phosphorylated after ligand-receptor binding, and the tyrosine kinase domain. 
1. EGFR Activation and Regulation 
Upon ligand (EGF or TGF-α) binding, the EGFR ectodomain dimerizes to form a 
2:2 complex (Kim et al. 2002; Lemmon et al. 1997). Dimerization of the EGFR leads to 
an autophosphorylation of EGFR, and these phospho-tyrosine sites provide a platform for 
the binding of a variety of signaling proteins, either directly or indirectly (Schlessinger 
2000). EGFR phospho-tyrosine residues are recognized by proteins containing Src-
homolgy (SH2) and phosphotyrosine binding (PTB) domains, such as Grb2, Shc and 
PLC-γ (Schlessinger 2000). The activation of the Ras/MAPK pathway, for example, 
occurs through phospho-tyrosine (SH2)Grb2(SH3) Sos Ras Raf MEK ERK. 
Sos is a guanine nucleotide exchange factor, activating Ras via an exchange of GDP to 
GTP on Ras. The signaling proteins that bind EGFR are listed in Table 1.1, and they lead 
to the activation of different signaling pathways. Activation of EGFR is tightly regulated 
by compensatory inhibitory mechanisms. The most commonly observed mechanism of 
EGFR down-regulation involves the activation of protein kinase C (PKC), which 
subsequently induces phosphorylation of serine and threonine residues on EGFR, 
resulting in less tyrosine kinase activity and ligand binding to receptors (Cochet et al. 
1984). Another mechanism of EGFR down-regulation involves endocytosis and 
degradation of the receptors, mediated by the binding of Cbl to EGFR (Joazeiro et al. 
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1999). Finally, dephosphorylation of EGFR by phosphatases is another potential 
mechanism for EGFR deactivation. 
2. ROS and EGFR 
The EGFR is regulated by ROS, and EGFR itself also induces generation of ROS. 
There are several possible mechanisms by which ROS mediate EGFR activation. For 
instance, ROS may mimic EGF:EGFR interaction via modification of cysteine residues 
on EGFR (Chen et al. 1998). ROS may also inactivate phosphatases, thereby inhibiting 
dephosphorylation of the EGFR (Knebel et al. 1996). Finally, ROS inhibit the 
internalization and degradation of EGFR, thereby enhancing the activation of the EGFR 
(Ravid et al. 2002). On the other hand, EGF (500 ng/ml) also induces a transient increase 
in the intracellular levels of ROS in A431 human epidermoid carcinoma cells (Bae et al. 
1997). This phenomenon explains the stimulatory effects of H2O2 on glucose transport 
and lipid synthesis in adipocytes (Mukherjee et al. 1978). MAPK activation occurs via 
EGFR activation in many cell systems. Since TGHQ is redox-active, and causes ROS-
dependent MAPK activation, it is likely that quinol-thioether-mediated MAPK activation 
occurs through the activation of the EGFR. This hypothesis has been tested and is 
discussed in Chapter 3. 
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Table 1.1. List of potential binding proteins for EGFR. 





Src kinases SH2 pY845, 
pY1101 
ERK,  tyrosine kinase 
Shp SH2 PY1173 kinases protein tyrosine 
phosphatase 
PLCγ SH2 pY992, 
pY1173 
PKC calcium regulation, 
ERK activation 
Grb2 SH2, SH3 pY1068, 
pY1086  
Ras adaptor protein 
Nck SH2, SH3 N/A Ser/Thr kinases adaptor protein 
Crk SH2, SH3 N/A Ras adaptor protein 
Shc SH2, PTB pY1148, 
pY1173 
Ras adaptor protein 
Cbl PTB pY1045 Receptor 
tyrosine kinases
ubiquitin ligase for 
EGFR degradation 
Dok PTB pY1086 
pY1148 



































Figure 1.4. Potential phospho-EGFR tyrosine residues and the subsequent signaling 
cascades.  
EGFR tyrosine residues are labeled with different colors according to their binding 
partners: red, major phospho-tyrosine residues; pink, minor phospho-tyrosine residues; 
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C. MAPKs  
1. ROS and MAPKs 
Following EGFR activation, the MAPK pathways are activated. Many studies 
have shown that ROS lead to the activation of MAPKs (Guyton et al. 1996; 
Ramachandiran et al. 2002; Wang et al. 1998). Prevention of ROS accumulation by 
antioxidants blocks MAPK activation in various systems. The mechanisms by which 
exogenous or endogenous ROS activate the MAPKs are not well known, but several 
mechanisms have been proposed. ROS likely activate the ERK pathway through the 
activation of EGFR. Alternatively, Ras, an upstream activator of the ERKs could also be 
activated directly by oxidation of a cysteine residue that resides close to the guanine 
nucleotide binding site, leading to the subsequent activation of the ERK cascade (Lander 
et al. 1995). Activation of the p38 MAPK and JNK pathways is probably involved in 
ROS-dependent dissociation of the MKKKs from inactivating regulators (Fanger et al. 
1998; Saitoh et al. 1998). Ask1 is a MKKK for p38 MAPK and JNK, and is associated 
with reduced thioredoxin (Trx), which negatively regulates the activity of Ask1. ROS 
cause oxidation of Trx and subsequent dissociation from Ask1, leading to JNK activation 
(Saitoh et al. 1998). 14-3-3 is also found being associated with MKK1, 2, or 3 (Fanger et 
al. 1998). 
2. MAPK Cascades 
The MAPKs are a family of evolutionary conserved serine/threonine kinases that 
require phosphorylation of a tyrosine and threonine motif (TxY). This motif is localized 
in the activation loop and is phosphorylated by a cascade of upstream kinases (Cobb 
1999; Torres and Forman 2003). This cascade of kinases is called a MAPK module, and 
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includes MAPK kinase kinase (MKKK), MAPK kinase (MKK or MEK), and MAPK 
(See Figure 1.4). MAPKKKs activate MAPKKs, and MAPKKs subsequently activate 
MAPKs. Overlap between these cascades may occur, but the activation of MAPKs by 
MAPKKs has relatively higher fidelity. There are four main subfamilies of MAPKs, and 
they are ERK1/2 (TEY), JNKs (TPY), p38 MAPKs (TGY), and ERK5 (TEY), the last 
one also refered to as Big MAPK. Each subfamily also has different isoforms, such as 
ERK1/2, JNK1/2/3, and p38 MAPKα, β1, β2, δ, γ. There is preferential activation of 
different isoforms by upstream kinase, for example, MKK4 preferentially phosphorylates 
Y182 of JNK, while MKK7 only phosphorylates T180 of JNK (Wada et al. 2001); 
MKK6, but not MKK3 selectivity activates p38β2, and both MKK3 and MKK6 can 
activate p38α and p38γ (Enslen et al. 1998). 
3. ERKs 
MAPKs are one of the most important signaling pathways that are activated by 
mitogenic factors, UV irradiation, oxidative stress, and many others. The ERK cascade is 
traditionally regarded as mitogenic, and is associated with cell proliferation or 
differentiation. In contrast, the stress-activated protein kinases (SAPKs), including both 
JNK and p38 MAPK, are more related to various stresses, and may lead to cell death. 
Oxidative stress induces intensive activation of ERK1/2, likely via the activation of 
growth factor receptors, because interference with the activities of these receptors 
attenuates ERK activation in response to oxidative stress (Knebel et al. 1996; 
Sachsenmaier et al. 1994; Zanella et al. 1996; Zhougang and Schnellmann 2004). EGFR 
activation leads to ERK activation through several different signaling pathways. The 
most well known pathway involves the activation of ERK1/2 by MEK1/2, which is 
activated by MKKK1 (c-Raf), which is activated by Ras, a binding partner of EGFR 
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through adaptor proteins, such as Grb2 and Shc. Upon translocation into the nucleus, 
ERK1/2 activates Rsk2 (Frodin and Gammeltoft 1999), phospholipase A2, Msk1, and a 
number of transcription factors (Sos, Elk-1, Ets1, Myc, Sap1a, STAT). ERKs are also 
constantly overexpressed in many tumors, and are current targets for cancer treatment. 
For instance, PD184352, a pharmacological inhibitor with in vivo activity is currently 
being developed as an anti-cancer drug by Pfizer (Delaney et al. 2002). Recent research 
has revealed that the ERK cascade is also activated by a variety of stresses and is 
associated with cell death. Thus, (i) ERK1/2 inhibition by pharmacological inhibitors 
protects renal epithelial cells from ROS-induced cell death (Ramachandiran et al. 2002), 
(ii) ERK activation is coupled to vanadate-induced oncotic cell death of vascular smooth 
muscle cells (Daum et al. 1998); and ERK1/2 activation is coupled to H2O2-induced cell 
death of (iii) oligodendrocytes (Bhat and Zhang 1999); in (iv) T cells (van den Brink et 
al. 1999) (v) and in pleural mesothelial cells (Jimenez et al. 1997). 
4. p38 MAPKs 
The p38 MAPK pathway is activated by various environmental stresses, including 
heat, osmotic and oxidative stresses, ionizing radiation and ischemia-induced vasoactive 
stresses, and inflammatory factors (New and Han 1998). The p38 MAPK pathway, in 
most studies, is involved in apoptosis, cell motility, transcription and chromatin 
remodeling. Different p38 MAPK isoforms are activated preferentially by upstream 
kinases (Chan-Hui and Weaver 1998; Enslen et al. 1998). The α and β isoforms of p38 
MAPK are the major isoforms studied in cells, and are responsible for activation of 
MAPK activated protein kinase-2/3 (MAPKAPK-2/3, or MK-2/3) and heat shock protein 
25/27 (Hsp25/27). α, γ and δ isoforms of p38 MAPK activate ATF2. Moreover, p38 
isoforms have opposite effects on AP-1 dependent transcription through regulation of c-
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Jun (Pramanik et al. 2003). Inhibitors of the p38 MAPK belong to the category of 
pyridinyl imidazole derivatives, which bind and inhibit p38 MAPK activation. However, 
only p38 α and β isoforms are sensitive to these inhibitors, while the other two isoforms 
are insensitive to these inhibitors (Lee et al. 1999). 
The differential expression, activation, and substrate specificity of different p38 
MAPK isoforms likely result in their various functions in different tissues. For example, 
p38γ is primarily expressed in skeletal muscle, and p38δ is expressed in lung, kidney, 
endocrine organs, and small intestine (Hu et al. 1999). p38 MAPK activated transcription 
factors include ATF2, Stat1, Max, MEF-2, Elk-1, CHOP, and CREB. The roles of p38 
MAPK in apoptosis are controversial, with evidences supporting pro-apoptotic, anti-
apoptotic, and no functions of p38 MAPK in oxidative injury in different systems 
(Martindale and Holbrook 2002). To the best of our knowledge, the role of p38 MAPK in 
oncotic cell death has not been well defined, and is discussed in this dissertation. 
5. JNKs 
The JNK subfamily includes JNK1,2,3, with JNK3 selectively expressed in brain 
(Davis 2000). JNKs may be activated by heat shock, osmotic stress, pro-inflammatory 
factors, ischemia, and UV irradiation (Hoeflich et al. 1999; Irving and Bamford 2002; 
Pombo et al. 1994). JNK activation often leads to apoptosis, but under certain conditions, 
it also promotes cell survival (Irving and Bamford 2002), and is involved in 
tumorogenesis and inflammation. JNKs are activated by MKK4/7, which may be 
activated by MKKK1 to 4, ASK1, or MLKs. The transcription factors activated by JNKs 
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6. Nuclear Translocation of MAPKs and Downstream Effectors 
Upon activation, MAPKs translocate from cytoplasm into nucleus to act on 
downstream transcription factors. As evidence, ERK2 is phosphorylated and is actively 
imported into the nucleus in a dimeric form, or by diffusion (Adachi et al. 1999, 2000; 
Fukuda et al. 1997). ERK2 is dephosphorylated and binds to MEK1 in the nucleus to exit 
the nucleus, because MEK1 possesses a nuclear export sequence and can facilitate a 
CRM1-dependent ERK2 export from the nucleus. Leptomysin B, an inhibitor of nuclear 
export, blocks the nuclear export of ERK2 (Adachi et al. 1999, 2000; Fukuda et al. 
1997). The transcriptional factors targeted by MAPKs include AP-1, CREB, ATF-2, c-
Jun, Elk1, Sos, Ets1, Sap1a, c-Myc, STAT. For example, ERKs translocate into the 
nucleus and phosphorylate/activate Elk-1. Elk1 then binds to the serum response element 
(SRE) in the promoter element of c-fos gene, activating transcription. AP-1 is a homo- or 
hetero-dimer of Jun/Fos and ATF families of transcription factors. AP-1 activation 
increases the transcription of the c-jun and c-fos genes. The induction of a particular gene 
is complicated, and usually requires more than one transcription factor, and is most likely 
involves multiple MAPK signaling pathways. In addition to transcription factors, MAPKs 
also activate kinases such as MAPKAPK1 (Rsk1) (Tan et al. 1996), MAPKAPK2/3 
(MK-2/3) (Freshney et al. 1994; McLaughlin et al. 1996), MAPK-interacting kinases 
(Mnk1/2), and mitogen- and stress-activated protein kinase (Msk) (Deak et al. 1998). 
Except for Msk1, which is localized within the nucleus, all the above kinases are 
localized in the cytoplasm, and translocate into the nucleus upon activation. 
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7. Specificity and Regulation of MAPK Activation 
The fidelity and specificity of MAPK activation is controlled by scaffold proteins 
which prevent cross-talk between pathways (Morrison and Davis 2003; Yoshioka 2004). 
Ste5p is a MAPK scaffold protein in yeast, but no mammalian counterpart of Ste5p has 
been found. Several other scaffold proteins in mammalian cells have been found to act as 
a MAPK scaffold, such as MP1, the beta-arrestins, and the JNK-inhibitory proteins (JIPs) 
(Perry and Lefkowitz 2002; Schaeffer et al. 1998; Yasuda et al. 1999). Similar to the 
regulation of EGFR activation, the duration and intensity of MAPK activation is tightly 
controlled by both positive and negative regulators, such as kinases and phosphatases. 
The serine/threonine phosphatase PP2a and tyrosine phosphatases can 
dephosphorylate/inactivate MAPKs. Another family of dual specificity phosphatases 
called MAPK phosphatases (MKP) can also inactivate MAPKs (Camps et al. 2000).  
Previous studies in our laboratory have revealed that ERK1/2, p38 MAPK and 
JNK1/2 are all activated by TGHQ treatment, and are all ROS-dependent in renal 
proximal tubule epithelial cells (Ramachandiran et al. 2002). Inhibition of both ERK and 
the p38 MAPK pathway, but not the JNK pathway, attenuates TGHQ-induced cell death. 
Therefore, MAPKs are important in TGHQ-mediated cytotoxicity. A goal of my studies 
was therefore to determine exactly how MAPKs are activated by TGHQ, and their roles 
in TGHQ-induced renal cell death. One role of MAPKs is probably to phosphorylate 
histone H3 via the activation of histone kinases, which could lead to cell death. This 
hypothesis has proposed as part of this dissertation. 
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D. Histone H3 Phosphorylation and Cell Death 
The eukaryotic genome has enormous length, and therefore requires packaging 
into a stable structure to prevent damage. During mitosis, correct modification of this 
higher-order structure allows selective access to genetic information. This higher-order 
structure is called chromatin, and contains the entire genome and associated proteins. 
Chromatin is comprised of nucleosomes, which consist of 146 base pairs of DNA 
wrapped in 1.75 turns around core histones, an octamer formed from two copies each of 
histone H2A, H2B, H3, and H4, and a linker histone H1. Histones are small basic 
proteins with a relatively high proportion of lysine and arginine residues, positively 
charged amino acids. These positive charges assisting in histone binding tightly to 
negatively charged DNA. At the same time, the location of the N-terminal tails of 
histones outside of the nucleosomal structure permits their covalent post-translational 
modification, including phosphorylation, acetylation, methylation, ubiquination, and 
ADP-ribosylation (Honda et al. 1975; Jump et al. 1979; Levinger and Varshavsky 1982; 
Mahadevan et al. 1991; Paulson and Taylor 1982; Rea et al. 2000), all of which may lead 
to chromatin remodeling. The combinatorial pattern of histone N-terminal modifications 
results in a unique identity for each nucleosome that the cell recognizes as a readable 
code (Nowak and Corces 2004), called the “histone code hypothesis” (Strahl and Allis 
2000). Acetylation and methylation of different lysine and arginine residues in histone 
H3 and H4 are linked to either transcriptional active or repressive states of gene 
expression (Fischle et al. 2003). In contrast, histone H3 phosphorylation is linked to 
chromosome condensation during mitosis and meiosis, or it can act as a transcriptional 
activator (Nowak and Corces 2004; Sassone-Corsi et al. 1999; Thomson et al. 1999; Wei 
et al. 1998). Two phosphorylation residues, S10 and S28 are present in the N-terminus of 
histone H3. The T11 residue of histone H3 may also be phosphorylated during mitosis 
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(Preuss et al. 2003). S10 phosphorylation of histone H3 is associated with chromosome 
condensation and mitosis (Strahl and Allis 2000; Wei et al. 1998). Histone H3 
phosphorylation at Ser10 is also associated with transcriptional activation of c-fos and c-
jun (Sassone-Corsi et al. 1999; Thomson et al. 1999). Various stimuli, including growth 
factor, okadaic acid, and stresses, may lead to histone H3 phosphorylation, but likely via 
the activation of different signaling pathways. Phosphorylation of H3 at S10 is also 
linked to acetylation of histone at lysine 14 (Lo et al. 2000). The S28 residue of histone 
H3 is phosphorylated at an early stage of mitosis, and is associated with mitotic 
chromosome condensation (Goto et al. 1999). 
TGHQ induces oncotic cell death in LLC-PK1 cells, yet the signal transduction 
pathways involved in this process remain unclear. After TGHQ treatment, there is a rapid 
and intensive time-dependent histone H3 phosphorylation, along with chromatin 
condensation, observed morphologicaly (Tikoo et al. 2001). For dividing cells, the timing 
of the initiation of DNA replication (S-phase entry) is rigidly controlled by multiple 
mechanisms, to prevent excessive DNA replications, as well as to prevent the initiation of 
mitosis before DNA replication is complete. Entry into mitosis before cells have the 
correct number of copies of DNA is called “mitotic catastrophe”, and occurs in yeast 
(Novak and Tyson 1997). Studies have cited this term to describe similar observations of 
morphological and molecular changes in mammalian systems (Castedo et al. 2004; Tikoo 
et al. 2001). Thus, TGHQ generated ROS induce DNA damage and consequent stress 
signaling pathway activation, whereas histone H3 phosphorylation drives cells into 
premature chromatin condensation (PCC) and subsequent mitotic catastrophe. The 
mechanisms coupling TGHQ-generated ROS with histone H3 phosphorylation are 
unclear. Because some phosphatase inhibitors are also able to induce PCC (Coco-Martin 
and Begg 1997), protein kinases therefore likely play an important role in this process. 
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Several kinases have been implicated as potential histone H3 kinases. Msk1 has been 
described as a potential histone H3 kinase (Thomson et al. 1999), and Rsk-2 is another 
potential histone H3 kinase, which is reported to be responsible for EGF induced 
phosphorylation of H3 (Sassone-Corsi et al. 1999). In addition, Msk1 is activated by both 
ERK and p38 MAPK (Deak et al. 1998), and Rsk2 is activated by ERK. Because 
phosphorylation of histone H3 at Ser10 and Ser28 is linked to chromatin condensation 
and early gene expression (c-fos, c-jun), and inhibition of the MAPK pathways lead to 
attenuation of inducible histone H3 phosphorylation (Tikoo et al. 2001; Zhong et al. 
2001; Zhong et al. 2000), histone H3 phosphorylation is linked to MAPK activation. 
Poly(ADP-ribose)polymerase (PARP) can also cause post-translational modification of 
histone H3 to remodel chromatin structures (D'Amours et al. 1999). PARP is involved in 
histone shuttling and nucleosomal unfolding (Realini and Althaus 1992), and possibly 
contributes to histone H3 phosphorylation. Inhibitors of PARP protect against hydrogen 
peroxide-induced cell death (Chatterjee et al. 1999), or shift the mode of cell death from 
oncotic to apoptotic cell death in oxidant exposed endothelial cells (Walisser and Thies 
1999). Interestingly, TGHQ-induced histone H3 phosphorylation is inhibited by the 
PARP inhibitor, 3-aminobenzamide (Tikoo et al. 2001). 
TGHQ-induced changes in chromatin structure are preceded by an increase in 
phosphorylation of histone H3 and a decrease in phosphorylation of histone H2A (Tikoo 
et al. 2001). Dephosphorylation of histone H2A is probably associated with the exit from 
the cell cycle or cell cycle arrest upon TGHQ treatment (Jeong et al. 1997b). TGHQ 
induces a rapid DNA damage and growth arrest in LLC-PK1 cells that is accompanied by 
the activation of the growth arrest and DNA damage-inducible gadd153 gene and down-
regulation of histone gene expression (Jeong et al. 1996; Monks and Lau 1998). 
Therefore, the dephosphorylation of histone H2A and phosphorylation of histone H3 may 
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disrupt the interaction between chromatin from the nuclear matrix, further contributing to 
chromatin condensation (Tikoo et al. 2001). TGHQ also induces an initial cell cycle 
arrest, followed by override of the cell cycle checkpoint, which indicates that cells enter 
mitosis in an “unprepared” state. Thus, ROS and DNA damage-inducible histone H3 
phosphorylation occurs within the content of an overall state of growth arrest and 
possibly contributes to ROS-induced renal cell death. 
E. Other ROS-regulated Signaling Pathways 
Since TGHQ can generate ROS both intracellularly and extracellularly, and 
TGHQ-induced cell death is ROS-dependent, oxidative stress induced responses must be 
important upon TGHQ treatment. We have found that EGFR, MAPKs, and histone H3 
are all regulated by ROS, and there remain some other pathways to be revealed that are 
targeted by ROS. A proteomics study has revealed novel TGHQ-induced changes in 
several proteins, including Hsp27 and peroxiredoxins (Prxs), both of which were found to 
be modified followed TGHQ treatment. These data will be discussed in Chapter 4. 
1. Heat Shock Protein 27 
Hsp27 belongs to the small heat shock protein family (sHsp), which is 
constitutively expressed in virtually all organisms and with a molecular weight ranging 
from 15-42 kDa (Ehrnsperger et al. 1998). sHsps can undergo oligomerization to form 
oligomeric complexes of up to 1 MDa. sHsps seem to play roles in different cellular 
processes, such as heat resistance (Knauf et al. 1994), RNA stabilization (Nover et al. 
1983), interaction with the cytoskeleton (Miron et al. 1991; Nicholl and Quinlan 1994), 
and apoptosis (Arrigo 1998; Mehlen et al. 1996b). sHsps also act as chaperones to 
prevent aggregation of unfolded proteins, by facilitating refolding of denatured or 
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malfolded proteins (Ehrnsperger et al. 1997; Horwitz 1992; Jakob et al. 1993; Lee et al. 
1997a; Merck et al. 1993). 
Both mouse Hsp25 and human Hsp27 are responsive to cellular stress. Heat shock 
increases both the expression and phosphorylation of Hsp27 and Hsp25, with 
phosphorylation more rapid (minutes) than induction of expression (hours) (Landry et al. 
1991). Since the kinetics of phosphorylation versus induction of expression are distinct, 
the acute effects mediated by ROS can be solely designated as post-translational. There 
are several residues in Hsp27 that can be phosphorylated, including S15, S78, and S82 
(Gaestel et al. 1991; Landry et al. 1992). Additionally, both S15 and S82 are evolutionary 
conserved phosphorylation residues, whereas S78 is not (Ehrnsperger et al. 1998). Stress-
induced phosphorylation of Hsp27 occurs subsequent to the activation of the p38 MAPK 
cascade, and MAPKAPK2/3 are direct upstream kinases for Hsp27 phosphorylation 
(Guay et al. 1997; Ludwig et al. 1996; Rouse et al. 1994; Stokoe et al. 1992). Hsp27 may 
also be phosphorylated by other classes of kinases, such as cGMP-dependent protein 
kinase, casein kinase, cAMP-dependent protein kinase, PKC, and Akt (Butt et al. 2001; 
Rane et al. 2003). Upregulation of Hsp27 within certain cells is capable of protecting 
cells from stress (Arrigo 1998; Baek et al. 2000; Landry et al. 1989; Lee et al. 2004; 
Mehlen et al. 1993; Park et al. 1998). Hsp25 overexpression also down-regulates ERK2 
expression, and the suppression of ERK2 is involved in cytoprotection against 
irradiation-induced damage (Cho et al. 2002). 
There are two types of modification for Hsp27, phosphorylation and S-thiolation 
(Summarized in Firgure 1.5). Phosphorylation of Hsp27 is known to lead to changes in 
the oligomeric organization of Hsp27, either resulting in smaller (Kato et al. 1994; 
Lavoie et al. 1995). Small oligomers and monomers are likely responsible for the 
stabilization of actin filaments (Benndorf et al. 1994; Lavoie et al. 1993a; Lavoie et al. 
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1993b). In contrast, large oligomers protect cells against various stresses (Ehrnsperger et 
al. 1997; Lee et al. 1997a; Mehlen et al. 1997; Preville et al. 1998). The influence of the 
changes in Hsp27 structures on its chaperoning activity has been characterized (Rogalla 
et al. 1999). Using mutants that mimic Hsp27 phosphorylation (S15D, S78+82D, and 
S15+78+82D), constitutive phosphorylation of Hsp27 at all three residues was found to 
decrease the chaperone function of Hsp27 (Rogalla et al. 1999). Unphosphorylated 
Hsp27 forms an oligomeric complex, whereas phosphorylated Hsp27 forms quaternary 
structures. The loss of the chaperone function of Hsp27 must be due to its altered 
oligomerization post phosphorylation. Interestingly, transfection of mutants (S15D or 
S78+82D) into L929 cells decreases TNF-α− and H2O2-induced cell death, but 
transfection of mutant (S15+78+82D) cannot decrease stress-induced cell death (Rogalla 
et al. 1999). This indicates that partial blocking of Hsp27 phosphorylation does not 
decrease the chaperoning function of Hsp27, and therefore the mutant transfections grant 
the cells an overall increase in large Hsp27 oligomers, with subsequent cytoprotective 
effects. These data suggest that a higher degree of oligomerization of Hsp27 is necessary 
for its full protective effects (chaperone functions), which is abolished when the three 
serine residues are all phosphorylated. Furthermore, phosphorylation of S82 of Hsp27 is 
located at the beginning of the second β-strand (β2) of Hsp27, which might influence the 
interaction between β2 and β6 of two different monomers, resulting in smaller oligomers.  
Besides phosphorylation, S-thiolation of Hsp27 also regulates its multimeric 
aggregate size, independently of phosphorylation (Eaton et al. 2002). During oxidative 
stress, a cysteine residue in rat cardiac Hsp27 is S-thiolated, and this modification, 
without phosphorylation, disaggregates multimeric Hsp27. These two independent 
mechanisms (phosphorylation and S-thiolation) ensure dissociation of large oligomeric 
Hsp27 into small oligomers or monomers, indicating that this process is necessary during 
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cellular stress. Therefore, Hsp27 may have multiple functions in different forms. Under 
non-stressful conditions, Hsp27 functions as a chaperone to assist in protein folding, 
whereas during stress, Hsp27 phosphorylation leads to breakdown of large Hsp27 
oligomers into small oligomers and monomers, which subsequently bind to the 
cytoskeleton (actin, desmin, or membrane proteins) (Barbato et al. 1996; Bennardini et 
al. 1992). 
Overexpression of nonphosphorylatable mutants of sHsps in attachment-
independent cells (Ehrlich ascites tumor cells and Raf transformed NIH 3T3 cell) confers 
stress-resistance, whereas in attachment-dependent cells (hamster fibroblast CCL39 cells) 
these mutants fail to confer stress-resistance (Lavoie et al. 1995). This is possibly due to 
the multiple functions of Hsp27 and post-translationaly modified Hsp27 in different cells, 
as discussed above. The observation that mutant Hsp27 (S15+78+82D) did not protect 
cells from the cytotoxic effects of H2O2, menadione, and TNF-α is in agreement with the 
finding that nonphosphorylatable mutants of Hsp25 (S15A, S86A) and Hsp27 
(S15+78+82A) form large oligomers and protect against oxidative stress in NIH 3T3-Ras 
and L929 cells (Mehlen et al. 1997; Preville et al. 1998). Therefore, the presence of large 
oligomers of Hsp27 and their chaperoning function may be important in protecting cells 
against ROS-induced cytotoxicity. These studies, while shedding light on the role of 
phosphorylated Hsp27 in stress-induced cell death, also serve to highlight the complexity 
within the Hsp27 stress response. Moreover, Hsp27 is associated with Akt (Konishi et al. 
1997; Rane et al. 2003), and controls apoptosis by regulating Akt activation (Rane et al. 
2003). Phosphorylation of Hsp27 at S82 both in vitro and in intact cells dissociates 
Hsp27 from Akt. The association between Hsp27 and S82 is also needed for the activity 
of Akt in neutrophils (Rane et al. 2003), which could be due to loss of the chaperoning 
function of Hsp27 upon phosphorylation. Inactivated Akt, in sequestration with Hsp27, 
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enhances the constitutive neutrophil apoptosis, and this process is reversed by 
introduction of constitutively active Akt. These observations are supported by other 
studies that found that Hsp27 inhibits apoptosis through inactivation of caspase 3, 
caspase 9, and cytochrome C (Bruey et al. 2000; Garrido et al. 1999; Pandey et al. 2000; 
Paul et al. 2002). Whether unphosphorylated Hsp27 oligermers bind to other signaling 
factors, especially those contributing to ROS-induced damage, would be interesting to 
investigate. 
The ability of sHsps to protect against oxidative stress is also reported to be 
dependent on their abilities to increase intracellular concentration of GSH (Mehlen et al. 
1996a), and to maintain the reduced form of GSH during oxidative stress. The 
chaperoning function of Hsp27 is also likely involved in the regulation of intracellular 
GSH levels and initiating oxidative stress, thus contributing to its protective effects. In 
support of this view, mutant Hsp27 (S15+78+82D) overexpressed in NIH 3T3-Ras cells 
is not able to increase intracellular GSH levels (Gao and Lenard 1995). Exactly how the 
chaperoning function of sHsps protect cells against cellular stress is unknown. However, 
one model proposes that sHsps actually bind to unfolded proteins and facilitate their 
transfer to ATP-dependent chaperones, such as Hsp70, which subsequently refold the 
malfolded proteins (Ehrnsperger et al. 1997), or direct the bound proteins for 
ubiquination and degradation (Parcellier et al. 2003b). Phosphorylation of sHsps releases 
the unfolded proteins, which cannot then be transfered to Hsp70 to be refolded, or 
degraded. On the other hand, sHsps could translocate from the cytoplasm to nucleus 
under stress in different cellular systems (Arrigo et al. 1988; Preville et al. 1998; Rossi 
and Lindquist 1989). Phosphorylation of sHsps could facilitate this stress-dependent 
nuclear translocation, which is probably also associated with the chaperoning functions of 
sHsps in the nucleus, since overexpression of Hsp27 in cells increases their recovery 
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from nuclear protein aggregation (Kampinga et al. 1994). Thus, phosphorylation of 
Hsp27 induces a transition from large oligomers to the smaller tetrameric rod-like 
particles, which are more easily translocated into the nucleus. Phosphatases in the nucleus 
may dephosphorylate Hsp27 and stimulate the formation of large oligomers that possess 
chaperoning functions.  
Finally, sHsps also contribute to the stabilization of intracellular actin filaments 
and contribute to the regulation of the organization of the cytoskeleton (Lavoie et al. 
1993a; Lavoie et al. 1993b; Lavoie et al. 1995). In contrast to the chaperoning function of 
sHsps that requires large oligomers, the actin stabilizing function of sHsps requires small 
oligomers or monomers of Hsp27 (Benndorf et al. 1994). Hsp27 binding to actin and 
regulation of the polymer dynamics of the cytoskeleton may allow Hsp27 to intervene 
during stressful events, and to provide cytoprotection (Huot et al. 1996; Landry and Huot 
1995; Wang and Spector 1996). Nevertheless, Hsp27 phosphorylation also leads to F-
actin polymerization, which is associated with misassembly of focal adhesions that is 
responsible for the induction of membrane blebbing mediated by various stressful agents 
(Huot et al. 1998). The appropriate timing and location of Hsp27 phosphorylation 
possibly determines whether Hsp27 is cytoprotective or deterious. In conclusion, many 
factors determine the roles of Hsp27 and its modification, including different cellular 
systems, stimuli, modifications of Hsp27, cellular locations, and timing, which in 














Figure 1.6 Roles for Hsp27 and the consequences of post-translational modifications 
(phosphorylation or S-thiolation). 
Stress such as ROS and heat shock induce the activation of the p38 MAPK cascade, 
leading to Hsp27 phosphorylation (S15, S78, S82). Unphosphorylated Hsp27 (large 
oligomers) is associated with its chaperoning function and maintainence of intracellular 
GSH concentration in response to stress. In contrast, phosphorylated Hsp27 (small 
oligomers/monomers) assist in stabilizing the actin cytoskeletal network. S-thiolation on 
the Hsp27 cysteine residue (Cys141) by ROS also induces a break down of large 
oligomers into smaller oligomers and monomers, which have a similar function as 
phosphorylated Hsp27. 
[Large oligomers]









































As discussed above, ROS possibly function as second messenger molecules, 
generated through a receptor-dependent pathway (Bae et al. 1997; Sundaresan et al. 
1995; Ushio-Fukai et al. 1999). But ROS are too simple structurally to be specifically 
recognized by other signaling factors/proteins. Therefore, ROS possibly function as 
second messenger by oxidizing other proteins on their cysteine residues. Only certain 
proteins possess cysteine residues that are susceptible to H2O2 (Kim et al. 2000). Thus, 
cysteine residues form cysteine thiolate anion (Cys-S-) when nearby positively charged 
amino acid residues are available for interaction with the negatively charged thiolate 
anion group (Kim et al. 2000). Proteins with these low pKa cysteine residues are readily 
oxidized by H2O2, and the reaction is reversible by thiol donors such as GSH and Trx. 
Examples of such proteins include protein tyrosine phosphatase (PTP), and 
peroxiredoxins (Prx). In this session we will focus on discussing Prxs. 
There are several enzymes which can eliminate intracellular ROS, such as SOD, 
catalase, glutathione peroxidase, and Prx. Prx is a family of peroxidases that use Trx to 
reduce H2O2 and alkylhydroperoxidates (Chae et al. 1994b; Rhee et al. 2001). Prx have 
received considerable attention in recent years as a new family of thiol-specific 
antioxidant proteins. Prxs are ubiquitously expressed in a wide range of organisms, and 
are abundantly expressed in cells. The peroxidase function of Prxs actually overlap with 
glutathione peroxidases and catalase, but exhibit moderate catalytic efficiencies when 
compared to these other two enzymes. Therefore, the peroxidase function of Prxs is 
questionable. Nonetheless, the high abundance of Prxs in cells makes their presence as a 
peroxidase important. Recently, a range of other roles have been described for Prx family 
 49
members, including the modulation of cytokine-induced H2O2 levels, and interacting with 
MAPKs (Butterfield et al. 1999; Rogalla et al. 1999).  
There are six known mammalian Prxs, with Prx1-4 having two conserved cysteine 
residues (2-Cys Prxs), and Prx6 having only one conserved cysteine residue involved in 
their peroxidase activity (1-Cys Prx) (Kang et al. 1998b; Kim et al. 1988; Lim et al. 
1994). Prx5 also possesses two cysteine residues, yet the cysteine residue in the N-
terminus is not conserved. All Prxs contain a reactive cysteine in a conserved region near 
the N-terminus, and this catalytic residue forms cysteine-sulfenic acid as a reaction 
intermediate during the reduction of peroxide (Claiborne et al. 2001). Prx1-4 contain an 
additional cysteine residue at a conserved position near the C-terminus, while Prx5 
contains an additional cysteine residue in the less conserved C-terminus, and Prx6 
contains only one cysteine residue. The cysteine residue in the N-terminus of Prx1-4 is 
separated from the cysteine residue in the C-terminus by 120-123 amino acids, and the 
sequences surrounding each of these cysteine residues are also highly conserved. Prxs 
exist as homodimers, with the two monomers arranged in a head-to-tail manner (Chae et 
al. 1994c; Choi et al. 1998; Hirotsu et al. 1999). The subcellular localization of the Prxs 
basically covers all the locations ROS are produced, and Prxs are able to translocate in 
response to stimuli, as demonstrated for Trx (Nakamura et al. 1997). For instance, Prx1 
and 2 exist in cytosol, Prx3 exists in mitochondria, Prx4 is a secreted protein, Prx6 is 
present in the plasma membrane, and Prx5 is found in mitochondria, peroxisomes, and 
cytosol (Fujii and Ikeda 2002).  
The catalytic mechanism of Prxs has been established (Rhee et al. 2003) (Figure 
1.7). The N-terminal cysteine residue is oxidized by ROS to cysteine sulfenic acid (Cys-
SOH), which is not stable. The Cys-SOH then reacts with the C-terminal cysteine residue 
of the second subunit of the homodimer to form an intermolecular disulfide. The disulfide 
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is then reduced by Trx (Chae et al. 1994a). Because the formation of the disulfide is a 
slow process, the sulfenic intermediate is occasionally hyperoxidized into sulfinic acid 
(Cys-SO2H) and sulfonic acid (Cys-SO3H), which results in loss of Prx function (Chae et 
al. 1994a; Rabilloud et al. 2002; Yang et al. 2002) (Figure 1.7). Proteins that contain 
hyperoxidized cysteine residues are identified in 2-dimensional polyacrylamide gels as 
the satellite spots with more acidic pIs corresponding to the unoxidized form of the 
protein (Rabilloud et al. 2002). Thus, after ROS treatment (tert-butyl hydroperoxide 
[BHP], or glucose oxidase), a satellite spot with a more acidic pI was found in addition to 
the spot with more basic pI, both identified as Prx2 or Prx3 (Rabilloud et al. 2002). LC-
MS/MS confirmed the modification of Prx2 as oxidation, and this oxidation was reversed 
in an ROS-free medium (Rabilloud et al. 2002). The reversible oxidation is also 
confirmed by immunoblots using specific antibodies to the sulfonylated Prx peptides 
(Woo et al. 2003b). The sensitivity of 2-Cys Prxs to inactivation by hyperoxidation is not 
a limitation of the Prxs catalytic mechanism, but rather an evolutionary selection for 
eukaryotes (Wood et al. 2003). Interestingly, Prx1 and 2 may also be phosphorylated 
specifically at the T90 residue by several Cdks, including Cdc2 kinase (Chang et al. 
2002), and this phosphorylation causes a decrease in Prx activity. Cdc2 kinase is 
inactivated by low dose of TGHQ treatment (100 µM), but this inhibitory effect is 
overriden at high doses of TGHQ treatment (200-400 µM) (Ramachandiran, unpublished 
data). Cdc2 activation is linked to cell cycle progress into mitosis, and is closely related 
to chromatin remodeling and condensation. Therefore, ROS generation by TGHQ likely 
regulate Prxs through both direct oxidation and indirect phosphorylation by the activation 
of Cdc2 kinase. 
Other functions of Prxs in addition to its peroxidase activity have recently been 
discovered. For example, overexpression of Prxs in a variety of cells reduces intracellular 
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levels of ROS, and blocks apoptosis, indicating Prxs serve as anti-oxidants and as a 
signaling molecule (Jin et al. 1997; Kang et al. 1998a; Kang et al. 1998b; Nonn et al. 
2003; Zhang et al. 1997). In vivo, 2-Cys Prxs are required for Myc-mediated 
transformation and apoptosis (Mu et al. 2002; Wonsey et al. 2002), and can regulate NF-
κB activation (Jin et al. 1997; Kang et al. 1998b). Because H2O2 a cellular damaging 
agent as well as a second messenger in signaling pathways, the question arises as to what 
precisely determines the cellular responses to ROS. We know that the amount of ROS 
determines responses, and Prxs can function as an intracellular switch for the 
consequences of ROS. Since Prxs are ubiquitously expressed in cells, and are reversibly 
oxidized by ROS, they are the ideal candidates as a molecular switch for the different 
effects of ROS. Prxs are present in the cells in large amounts, and ensure that ambient 
levels of peroxides are maintained at very low levels to ensure no inappropriate signaling 
is triggered by ROS. In contrast, a burst of exposure of cells to ROS inactivates Prxs 
rapidly, and these ROS could then act as second messengers by interacting with other 




















Figure 1.7 The peroxidase reaction of Prx and the oxidation of Prx. 
A. The reduction of peroxides by Prx. Prx is subsequently reduced by the Trx and Trx 
reductase system. B. Oxidation of Prx cysteine residues to sulfenic (SOH), sulfinic 
(SO2H), or sulfonic (SO3H) acids. Only the reduced form of Prx (SH) is active as a 
peroxidase. The cysteinyl sulfenic acid or disulfide is easily reduced by Trx, whereas 










































F. Inhibitors of Signaling Pathways 
Pharmacological inhibitors have been widely used in the studies on signal 
transductions. Most of the inhibitors are ATP-competitive, except PD98059, PD184352 
U0126, and Li+ (Cohen 1999). PD98059 binds to unphosphorylated rather than 
phosphorylated MKK1 (also called MEK1), and prevents its activation by upstream 
kinase MKKK1 (Alessi et al. 1995). At a concentration of 50 µM, PD98059 prevents 
activation of the classical MAPK cascade in cell-based assays but does not inhibit other 
kinases (Davies et al. 2000). PD98059 also prevent the activation of ERK5, another 
MAPK family member. The concentration needed to inhibit ERK5 activation was 
comparable to that to inhibit MEK1 (Davies et al. 2000). PD98059 is also known to 
inhibit cyclo-oxygenases 1 and 2, which are required for production of prostaglandins 
and leukotrienes (Borsch-Haubold et al. 1998). Another MEK1 inhibitor that functions 
similar to PD98059 is U0126, and it does not inhibit COX1&2 yet is more potent than 
PD98059 (Davies et al. 2000). PD184352 is another potent MEK1 inhibitor, and is 
applicable in vivo (Delaney et al. 2002). SB202190 and SB203580 are two pyridinyl 
imidazoles that inhibit the activity of p38 MAPK α and β isoforms, but not δ and γ 
isoforms (Davies et al. 2000). SB202190 has specificity similar to that of SB203580, 
which has high degree of specificity toward other protein kinases, including a number of 
closely related MAPK family members (Cuenda et al. 1995). However, Raf, PDK1 and 
LCK are inhibited by SB203580, but less potently than p38 MAPK (Davies et al. 2000). 
AG1478 (tyrphostin, 4-[3-chloroanilino]-6,7-dimethoxyquinazoline) is a potent ATP-
dependent inhibitor of EGFR (Levitzki and Gazit 1995). At a concentration of 0.25 mM, 
AG1478 blocks EGF-mediated cell cycle progression, proliferation and Src kinase 
activation (Levitzki and Gazit 1995). Pharmacological inhibitors are beneficial because 
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they can be used simply and rapidly for various researches, and they don’t cause artificial 
up- or down-regulation of signaling pathways by genetic manupulation of kinases. But 
there are concerns on the specificity of these inhibitors, which should be taken into 
consideration during experimental designs. 
IV. DISSERTATION AIMS 
Because of the ubiquity of quinones and quinone-derivatives and subsequent 
constant human exposure, we performed studies to elucidate the mechanisms by which 
quinones and quinone metabolites produce their adverse effects. GSH conjugation to 
hydroquinone accounts for hydroquinone’s nephrotoxicity and nephrocarcinogenicity. In 
particular, TGHQ is even more reactive than hydroquinone. The renal selectivity of 
polyphenolic GSH conjugates is due to the high activity of enzymes which further 
metabolize GSH-conjugates of quinones and which faciliate the uptake of the metabolites 
into target cells. Due to the abilities of quinol-thioethers to redox cycle and alkylate 
macromolecules, two coupled properties, these chemicals or their metabolites are 
extremely toxic to cells. It is most likely that the nephrotoxicity and/or 
nephrocarcinogenicity induced by GSH conjugates of quinones is due to their reactive 
biological properties. Thus, TGHQ is metabolized by γ-GT and dipeptidase to generate a 
cysteine conjugate of hydroquinone, which can be transported into cells by the L-amino 
acid transporter. TGHQ generates ROS both exogenously and endogenously, providing a 
good example to study the mechanisms of nephrotoxicity and nephrocarcinogenicity 
induced by similar chemicals. 
The molecular mechanisms of quinone-thioether induced acute nephrotoxicity and 
nephrocarcinogenicity are not clear. Although substantial studies have been performed to 
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understand ROS-mediated signaling pathways within cell systems and in animal models, 
relatively less is understood on the molecular mechanisms by which ROS-generating 
chemicals mediate acute toxicity and carcinogenicity. In this dissertation, I have 
endeavored to define the molecular mechanisms of TGHQ-mediated nephrotoxicity and 
nephrocarcinogenicity, by understanding ROS and alkylation mediated adverse effects in 
renal cells. There are two types of cell death, oncotic and apoptotic cell death. The first 
goal of my study was to define the type of renal cell death induced by TGHQ. Previous 
studies have found that TGHQ induces DNA damage, growth arrest, and rapid cell death 
in LLC-PK1 cells. TGHQ also induces DNA damage (8-oxo-dG), acute nephrotoxicity, 
and nephrocarcinogenicity in rats. Multiple signaling pathways are activated by TGHQ 
treatment, and MAPKs are all activated by TGHQ, rapidly and intensively in renal cells. 
Histone H3 is phosphorylated by TGHQ treatment, a response linked to ERK pathway 
activation. Histone H3 phosphorylation under oxidative stress likely causes premature 
chromatin condensation and mitotic catastrophe, leading to cell death. However, 
relatively less is known of how MAPKs are activated, and a systematic understanding of 
the signaling pathways activated in association with histone H3 phosphorylation is 
needed. The first Specific Aim of this dissertation is to find out how MAPKs are 
activated, and how MAPKs are linked to histone H3 phosphorylation and cell death. 
p38 MAPK is responsive to oxidative stress, and has differential functions in 
different cell systems. TGHQ induces a rapid activation of p38 MAPK, and the activation 
is linked to TGHQ-mediated renal cell death. However, what is the role or mechanism of 
action of p38 MAPK in TGHQ-induced renal cell death? One mechanism of p38 MAPK-
mediated renal cell death, as stated, is probably through the activation of histone 
kinase(s), which phosphorylate histone H3 to induce premature chromatin condensation 
and mitotic catastrophe. However, there are many substrates for p38 MAPK, some of 
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which are kinases, and some are transcription factors. But since TGHQ-mediated cell 
death is rapid (60% live cells following a 2 h treatment with 200 µM of TGHQ), the 
molecular changes must largely be due to post-translational modifications. In addtion to 
histone kinases, there could be other key kinases downstream of the p38 MAPK cascades 
that are activated and contribute to the determination of cell fate during oxidative stress. 
A proteomics study revealed changes in Hsp27, a downstream effector of p38 MAPK, 
after TGHQ treatment. Therefore, further investigations into the roles of p38 MAPK 
signaling pathways involved in TGHQ-mediated cell death are included in this 
dissertation. 
Oxidative stress tends to influence a combination of signaling pathways in 
different cells, a network of signaling pathways that is fairly complicated and which 
likely involves substantial cross-talk. For example, H2O2 can inhibit phosphatases, and 
therefore indirectly “activate” a number of kinases. ROS may also oxidize thiol-
containing molecules, such as GSH, Trxs, and Prxs, which are the first defense against 
oxidative stress. Extensive ROS generation causes depletion or loss of functions of these 
anti-oxidant proteins, which leads to the activation of a number of signaling pathways. In 
addition, alkylation of macromolecules by quinones or quinone-thioethers may also lead 
to signaling activation. Due to the complex nature of the oxidative-response system, and 
the development of new techniques for high throughput screening for cellular responses 
to stimuli, I intend to use these techniques to discover meaningful and novel targets 
during TGHQ-induced renal cell death. The results I acquire will persuit have a new and 
generic view of the most dramatic signaling changes induced by TGHQ. Subsequent 
studies to confirm these results, and analysis of the association of these signaling 
pathways compared to previous findings, may assist in providing a better understanding 
of the mechanisms of TGHQ-mediated renal cell death. 
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TGHQ induces renal tumor in Eker rats, likely acting as an initiator. Eker rats 
possess a germ-line insertion in one allele of the Tsc-2 gene, which predisposes these 
animals to the development of renal tumors. Repeated doses of TGHQ cause 
nephrotoxicity in the OSOM region of the kidneys, and subsequent excessive 
proliferation, which likely enhances the DNA damage caused by TGHQ treatment, 
leading to tumor formation. Loss of heterozygosity was found in TGHQ treated Eker rats, 
confirming that genetic instability is amplified by the compensatory proliferation of renal 
tubule cells after toxicity. Studies have linked tumor formation to loss of tuberin function 
following chronic administration of TGHQ. DNA damage was found following acute 
treatment of Eker rats with TGHQ, evidenced by the formation of 8-oxo-dG. TGHQ also 
upregulates Raf and ERK activities in TGHQ transformed QT-RRE cells. Because 
nephrotoxicity precedes nephrocarcinogenicity, and the toxicity-induced cellular 
responses contribute to the ultimate tumor formation, studies on the early molecular 
mechanisms of nephrotoxicity leading to nephrocarcinogenicity are important. Therefore, 
the last Specific Aim of this dissertation was designed to examine the early molecular 
changes that occur in TGHQ-treated Eker rats, focusing on the MAPKs and histone H3 
phosphorylation, targets identified by in vitro studies. These studies, hopefully, will shed 
light on the molecular mechanisms possibly involved in later nephrocarcinogenicity. 
In summary, this dissertation focuses on deciphering the signaling pathways 
involved in quinol-thioether-mediated renal cell death, and attempts to contribute to an 
understanding of the nephrotoxicity and nephrocarcinogenicity induced by ROS 
generating or alkylating chemicals. A significant number of chemicals are known to 
cause renal disease and toxicity, a majority of them being redox-active and generating 
ROS. Therefore, I hope that the studies and discussion in this dissertation will provide 
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important information on the mechanisms of ROS induced renal disease, and contribute 
to future therapeutic intervention and prevention of ROS-related renal disease. 
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Chapter 2: MATERIALS AND METHODS 
I. MATERIALS 
A. Chemicals and Reagents 
2,3,5-Tris-(glutathion-S-yl)hydroquinone (TGHQ) was freshly synthesized and 
purified according to established protocols (Lau et al. 1988), and used at >98% purity. 
PD98059, SB202190, SB203580, U0126 were purchased from CalBiochem (San Diego, 
CA). AG1478 was obtained from Biomol Biomolecules (Plymouth Meeting, PA). 
FuGENE 6 Reagent for transfection was purchased from Roche Molecular Biochemicals 
(Indianapolis, IN). Plasmid DNA purification kit was purchased from QIAGEN 
(Valencia, CA). Annexin V-PI apoptosis detection kit was purchased from Beckman 
Coulter, Inc. (Fullerton, CA). Antibiotics were all purchased from Invitrogen (Carlsbad, 
CA). Antibodies were purchased from either Cell Signaling Technology, Inc. (Beverly, 
MA), Upstate Biotech. Inc. (Lake Placid, NY), Santa Cruz Biotechnology (Santa Cruz, 
CA), Stressgen (Victoria, BC, Canada), or BioSource International, Inc. (Camarillo, CA). 
Prx3 antibody was generously provided by Dr. Garth Powis (University of Arizona 
Cancer Center, AZ). ABC immunostaining kits were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). All other chemicals were from Sigma (St. Louis, MO) 
or Fisher Scientific (Houston, TX), and of the highest grades available. 
 
B. Plasmids 
The plasmids pcDNA3 containing a cDNA of wild type p38 MAPK, or dominant 
negative mutant p38 MAPK were kindly provided by Dr. Roger Davis (University of 
Massachusetts, Worcester, MA). Plasmids pcDNA3.1 containing mutated Hsp27s that 
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mimics the phosphorylated Hsp27 (S15, S78, S82 mutated to D15, D78, D82), or 
unphosphorylated Hsp27 (S15, S78, S82 mutated to A15, A78, A82) were generously 
provided by Dr. Michael J. Welsh (University of Michigan, Ann Arbor, MI). Plasmids 
pcDNA3, pcDNA3.1 were both purchased from Invitrogen (Carlsbad, CA). 
II. METHODS 
A. TGHQ Purification 
TGHQ was freshly synthesized and purified according to established protocols 
(Lau et al. 1988). Briefly, 200 mM of GSH in 50 mL water was added drop wise to 1,4-
benzoquinone (200 mM in 50 mL water) with stirring. The mixture was stirred at room 
temperature for additional 30 min, and was extracted twice with 3 volumes of ethyl 
acetate (HPLC grade) to remove residual 1,4-benzoquinone and hydroquinone formed by 
reduction. The organics in the aqueous phase extract were removed with a roto-
evaporator. The extraction was then frozen on dry ice in acetone, and lyophilized. The 
resulting crystals were dissolved in 1% acetic acid, and injected onto a Beckman 
Ultrasphere ODS reverse phase column. Fractions of TGHQ were collected, pooled, 
frozen, and lyophilized. The purity of TGHQ was examined by HPLC, and had identical 
HPLC retention times and exhibited characteristic UV absorption spectra when compared 
to previously synthesized authentic standards. 
B. Cell Culture and Treatment Regimen 
LLC-PK1 cells (American Type Culture Collection, Rockville, MD), a renal 
proximal tubule epithelial cell line derived from the New Hampshire Mini-Pig, were 
maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal 
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bovine serum (FBS) at 37oC in a humidified incubator, with 5% carbon dioxide. Cells 
were plated in 24-well, 12-well, 6-well plates, or in 100 mm dishes, as needed, and grown 
to 70-80% confluence before treatment. Cells were then washed once, and treated with 
various agents in DMEM containing 25 mM HEPES. Cells were washed three times with 
DMEM containing 25 mM HEPES to terminate treatment, and subject to various 
analyses. 
C. Experimental Protocols 
1. Neutral Red Assay 
To determine the viability of LLC-PK1 cells after challenge with various agents, 
Neutral Red uptake was determined as previously described (Mertens et al. 1995). 
Briefly, cells were plated in 24-well plates at a density of 5 × 104 cells/well, and used 
upon reaching 70% confluence. Cells were washed once and treated with various agents 
in DMEM containing 25 mM HEPES. After treatment, cells were washed three times, 
and incubated with neutral red (0.25 mg/mL) dissolved in DMEM with HEPES at 37oC 
in the incubator for 1 h, followed by one wash in DMEM with HEPES, and then in 
washing/fixation solution (1% formaldehyde and 1% calcium in water). Neutral red was 
extracted by 1 ml extraction solvent (1% acetic acid in 50% ethanol), and was measured 
with a spectrophotometer at λ=540 nm. The absorbance of treated samples was compared 
to that of control samples, and expressed as % of control. 
2. Apoptosis by In Situ Terminal Deoxynucleotidyltransferase-Mediated Deoxy-UTP 
Nick End Labeling Assay (TUNEL)  
LLC-PK1 cells were plated on sterilized square cover slides in 6-well plates at a 
density of 3 × 105 cells/well and grown for 48 h to 60-70% confluency. The cells were 
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then washed once and incubated with TGHQ (200 µM) for 2 h or gliotoxin (100 ng/mL) 
for 30 min followed by TNF-α (30 ng/mL) for 2 h in DMEM with 25 mM HEPES (pH 
7.4). Apoptosis was detected using the ApopTag kit (Intergen, Purchase, NY). Cells were 
fixed in 10% neutral buffered formalin for 10 min at room temperature, and ethanol-
acetic acid (2:1) for 5 min at -20oC, and then incubated in 2% hydrogen peroxide for 5 
min followed by equilibration buffer for 2 min. The TdT enzyme solution (50 µL) was 
incubated with the cells at 37oC for 60 min in a humid environment, and then washed in 
stop-wash buffer at 37oC for 30 min, with gentle agitation. Cells were subsequently 
incubated with 50 µL anti-digoxigenin peroxidase enzyme at 37oC for 45 min followed 
by 50 µL of DAB solution for 10 min in dark. The cover slides were then counterstained 
in methyl green for 1-5 min and dehydrated in 100% butanol and Hemo-de fixative 
solutions. Finally the cover slides were mounted on rectangular slides for microscopic 
examination. Images were taken with a Kodak DC120 digital camera and processed with 
Adobe Photoshop 6.0 software. 
3. Apoptosis by Caspase 3 Activity Assay  
LLC-PK1 cells were plated in 6-well plates at a density of 3 × 105 cells/well and 
treated as described above. Apoptosis was assessed by measuring caspase 3 activity 
(Caspase 3 Activity Assay Kit, Roche Molecular Biochemicals, Indianapolis, IN). 
Briefly, cells were lysed in lysis buffer containing 10 mM dithiothreitol (DTT) on ice for 
30 min. Microtiter plates were coated with anti-caspase 3 coating buffer for 1 h at 37oC 
and blocked in blocking solution for 30 min at room temperature. After three washings of 
the plate with incubation buffer, the lysates were added to the plates and incubated at 
37oC for 1 h. Plates were then washed carefully and incubated with substrate solution 
containing 50 mM Ac-DEVD-AFC at 37oC for 2 h. Ac-DEVD-AFC is cleaved by 
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caspase 3 in the cell lysates, and the liberated fluorescent AFC was quantified with a Bio-
Tek FL600 microplate fluorescence reader and KC4 software (V2.5) (Bio-Tek 
Instruments, Inc., Winooski, Vermont) at 505 nm. 
4. Western Blot Analysis  
Cells were plated in 100 mm dishes at a density of 1 × 106 cells/dish, or 6-well 
plates at a density of 3 × 105 cells/well and grown for 36 h (70-80% confluent) before 
treatment. Cells were washed in ice cold PBS twice, and lysed with 1 × lysis buffer (Cell 
Signaling Technology, Inc., Beverly, MA.), containing 20 mM Tris-HCl (pH 7.5), 150 
mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 
mM β-glycerophosphate, 1 mM Na3VO4, 1 µg/mL leupeptin, and 1 mM PMSF. Cell 
lysates were centrifuged at 10000 × g for 10 min, and supernatants were stored at -80oC. 
Rat tissues (OSOM) were homogenized and lysed in RIPA buffer (1 × PBS, 1% Nonidet 
P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 1 cocktail protease inhibitors 
from Roche, 1 mM NaVO4, 10 mM β-glycerophosphate, 5 mM sodium pyrophosphate, 
50 mM NaF). Aliquots of 2-50 µg of lysates were separated by 7-15% SDS-PAGE, or 
PAGE without SDS (non-denaturing condition), and transferred to nitrocellulose 
membranes. The membranes were blocked in 5% non-fat dry milk (Bio-Rad, Hercules, 
CA) in tris-buffered saline (TBS) with 0.1% Tween-20 (TBST) for 1 h and then 
incubated with primary antibodies overnight at 4oC or for 1 h at room temperature in 
blocking solution. Secondary antibodies, goat anti-rabbit, goat anti-mouse, or bovine anti-
goat IgGs conjugated with HRP were diluted to 1:2000 in blocking solution (5% non-fat 
dry milk in TBS containing 0.1% Tween20), and incubated with the membranes for 1 h at 
room temperature. Blots were finally developed with the ECL (enhanced 
chemiluminescence), and exposed to Hyperfilm (Amersham Pharmacia Biotech, UK). 
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5. Immunoprecipitation   
Cells were plated in 100 mm dishes at a density of 1 × 106 cells/dish, and treated 
when reaching 70% confluence. Cells were washed in ice cold PBS twice, and lysed as 
described for the western blot analysis. Total cell lysate (200 µL) was precleared by 
incubation with 1 µg of normal IgG (same species as primary antibody) and 20 µL of 
protein A/G agarose (Santa Cruz Tech., Santa Cruz, CA) on ice for 30 min, followed by 
centrifugation at 1000 × g for 30 sec at 4oC. Primary antibody (1-10 µg) was added to the 
lysate, and incubated overnight at 4oC. Protein A/G agarose (20 µL) was added to the cell 
lysate and incubated at 4oC for 1 h with gentle rocking. The mixture was centrifuged at 
1000 × g for 30 sec at 4oC, and supernatant was discarded. The pellet was washed with 
RIPA buffer (Santa Cruz Tech., Santa Cruz, CA) for 4 times, with centrifugation after 
each wash. The pellet was resuspended in 20 µL of 2 × loading buffer (Bio-Rad 
Laboratories, Hercules, CA) containing 5% reducing agent (β-mercapturic acid) was 
boiled for 3 min. Samples were loaded onto SDS-PAGE, and subjected to Western blot 
analysis. 
6. Immunohistochemistry   
Paraffin sections (4 µm) were incubated at 65˚C overnight, and then 
deparaffinized and rehydrated in xylene, 100% ethanol and 95% ethanol separately. The 
sections were then incubated in 0.5% hydrogen peroxide for 10 min to quench 
endogenous peroxidase activity. The slides were then heated at 100°C for 10 min in 10 
mM sodium citrate buffer (pH 6.0) to unmask antigens. Subsequently, the slides were 
incubated with primary antibodies [phospho-p42/44 MAPK (polyclonal, 1:50), phospho-
p38 MAPK (monoclonal, 1:50), phospho-JNK/SAPK (polyclonal, 1:50), and phospho-
histone H3 (Ser10) (monoclonal, 1:50)] at 4°C overnight. The slides were then incubated 
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with secondary antibodies (goat anti-rabbit IgG, biotin-conjugated; or goat anti-mouse, 
biotin-conjugated) at room temperature for 30 min. An ABC staining kit was used to 
probe the proteins of interest. Briefly, the slides were incubated with AB enzyme 
reagents provided by the ABC staining kit for 30 min at room temperature, and then 
washed in PBS for 3 times at 5 min each, and then incubated with peroxide substrate 
solution (DAB, substrate, in substrate buffer) for 5 to 10 min. Finally, the slides were 
washed in double distilled water, counterstained with hematoxylin, and observed by light 
microscopy. Images were taken with a Kodak DC120 digital camera and processed with 
Adobe Photoshop 6.0 software. 
7. Immunocytochemistry   
LLC-PK1 cells were plated on sterile square cover slides in 6-well plates until 
reaching 70-80% confluency. Cells were then treated, rinsed in PBS twice, and fixed with 
100% methanol (–20oC) for 10 min. Cells were then washed three times for 5 min each 
with 1 mL TBS containing 0.1% Triton X-100 (TBS/Triton) and then rinsed with TBS at 
room temperature. Subsequently, cells were blocked with blocking solution containing 
5% goat serum and 1% BSA in TBS/Triton at room temperature for 1 h and washed for 5 
min with TBS. Subsequently, cells were incubated with primary antibodies in 3% BSA in 
TBS at room temperature, washed twice with TBS/Triton, and once with TBS, and then 
incubated with biotinylated secondary antibodies in 3% BSA in TBS at room temperature 
for 1 h. Cells on the cover slips were washed three times for 5 min each in TBS/Triton 
and once with TBS. Hydrogen peroxide (0.6%, room temperature, 10 min) was used to 
quench the endogenous peroxidases, and cells were washed for 5 min with TBS/Triton, 
once with TBS, and then incubated with ABC reagent for 1 h at room temperature. After 
two washes in TBS, cells were then incubated with 1 mL DAB reagent for 10 min at 
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room temperature, and then rinsed with DDI H2O. Cover slips were then counterstained 
in hematoxylin, washed, and mounted onto rectangle slides with VectaMount (Vector 
Laboratories, Burlingame, CA), and observed under light microscope. For IgG control 
slides, only secondary antibody was incubated with the cells in the absence of primary 
antibody. 
8. Transformation and Plasmid DNA Purification   
Plasmids (2 µg) were mixed and incubated with 50 µL of competent cells (DH5α, 
Invitrogen, Carlsbad, CA, or XL1-Blue, Stratagene, La Jolla, CA) on ice for 30 min, 
followed by being subject to heat shock in a 42oC water bath for 90 sec. The cells were 
then incubated in 1 mL LB medium with selective antibiotics for 45 min at room 
temperature with rocking. The above cells (50 µL) were subsequently spread onto LB-
Agar plates containing antibiotics, and incubated at 37oC for 18 h. Colonies were selected 
and dropped into 25 ml LB medium with antibiotics, and incubated at 37oC for 8 h with 
shaking (2500 rpm). The above cells (20 mL) were transferred to a 1 L LB medium with 
antibiotics, and incubated at 37oC for 18 h with shaking (2500 rpm). 
Plasmid DNAs were purified by MegaPrep plasmid DNA purification kits 
(Qiagen, Valencia, CA). Briefly, cells were centrifuged at 6000 × g for 10 min at 4oC, 
and resuspended in 50 mL of buffer P1 containing freshly added RNase. Buffer P2 (50 
mL) was added gently to the bottle, and mixed gently but thoroughly 4-6 times, and 
incubated for 5 min at room temperature. Pre-chilled buffer P3 (50 mL) was added and 
mixed gently by inverting 4-6 times, followed by incubation on ice for 30 min. The 
mixture was centrifuged at 20000 × g for 30 min at 4oC, and supernatant was transferred 
to another tube, and re-centrifuged at 20000 × g for 15 min at 4oC. Supernatant was 
transferred to a pre-equilibrated QIAGEN tip 2500 (by applying 35 mL buffer QBT). The 
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tip was washed with 200 mL of QC buffer. Plasmid DNA was eluted with 35 mL of QF 
buffer, and was precipitated in isopropanol, and centrifuged at 15000 × g for 30 min at 
4oC. The pellet was washed with 7 mL of 70% ethanol at room temperature, and re-
centrifuged at 15000 × g for 10 min at 4oC. Supernatant was removed, and the pellet was 
air dried for 10-20 min, followed by dissolvation in TE buffer (pH 8.0). DNA was 
quantified by spectrophotometry at λ=260 nm, and purity was assured by the ratio of 
A260/A280. 
9. Transfection   
LLC-PK1 cells were seeded in 6-well plates or 24-well plates, and grown for 16 h, 
followed by transient transfection with native p38 MAPK, dominant negative mutant p38 
MAPK expressing vector (pcDNA3-p38, pcDNA3-DNp38), and empty vectors 
(pcDNA3), using FuGENE 6 Reagent according to the manufacturer’s instructions. Cells 
were incubated with a mixture of DMEM medium, tranfection reagent, and vectors at 
37oC for 4 h, and then DMEM medium, containing 10% FBS, was added to each well, 
and incubated for 48 h before treatment. 
10. Metabolic Labeling of Cells and Histone Extraction for Phosphorylation Studies   
To determine the effects of TGHQ-induced oxidative stress on histone 
phosphorylation, LLC-PK1 cells were labeled with 40 µCi/mL of [32P]-orthophosphoric 
acid in DMEM with 25 mM HEPES for 4 h. Radioactivity was removed and cells were 
treated in DMEM containing 25 mM HEPES. Cells were washed in ice-cold low salt 
buffer (LSB; 10 mM Tris-HCl pH7.4, 10 mM NaCl, 2.5 mM EDTA) and then lysed in 
lysis buffer (LSB containing 0.25 mM sucrose, 1% Triton-X-100). Histones were 
extracted with 0.25 M HCl and precipitated in 20% trichloroacetic acid. The precipitate 
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was washed twice, once with 0.25 M HCl containing acetone and then with acetone only. 
Proteins were separated on a 13.5% SDS polyacrylamide gel by electrophoresis. After 
electrophoresis, the proteins were stained with Coomassie Blue, dried, and then exposed 
to Kodak XAR film. 
11. 2-Dimensional Gel Electrophoresis   
LLC-PK1 cells (1×106) were treated, washed in phosphate buffered saline (PBS), 
centrifuged, and resuspended in 100 µL of a modified RIPA buffer containing 50 mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.5% Triton X-
100, and 10 mM EDTA. The cells were subjected to freezing and thawing three times, 
followed by sonication (3 x 15s). Cell lysates were then centrifuged at 14,000×g for 15 
min at 4 °C. To remove DNA and RNA, proteins was treated with DNase and RNase, 
followed by overnight acetone precipitation at –20°C. The protein pellet (150 µg) was 
resuspended in 185 µL of rehydration buffer, and incubated at room temperature for 1 h 
for complete protein solubilization. The protein mixture was centrifuged at 15,000×g for 
30 min at ambient temperature, and the supernatant was loaded onto an 11 cm focusing 
tray. 2-D SDS-PAGE was performed using Bio-Rad PROTEAN IEF Cell (Hercules, 
CA). A pre-cast IPG dry strip (pH 3-10) was layered onto the protein mixture (150 
µg/sample) with the gel side down, and covered with mineral oil. After rehydration for 12 
h at 50 V, the focusing was carried out automatically with the following program: 250 V 
for 15 min, from 250 V to 5,000 V for 2.5 h, and a final focusing step at 8000 V for 
55000 VH. Focused IPG strips were equilibrated in 5 mL of equilibration solution (150 
mM Tris-HCl, pH 8.8, 6 M urea, 30% v/v glycerol, 2% SDS with 2.5% DTT added for 
the first 10 min and 2% iodoacetamide added for the last 10 min). SDS-PAGE was 
carried out using a pre-cast Criterion 8-16% gradient gel in Criterion Cell, at 20 V for 10 
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min and then at 200 V for 45 - 55 min. Gels were then fixed in 10% methanol-7% acetic 
acid for 40 min, stained with SYPRO Ruby protein stains (Bio-Rad) overnight, and then 
destained in 10% methanol-7% acetic acid for 1 h. Images of stained 2-D gels were taken 
on a Vistra FluorImager SI (Amersham Phamacia Biotech, Piscataway, NJ), and analyzed 
using PDQUEST software package (Bio-Rad). 
12. MALDI-TOF and PSD   
2-D images were visualized by at least 2 individuals. Spots were analyzed 
quantitatively using Kodak 1D Image Analysis Software as well as by PDQUEST 7.0 
software (Bio-Rad). Spots with altered densities were manually cut out of the gel, subject 
to in-gel tryptic digestion, and analyzed on a Voyager DePROTM MALDI-TOF MS 
system (Applied Biosystems, Foster City, CA). The samples were mixed with matrix at 
1:1 ratio on a 100-well steel MALDI target for analysis, with 1 mL total volume. The α-
cyano-4-hydroxy cinnamic acid matrix was prepared at 2 mg/mL in 50% ACN/0.3% 
trifluoroacetic acid solvent. Samples were analyzed in the positive ion mode with delayed 
extraction.  The co-crystallized target spot was ionized with a UV nitrogen laser (337 nm) 
at 20 Hz, accelerated at 20 kV and analyzed in the reflector mode.  Each sample mass 
spectrum is the average of 200 laser shots.  Instrumental parameters used were as 
follows: bin size – 0.5 nsec, delay time – 100 nsecs, mass range – 800-3200 Da, low mass 
gate 750 Da, grid – 78.4% of accelerating voltage, guide wire – 0.005% of accelerating 
voltage. Automated database search was performed on the Proteomic Solution 1 data 
station (Applied Biosystems, Foster City, CA).  Peptide mass lists were filtered to remove 
trypsin autolysis peaks. The mass list for each sample was entered in the search program, 
MS-Fit 3.3.1, in the Protein Prospector suite. The Swiss-PROT database was searched 
using a 15 ppm peptide mass tolerance for tryptic digest and a maximum of 3 missed 
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cleavages and carbamidomethylation of the cysteines. The search was performed for all 
species with unrestricted pI and molecular weight. The protein represented by the highest 
scoring match is reported and peptide sequences assigned according to the best match. 
Following the analysis of each sample by peptide mass mapping, one ion from each MS 
spectrum was subjected to Post Source Decay (PSD) analysis in order to further confirm 
the protein identification by peptide sequencing. The PSD spectra of each ion was 
acquired in automated mode and is a composite of several segments of spectrum each 
acquired at a different PSD mirror ratio (each mirror ratio focusing a certain m/z region). 
The mirror ratios ranged from 1.000 to 0.03 with the actual number of mirror ratios 
depending on the mass of the ion fragmented.   Each segment of the spectrum was the 
average of 250 laser shots. For MALDI-PSD spectra, the raw data was smoothed and the 
mass list exported to the MS-Tag peptide fragmentation database search engine in the 
Protein Prospector suite. Similar parameters were used vide infra, except that the parent 
ion mass tolerance was 20 ppm and the fragment ion tolerance was 800 ppm.  The protein 
identified in each case as the highest scoring match was identical to that identified in the 
peptide mass mapping analysis.  Since the two methods use different data sets and 
independent database searches, the resulting identification has a very high confidence 
level. 
13. Animal Treatment and Tissue Preparation  
Frozen kidney tissues derived from male Eker rats (Tsc-2EK/+) were from previous 
in vivo studies (Habib et al. 2003). Briefly, male Eker rats (Tsc-2EK/+) were obtained from 
the University of Texas MD Anderson Cancer Center, Smithville, TX. Animals were 
treated with a single dose of TGHQ (7.5 µmol/kg in PBS, pH 7.4 i.v.). Control animals 
were administered phosphate buffered saline (PBS) only. Animals were euthanized at 0, 
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0.5, 1, 2, 4, 8, 12, 24, 48 and 72 hours following TGHQ treatment. Kidneys were 
removed and dissected longitudinally. Half of the kidney was preserved in 10% formalin 
in PBS, 0.01 M, pH 7.4. The outer stripe of the outer medulla (OSOM) was excised from 
the remaining kidney sections and immediately snap frozen in liquid nitrogen. 
III. STATISTICAL ANALYSIS 
All data are expressed as mean ± standard deviation. Analysis of variance with a 
post-hoc Student Newman Kuel's test was used to compare the mean values, and p<0.05 




Chapter 3: EGFR-DEPENDENT ERK ACTIVATION AND EGFR-
INDEPENDENT P38 MAPK ACTIVATION CONTRIBUTE TO 
TGHQ-INDUCED ONCOTIC RENAL CELL DEATH 
I. INTRODUCTION AND RATIONALE 
Oxidative stress is known to activate mitogen activated protein kinases (MAPKs) 
(Cobb 1999; Martindale and Holbrook 2002). The MAPK family is comprised of three 
major subgroups, extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal 
kinases/stress-activated protein kinase (JNK/SAPK), and p38 MAPK (Cobb 1999). ERKs 
behave mainly as mitogen-activated proliferation/differentiation factors, whereas 
JNK/SAPK and p38 MAPK are mainly stress-activated proteins related to apoptotic cell 
death. The MAPKs are all rapidly activated by TGHQ in LLC-PK1 cells, and inhibition 
of ERK1/2 activation with PD98059 or inhibition of p38 MAPK activation with 
SB202190 attenuates cell death induced by TGHQ (Ramachandiran et al. 2002). In 
contrast, the JNK inhibitor SP600125 has no effect on TGHQ-induced cell death 
(Ramachandiran et al. 2002). Upon activation, following phosphorylation of tyrosine and 
threonine residues, MAPKs subsequently activate a variety of substrates, the majority of 
which are transcription factors. However, one indirect downstream target of the MAPKs 
is histone H3, which becomes phosphorylated following TGHQ-induced ERK activation 
(Tikoo et al. 2001). ERK1/2 activation may contribute to both cell proliferation and cell 
death in a variety of cells. In a few cases, activated ERK1/2 may act as a cell death-
inducing factor. Thus, ERK activation is related to vanadate-induced oncotic cell death of 
vascular smooth muscle cells (Daum et al. 1998), to H2O2-induced cell death of 
oligodendrocytes (Bhat and Zhang 1999), of T cells (van den Brink et al. 1999) and of 
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pleural mesothelial cells (Jimenez et al. 1997). Therefore, the inappropriate 
phosphorylation of histone H3 by ERK1/2 may lead to premature chromatin 
condensation (PCC) and cell death in LLC-PK1 cells (Tikoo et al. 2001). p38 MAPK and 
JNK1/2 are more responsive to cell stress than ERK1/2 including stress induced by 
inflammatory cytokines, heat shock, and ROS (Paul et al. 1997). Interestingly, in certain 
cell systems, p38 MAPK and JNK1/2 can be activated in an EGFR-dependent manner 
(Chen et al. 2001; Kanda et al. 2001).  
The events that couple ROS generation to MAPKs activation in TGHQ-treated 
LLC-PK1 cells are unknown. Oxidants can activate growth factor-linked signaling 
pathways (Meves et al. 2001), but the initial events of this activation are not clear. Two 
possible mechanisms may exist: (i) oxidants mimic epidermal growth factor (EGF)-EGF 
receptor (EGFR) interactions by modification of the cysteine residues on the receptors 
(Chen et al. 1998); or (ii) oxidants inactivate phosphatases, thereby inhibiting 
dephosphorylation of the EGFR (Knebel et al. 1996). The EGFR, platelet derived growth 
factor (PDGF) receptor, and T-cell receptor complexes are all activated following 
oxidative stress, and are coupled to the subsequent activation of ERKs (Guyton et al. 
1998; Meves et al. 2001; Sachsenmaier et al. 1994). Binding of EGF to the EGFR 
induces the dimerization, autophosphorylation and transactivation of the tyrosine kinase 
activity of EGFR, providing a variety of binding sites for a series of proteins, thereby 
initiating the activation of downstream signaling pathways. For example, phospho-
tyrosine 992 (pY992) within the EGFR provides a binding motif for phospholipase C-γ 
(PLC-γ), initiating downstream signaling, including protein kinase C (PKC) activation 
and subsequent ERK activation (Emlet et al. 1997). Phospho-tyrosine 1068 (pY1068) 
within the EGFR provides a binding motif for Grb2/SH2 domain binding, which also 
leads to ERK activation (Rojas et al. 1996). Phospho-tyrosine 1173 (pY1173) represents 
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a motif for PLC-γ and Shc, both of which can initiate activation of the ERK cascade 
(Sorkin et al. 1992). Interestingly, pY1068, pY1148, and pY1173 are essential for EGFR 
internalization and degradation, as well as for tyrosine kinase activity (Helin and 
Beguinot 1991). Additional phospho-tyrosine sites on the EGFR (pY845, pY1148, 
pY1086, pY1101) permit the differential activation of a number of other proteins in 
response to EGF stimulation (Biscardi et al. 1999; Bishayee et al. 1999; Levkowitz et al. 
1999; Sakaguchi et al. 1998; Sieg et al. 2000). Although all MAPKs appear to be EGFR-
dependent in different cellular systems (Chen et al. 2001; Kanda et al. 2001), whether 
TGHQ mediated MAPK activation occurs through EGFR activation, and which tyrosine 
phosphorylation site(s) are targeted by TGHQ remain unclear.  
Following TGHQ-induced MAPK activation, histone H3 is phosphorylated in 
LLC-PK1 cells (Tikoo et al. 2001). Because histone H3 phosphorylation is usually 
associated with mitosis, inappropriate histone H3 phosphorylation may provide a signal 
that conflicts with the cell cycle arrest induced by TGHQ (Jeong et al. 1997a), resulting 
in PCC and subsequent oncotic cell death. Both ERK1/2 and p38 MAPK have the 
potential to induce histone H3 phosphorylation by activating downstream histone kinases 
(Tikoo et al. 2001). Another downstream signaling factor of p38 MAPK is MAPKAP 
kinase-2 (MK-2), which can phosphorylate heat shock protein 27 (Hsp27). Hsp27 is a 
chaperone protein that regulates actin stabilization (Landry and Huot 1995) and apoptosis 
(Parcellier et al. 2003a). Both histone H3 and Hsp27 have the potential to remodel 
chromosome structure, and to possibly contribute to TGHQ-induced PCC and oncotic 
cell death. The present study was therefore designed to determine how MAPKs are 




A. TGHQ induced oncotic renal cell death 
TGHQ induces oncotic cell death of LLC-PK1 cells (Ramachandiran et al. 2002). 
We further determined whether TGHQ induces apoptosis in LLC-PK1 cells, as measured 
by caspase 3 activity and TUNEL assays (Figure 3.1). Cell death at different doses of 
TGHQ (50 µM to 400 µM) and at different exposure times (5 min to 24 h) to TGHQ, 
were examined, but no indication of apoptosis was ever found. The data shown in Figure 
3.1 indicate no apoptotic cell death in TGHQ (200 µM, 2h) treated and untreated LLC-
PK1 cells, whereas cells treated with TNF-α (30 ng/ml) for 2 h revealed significant 
amounts of apoptosis, as evidenced by both caspase 3 activation and DNA fragmentation 
(TUNEL staining). Apoptotic and oncotic cell death are distinguished by both 
morphological and biochemical changes. For example, apoptosis is characterized by cell 
shrinkage, formation of apoptotic body, DNA fragmentation, and activation of caspases, 
whereas oncotic cell death is usually accompanied by cell and organelle swelling, loss of 
membrane integrity, and diffuse chromatin condensation and margination. From 
microscopic observations, TGHQ-induced cell death of LLC-PK1 cells is manifest by 
chromatin condensation and cell swelling. The evidence for TGHQ-mediated oncotic cell 
death rather than apoptotic cell death is reinforced by biochemical assays, including 
assays for caspase 3 activity measurement, and DNA damage staining (TUNEL assay). 
The combined data reveal that TGHQ induces oncotic rather than apoptotic cell death in 
renal proximal tubule epithelial cells. 
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B. TGHQ but not EGF Induces Histone H3 Phosphorylation: 
TGHQ induces the rapid phosphorylation of both ERK1/2 (Figure 3.2) and 
histone H3 (Figure 3.3) in renal proximal tubule epithelial cells (LLC-PK1), in a ROS- 
dependent manner (Tikoo et al. 2001). EGF, a ligand for the EGFR, also induces the 
rapid phosphorylation of ERK1/2 in LLC-PK1 cells (Figure 3.2), but fails to induce 
histone H3 phosphorylation within 24 hours (Figure 3.3). H2O2 induces ERK1/2 
phosphorylation (Figure 3.2) and histone H3 phosphorylation (data not shown) in a 
manner similar to TGHQ, confirming the ROS-dependent manner of TGHQ-induced 
histone H3 phosphorylation. The data therefore imply that the consequences of ERK1/2 
activation in LLC-PK1 cells are different in TGHQ or EGF-treated cells, and that the 
activation of the ERK pathway alone is probably insufficient for histone H3 
phosphorylation and cell death. Differences in the kinetics of ERK1/2 activation may also 


















Figure 3.1. TGHQ does not induce apoptosis in LLC-PK1 cells.  
(A) Biochemical assessment of apoptosis was performed with a caspase 3 assay kit as 
described in methods. LLC-PK1 cells were treated with TGHQ (200 µM; hatched bar) 
for 2 h, or gliotoxin (100 ng/mL) for 0.5 h followed by TNF-α (30 ng/mL) for 2 h (black 
bar). Means of each sample were compared by T-test (n=3), and p<0.05 is considered 
statistically significant. (B) Histological assessment of apoptosis was monitored by the 
TUNEL assay as described in the Materials and Methods. Apoptotic cells stain dark 
brown, whereas normal cells counter stain with methyl green. Data shown here represent 











Figure 3.2. TGHQ, EGF and H2O2 all induce EGFR-dependent ERK1/2 phosphorylation, 
but with varying kinetics.  
LLC-PK1 cells were treated with TGHQ (200 µM), H2O2 (88.2 µM) or EGF (50 ng/mL) 
for different periods of time (0, 0.25. 0.5, 1, 2, 4 h). Some cells were pretreated with 
AG1478 (0.25 µM) for 1 h, followed by treatment with TGHQ (1 h), H2O2 (1 h), or EGF 
(15 min). DMSO treated samples represent the solvent control for AG1478. Catalase was 
used at a concentration of 10 U/mL in DDI H2O, and was co-administered with the 
various agents. Whole cell lysates were extracted and electrophoretically resolved on a 
10% SDS-PAGE gel, followed by Western blot analysis. A. EGF treated cells; B. TGHQ 
treated cells. C. H2O2 treated cells. Numbers shown represent hours of treatment. Total 
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AG+                                 EGF
Control  DMSO  +H2O2 H2O2 0.25   0.5          1        2     4


















Figure 3.3. TGHQ, but not EGF, induces histone H3 phosphorylation in renal epithelial 
cells.  
[32P]-Labeled LLC-PK1 cells were treated with TGHQ (400 µM) or EGF (50 ng/mL) for 
different periods of time (0, 2, 4, 6, 8, 12, 24 h). Histones were extracted and 
electrophoretically resolved on a 13.5% SDS polyacrylamide gel. A. Coomassie stained 
gel; B. Autoradiography. Numbers shown represent hours of treatment. 
A B
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C. EGFR Tyrosine Phosphorylation Induced by EGF, TGHQ, and H2O2: 
To determine whether the differences in the downstream consequences of ERK1/2 
activation arise as a consequence of the differential interaction between EGF or TGHQ 
and the EGFR, we compared the effects of EGF and TGHQ on the pattern of EGFR 
phosphorylation. Because TGHQ induces ERK1/2 activation in a ROS-dependent 
manner, the effects of H2O2 were also compared with TGHQ and EGF. The dose of H2O2 
(88.2 µM) was selected based upon the dose at which it induced the same level of loss in 
cell viability as TGHQ (200 µM) following 2 h of treatment (Figure 3.4). EGF (50 ng/ml) 
induced rapid ERK1/2 phosphorylation (Figure 3.2), without subsequent loss of cell 
viability (Figure 3.4). Time-response curves for TGHQ and H2O2 are shown in figure 3.4. 
Phosphorylation of EGFR at Y992, Y1068, Y1086, Y1148, and Y1173 was 
specifically investigated, because phosphorylation at any of these sites could result in 
MAPK/ERK activation, but through different downstream signaling events (Scheme 1). 
EGF, as a competent ligand for the EGFR, is able to bind to the EGFR, cause 
dimerization and autophosphorylation of the EGFR, and tyrosine kinase transactivation at 
all the pY sites examined (Figure 3.5). TGHQ induced rapid and intensive EGFR 
phosphorylation at Y992 and Y1068, and weaker EGFR phosphorylation at Y1086 and 
Y1148, but not at Y1173 (Figure 3.5). In contrast, H2O2 induced significant amounts of 
EGFR phosphorylation only at Y992, and trace amounts of EGFR phosphorylation at 
Y1086 and Y1148  (Figure 3.5). EGF-induced EGFR phosphorylation reached maximal 
levels as early as 15 min, whereas both TGHQ and H2O2-induced EGFR phosphorylation 
peaked at 1 h (Figure 3.5). Differences in the patterns and kinetics of EGFR 
phosphorylation among TGHQ, EGF and H2O2 (Scheme 1) likely determine the 
activation of the subsequent downstream signaling pathways engaged subsequent to 
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EGFR phosphorylation. The pattern of TGHQ-induced EGFR phosphorylation is also 
different from that seen with H2O2, suggesting a ROS-independent component to TGHQ-
induced EGFR phosphorylation. EGF-mediated EGFR phosphorylation is followed by 
decreases in total EGFR levels (Figure 3.5) probably due to the rapid internalization and 
degradation of the activated receptor required to desensitize the system (Levkowitz et al. 
1998; Ravid et al. 2002; Waterman and Yarden 2001). 
D. TGHQ, EGF, and H2O2-mediated ERK1/2 Phosphorylation is EGFR Dependent, 
whereas TGHQ and H2O2-induced p38 MAPK and JNK1/2 Phosphorylation are 
EGFR Independent:  
TGHQ, EGF, and H2O2 all induced ERK1/2 phosphorylation very rapidly (Figure 
3.2). However, the kinetics of ERK1/2 phosphorylation by each of these agents varied. 
EGF induced extremely rapid and relatively sustained ERK1/2 phosphorylation, peaking 
at 15 min, whereas TGHQ induced a slower, less sustained but more intense ERK1/2 
phosphorylation, reaching a maximum at 1 h. H2O2-induced ERK1/2 phosphorylation 
was more rapid and more sustained than TGHQ, consistent with its effects on EGFR 
tyrosine phosphorylation at Y992. H2O2 induces phosphorylation of relatively fewer 
tyrosine residues in the EGFR, but more intensive ERK1/2 phosphorylation, perhaps 
implying the presence of additional tyrosine phosphorylation sites on EGFR for H2O2. 
Whether differences in the kinetics of both EGFR and ERK1/2 phosphorylation by EGF, 
TGHQ, or H2O2 contribute to the different effects on the downstream targets is not clear 
at present and requires further investigation.  
An EGFR antagonist, AG1478, totally blocked constitutive ERK1/2 
phosphorylation in untreated cells (Figure 3.2). AG1478 also completely blocked EGF 
induced ERK1/2 phosphorylation (Figure 3.2), while it reduced TGHQ and H2O2 induced 
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ERK1/2 phosphorylation to levels significantly lower than those seen in untreated cells 
(Figure 3.2). The mechanism of ERK1/2 activation by either EGF or TGHQ/H2O2 are 
likely different. EGF is an EGFR ligand, causing dimerization and autophosphorylation 
of EGFR, and subsequent ERK1/2 activation. In contrast, TGHQ/H2O2 probably 
stimulate EGFR phosphorylation by either modifying the cysteine residues or mimicking 
EGF-EGFR interactions, or by inactivating phosphatases, thereby inhibiting 
dephosphorylation of the EGFR, or by inducing cytokine release from the cells to activate 
the EGFR. Thus, residual ERK1/2 phosphorylation may be a consequence of the 
inhibition of phosphatase(s). DMSO, the solvent for AG1478, had no effect on ERK1/2 
phosphorylation. Thus, ERK1/2 phosphorylation caused by TGHQ, EGF, and H2O2 
appears to be EGFR dependent. We subsequently determined whether p38 MAPK and 
JNK1/2 phosphorylation requires EGFR activation. TGHQ and H2O2, induced 
phosphorylation of p38 MAPK and JNK1/2 (Figure 3.6), but EGF did not (data not 
shown). AG1478 failed to block either TGHQ or H2O2 induced p38 MAPK and JNK1/2 
phosphorylation, indicating that both TGHQ and H2O2 induced p38 MAPK and JNK1/2 















Figure 3.4. Cell viability in TGHQ, H2O2, and EGF treated cells at different 
concentrations and different time points.  
Cell viability was determined by measuring lysosomal neutral red uptake by live cells. 
Neutral Red uptake compared to untreated cells (% of control) represents cell viability 
after treatment. LLC-PK1 cells were treated with different concentrations of A. TGHQ 
(50, 100, 200, 400 µM), or B. H2O2 (0, 29.4, 44.1, 88.2, 176.4, 882.0 µM) for 2 h in 
DMEM+HEPES. C. LLC-PK1 cells were treated with EGF (50 ng/ml) for 0, 0.25. 0.5, 1, 
2, 4 h and neutral red uptake measured. D & E. Neutral Red uptake in LLC-PK1 cells 
treated with TGHQ (200 µM) or H2O2 (88.2 µM), respectively, for different time periods 
















Figure 3.5. Differential EGFR tyrosine phosphorylation induced by TGHQ, EGF and 
H2O2.  
LLC-PK1 cells were treated with TGHQ (200 µM), H2O2 (88.2 µM) or EGF (50 ng/ml) 
for different periods of time (0, 0.25. 0.5, 1, 2, 4 h). Whole cell lysates were extracted and 
equal amount of proteins were electrophoretically resolved on a 10% SDS-PAGE gel. 
Western blot analysis was performed as described. Representative blots of EGFR tyrosine 
phosphorylation at Y992, at Y1068, at Y1086, at Y1148, at Y1173, and total EGFR are 
shown in the microphotographs. Total EGFR levels and EGFR tyrosine phosphorylation 






































Figure 3.6. TGHQ and H2O2 induced EGFR-independent p38 MAPK and JNK1/2 
phosphorylation.  
LLC-PK1 cells were treated with TGHQ (200 µM), H2O2 (88.2 µM) or EGF (50 ng/ml), 
and/or with AG1478 (0.25 µM). Whole cell lysates were extracted and 
electrophoretically resolved on a 10% SDS-PAGE gel and examined by Western blot 
analysis. A & B. p38 MAPK phosphorylation. C & D. JNK1/2 phosphorylation. A & C.  
LLC-PK1 cells treated with TGHQ at various time (0, 1, 2, 4 h), or pretreated with 
AG1478 for 1 h, and co-treated with TGHQ for 1 h. B & D. LLC-PK1 cells treated with 
H2O2 at various time (0, 1, 2, 4 h), or pretreated with AG1478 for 1 h, and co-treated with 
H2O2 for 1 h. Results from EGF-treated cells are not shown because neither p38 MAPK 
nor JNK1/2 phosphorylation was observed in cells treated with EGF. Total p38 MAPK or 
JNK1/2 expression levels did not change within the observed time (data not shown). 
Control       1h           2h           4h     TGHQ 1h
TGHQ                    AG+
Control       1h           2h           4h    H2O2 1h
H2O2 AG+
Control   0.25    0.5       1h       2h       4h  TGHQ 1h
TGHQ                        AG+















E. Histone H3 is phosphorylated via both ERK and p38 MAPK Pathways:  
TGHQ induced the activation of all three subfamilies of MAPKs (Figure 3.2 & 
3.6), among which ERK1/2 and p38 MAPK could potentially induce histone H3 
phosphorylation (Tikoo et al. 2001). To determine whether TGHQ-induced histone H3 
phosphorylation occurs through ERK1/2 and p38 MAPK pathways, we used PD98059, 
an ERK1/2 pathway inhibitor, SB202190, a p38 MAPK pathway inhibitor, and AG1478, 
an EGFR inhibitor. Cells were pretreated with each of the inhibitors, and were 
subsequently exposed to TGHQ. Treatment of LLC-PK1 cells with either inhibitor alone 
had no effect on histone H3 phosphorylation (Figure 3.7). Histone H3 phosphorylation 
was significantly increased by TGHQ treatment (400 µM, 1 h), and both PD98059 and 
SB202190 attenuated TGHQ-induced histone H3 phosphorylation, PD98059 being more 
effective than SB202190 (Figure 3.7). The data imply that histone H3 phosphorylation 
likely occurs through the activation of both ERK and p38 MAPK pathways. The 
combination of the two inhibitors had no additive effects against TGHQ-induced cell 
death (Ramachandiran et al. 2002). Equal loading of the extract is illustrated in the 
Coomassie stained gel. Surprisingly, AG1478, an inhibitor of EGFR, decreased histone 
H3 phosphorylation to a less significant extent compared with either ERK or p38 MAPK 
pathway inhibitors (Figure 3.7). AG1478 did not alter cell death induced by TGHQ 
treatment, which matches its absence of effect on histone H3 phosphorylation induced by 
TGHQ (data not shown). 
F. TGHQ-Induced Phosphorylation of MK-2 and Hsp27 is p38 MAPK-Dependent:  
One downstream target of p38 MAPK is the mitogen activated protein kinase 
activated protein kinase (MAPKAP kinase-2, or MK-2), which is known to 
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phosphorylate Hsp27. MK-2 was phosphorylated by TGHQ (200 µM, 1 h) at both 
phosphoserine residues: Thr222 and Thr334 (Figure 3.8). Both SB202190 and SB203580 
are inhibitors of the p38 MAPK pathway, and pretreatment of LLC-PK1 cells with each 
of these inhibitors for 1 h significantly decreased or completely blocked TGHQ-induced 
MK-2 phosphorylation at Thr222 and Thr334 respectively, indicating that MK-2 
activation occurs via the p38 MAPK pathway (Figure 3.8). Equal loading was confirmed 
by Western blot analysis for actin on the same blots after stripping (Figure 3.8).  
We subsequently investigated whether Hsp27 phosphorylation occurs through the 
p38 MAPK pathway. Hsp27 is a chaperone protein that regulates actin polymerization 
and subcellular localization in response to ROS generation (Martindale and Holbrook 
2002). Interestingly, in an independent study using 2-dimensional electrophoresis, 
followed by matrix-assisted laser desorption/ionisation-time of flight mass spectrometry 
(MALDI-TOF) peptide mass mapping and post source decay (PSD), we found that 
TGHQ altered the relative intensity of three spots, each identified as Hsp27, in LLC-PK1 
cells, such that the more intense spot migrated with a more acidic pI. We confirmed that 
the shift in pI was due to the phosphorylation of Hsp27 at three serine residues (Ser15, 
Ser78, Ser82), using phospho-specific antibodies for phosphorylated Hsp27 by Western 
blot analysis (Figure 3.9). The phosphorylation of Hsp27 at all three sites increased as 
early as 15 min following treatment of cells with TGHQ, and reached a peak between 1 h 
and 2 h. Total levels of Hsp27 did not change during the period of treatment (Figure 3.9). 
Phosphorylation of Hsp27 was similarly attenuated or blocked by inhibition of the p38 
MAPK pathway (by SB202190, SB203580), but not by inhibition of the ERK pathway 
(PD98059) (Figure 3.10). In fact, PD98059 appeared to slightly enhance TGHQ-induced 
phosphorylation of Hsp27 at Ser78 (Figure 3.10). The overall expression of Hsp27 did 
not change in all samples examined (Figure 3.10). 
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To confirm the effects of pharmacological inhibitors of the p38 MAPK pathway 
on TGHQ-induced Hsp27 phosphorylation, LLC-PK1 cells were transfected with 
dominant negative mutant p38 MAPK expressing vectors (pcDNA3-DNp38), or empty 
vectors pcDNA3, or native p38 MAPK expressing vectors (pcDNA3-p38). In 
untransfected, pcDNA3-transfected, or native p38-transfected cells, TGHQ was capable 
of inducing intensive p38 MAPK phosphorylation. Indeed, in pcDNA3-p38-transfected 
cells, phosphorylation of p38 MAPK was higher than in untreated cells, and TGHQ 
induced even more p38 MAPK phosphorylation in these cells (Figure 3.11), probably due 
to the significantly increased levels of p38 MAPK in these cells. In contrast, in DNp38-
transfected cells, TGHQ failed to induce p38 MAPK phosphorylation (Figure 3.11). 
Consistent with these findings, only in DNp38-transfected cells did TGHQ fail to induce 
MK-2 (both Thr222 and Thr334) and Hsp27 (Ser15, Ser78, Ser82) phosphorylation 
(Figure 3.11). Again, total Hsp27 expression levels were similar in all samples. The data 
therefore confirm that phosphorylation of both MK-2 and Hsp27 occurs via the p38 













Figure 3.7. TGHQ-induced histone H3 phosphorylation is associated with both ERK and 
p38 MAPK pathways.  
[32P]-Labeled LLC-PK1 cells were treated with TGHQ (400 µM) for 1 h, or pretreated 
with each inhibitor (PD98059, 50 µM; SB202190, 50 µM; AG1478, 0.25 µM) for 1 h, 
and co-treated with TGHQ (400 µM) for an additional hour. Histones were extracted and 
electrophoretically resolved on a 13.5% SDS polyacrylamide gel. A. Coomassie stained 





















Figure 3.8. TGHQ induced MK-2 phosphorylation, dependent on p38 MAPK activation.  
LLC-PK1 cells were treated with TGHQ (200 µM) for 1 h, or pretreated with inhibitors 
(SB202190, 50 µM; SB203580, 50 µM) for 1 h, and co-treated with TGHQ (200 µM) for 
an additional hour. Cells were lysed and loaded to 10% SDS-PAGE gel at equal amount 
of protein, and analyzed by Western blot analysis. Phospho-MK-2 at Thr222 and Thr334 
were examined. Western on actin denotes equal loading of the proteins for each sample. 
Negative and positive controls were provided by the vendor to confirm MK-2 































Figure 3.9. TGHQ induced Hsp27 phosphorylation at Ser15, Ser78 and Ser82, occurring 
in the absence of changes in Hsp27 expression. 
LLC-PK1 cells were treated with TGHQ (200 µM) for 0, 0.25, 0.5, 1, 2, 4 h. Whole cell 
lysates were extracted and electrophoretically resolved on a 10% SDS-PAGE gel, 
followed by Western blot analysis using phospho-specific antibodies for Hsp27 with 
phosphorylation each at Ser15, Ser78, or Ser82. Total Hsp27 expression level was 
examined and no changes were revealed. 


















Figure 3.10. TGHQ induced Hsp27 phosphorylation is dependent on p38 MAPK 
activation.  
LLC-PK1 cells were treated with TGHQ (200 µM) for 1 h, or pretreated with inhibitors 
(SB202190, 50 µM; SB203580, 50 µM) for 1 h, and co-treated with TGHQ (200 µM) for 
an additional hour. Cells were lysed and loaded onto 10% SDS-PAGE gels at equal 
amounts of protein, and analyzed by Western blot analysis. Hsp27 phosphorylation at 
Ser15, Ser78, and Ser82 induced by TGHQ was examined using phospho-specific 
antibodies. PD98059 (50 µM, 1 h pretreatment), an inhibitor of ERK pathway was used 
to examine whether Hsp27 phosphorylation is through the ERK pathway. Total Hsp27 

























Figure 3.11 LLC-PK1 cells transfected with a dominant negative mutant of p38 MAPK 
expressing vector fail to respond to TGHQ-induced responses.  
LLC-PK1 cells were transfected with pcDNA3 (empty vector), pcDNA3 vector 
expressing native p38 MAPK (p38), or pcDNA3 vector expressing dominant negative 
mutant p38 MAPK (DNp38) as described in Methods. Transfected cells or untransfected 
cells were treated with TGHQ (200 µM) for 1 h, and cell lysates were separated by 10% 
SDS-PAGE gels, followed by Western blot analysis using phospho-specific antibodies 
for p38 MAPK, MK-2, and Hsp27. Total p38 MAPK expression levels was higher in p38 
and DNp38 MAPK expressing vector transfected cells. Total Hsp27 expression levels 
























ROS are well known inducers of apoptosis, but can also induce oncosis under 
specific conditions, such as during ischemia reperfusion injury and hypoxia-induced ung 
cell death. The chromatin condensation and morphological changes that occur during 
TGHQ-induced renal cell death are indicative of oncotic cell death (Tikoo et al. 2001). 
To determine whether TGHQ, a ROS generating chemical, induces apoptosis in renal 
proximal tubule epithelial cells, I used various methods to detect apoptosis in TGHQ-
treated LLC-PK1 cells. No apoptosis was detected at several different consentrations and 
exposure times to TGHQ. In contrast, TNFα induced substantial apoptotic cell death in 
LLC-PK1 cells. Therefore, TGHQ induces oncotic rather than apoptotic cell death in 
LLC-PK1 cells. It is well known that apoptosis is a genetically programmed mode of cell 
death, and which can be manipulated. In contrast, fewer studies have attempted to 
manipulate oncotic cell death, which appears also to engage various signaling pathways. 
Our studies on the signaling pathways activated during TGHQ-mediated oncotic cell 
death may eventually permit the manipulation of this deleterious and inflammatory type 
of cell death. At the least, manipulation of these signaling pathways such that the renal 
epithelial cells are driven from oncotic to apoptotic mode of cell death may better limit 
the adverse effects on adjacent cells and promote tissue survival. 
Although we confirmed that TGHQ induces MAPKs phosphorylation robustly 
and in a time-dependent fashion (Figure 3.2 & 3.6), the upstream and downstream targets 
during TGHQ-mediated activation of the MAPK pathway remained unclear. Because 
MAPKs activation is EGFR–dependent in most cells, we examined whether TGHQ-
induced MAPK activation in LLC-PK1 cells also occurs through the EGFR. TGHQ 
induced histone H3 phosphorylation rapidly in LLC-PK1 cells, whereas EGF did not 
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induce histone H3 phosphorylation, for at least 24 h (Figure 3.3). Histone H3 
phosphorylation induced by TGHQ is ROS-dependent, and is associated with TGHQ-
induced oncotic cell death (Tikoo et al. 2001). TGHQ, H2O2, and EGF all induced 
ERK1/2 phosphorylation in an EGFR-dependent manner, since AG1478, an inhibitor of 
EGFR, blocked ERK1/2 phosphorylation induced by each agent (Figure 3.2). In contrast, 
TGHQ and H2O2-induced p38 MAPK and JNK1/2 activation were EGFR-independent 
(Figure 3.6), and EGF failed to induce p38 MAPK or JNK1/2 phosphorylation in LLC-
PK1 cells. Since pharmacological inhibitors of the p38 MAPK and ERK, but not the JNK 
pathway decrease histone H3 phosphorylation (Figure 3.7), and protect LLC-PK1 cells 
from TGHQ-induced cell death (Ramachandiran et al. 2002), we conclude that both p38 
MAPK and ERK pathways contribute to TGHQ-induced histone H3 phosphorylation and 
cell death. Thus, in contrast to the general concept that p38 MAPK is an 
inflammation/apoptosis-related kinase, p38 MAPK also participates in ROS-induced 
oncotic renal proximal tubule epithelial cell death. 
Several tyrosine residues on the EGFR that are prone to autophosphorylation have 
been identified, including three major sites (Y1068, Y1148, and Y1173), and two minor 
ones (Y992 and Y1086) (Biscardi et al. 1999). Upon phosphorylation, these residues 
promote the binding of a number of downstream signaling proteins that possess SH2 
domains, such as Shc, PLC-γ, Grb2, and SHP1, or PTB domain, such as Shc, c-Cbl. 
Binding of these molecules to the EGFR results in the activation of multiple signaling 
pathways that enhance DNA synthesis and promote cell division. Interestingly, TGHQ, 
H2O2, and EGF induce differential phosphorylation of EGFR tyrosine residues and 
subsequent different kinetics of MAPK activation in LLC-PK1 cells (Figure 3.2 & 3.5). 
EGF, the endogenous ligand of the EGFR, induces rapid (<15 min) EGFR tyrosine 
phosphorylation at all residues examined (Y992, 1068, 1086, 1148, 1173) (Figure 3.5, 
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and summarized in 3.12). In contrast, TGHQ induced much slower (1 h) EGFR tyrosine 
phosphorylation, and only at residues Y992 and Y1068. Surprisingly, H2O2 only induced 
significant EGFR tyrosine phosphorylation at Y992, but H2O2-mediated ERK1/2 
phosphorylation was dependent on EGFR activation (Figure 3.2). Additional, as yet 
unidentified phosphorylation site(s) may exist on the EGFR that are responsive to H2O2. 
One possibility is through the activation of the Src kinase. Src kinase binds to 
phosphorylated EGFR tyrosine residues at either 845 or 1101, and Src kinase can also 
phosphorylate EGFR at both residues (Sato et al. 2003; Tice et al. 1999). Interestingly, 
phosphorylation of EGFR tyrosine residue 1068, but no 992, recruits Grb2 binding to 
EGFR, which provides binding of C-Cbl binding and lead to degradation of EGFR (Jiang 
et al. 2003). Both TGHQ and H2O2 induced weaker EGFR tyrosine phosphorylation at 
residues Y1086 and Y1148, compared to EGF (Figure 3.5). Phosphorylation of Y1068, 
Y1148, and Y1173 can lead to the degradation of the EGFR, but they are also required 
for maximum kinase activity (Helin and Beguinot 1991). Absence or weak 
phosphorylation of EGFR Y1173 in TGHQ and H2O2-treated cells may prolong the 
activation of EGFR by these two agents. Moreover, H2O2 poorly phosphorylates the 
EGFR at Y1045, the major docking site for the ubiquitin ligase c-Cbl (Ravid et al. 2002). 
Consequently, H2O2 activated EGFR fails to recruit c-Cbl and does not undergo 
ubiquination and endocytosis(Ravid et al. 2002).  
Since TGHQ generates ROS in LLC-PK1 cells (Monks and Lau 1998), it is likely 
that there exist(s) common EGFR phosphorylation site(s) for both TGHQ and H2O2. Src 
phosphorylation sites, Y845 and Y1101, could represent additional phosphorylation 
targets of TGHQ and H2O2. Differential EGFR tyrosine phosphorylation profiles induced 
by different agents will likely contribute to the differential recruitment of signaling 
factors to the EGFR, resulting in different cellular responses (Schlessinger 2000). Based 
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on this view, TGHQ, EGF, or H2O2-induced EGFR tyrosine phosphorylation likely 
results in the recruitment of different signaling proteins to the EGFR that determines the 
differences in the cellular response. Additionally, AG1478 blocked TGHQ, H2O2 and 
EGF induced EGFR Y992 phosphorylation (data not shown), verifying its ability to block 
EGFR phosphorylation. However, AG1478 does not decrease histone H3 
phosphorylation to a significant degree (Figure 3.7), neither does it protect cells from 
TGHQ-induced cell death (data not shown). We conclude that although AG1478 blocks 
ERK1/2 activation, it could also interfere with other signaling pathways, compromising 
its effects on cell death. The specificity of the pharmacological inhibitors should also be 
examined in our cell system to ensure their blocking of the designated signaling pathway. 
Oxidative stress induces the phosphorylation of heat shock protein 27 (Hsp27), 
and both oligomerization and phosphorylation of Hsp27 may play an important role in 
the regulation of actin dynamics in response to growth factors and stress (Garrido 2002). 
Overexpression of Hsp27 prevents kidney ischemia/reperfusion-induced functional injury 
(Park et al. 2002). Because SB202190, an inhibitor of the p38 MAPK pathway, protects 
LLC-PK1 cells against TGHQ-induced cell death (Ramachandiran et al. 2002), TGHQ-
induced p38 MAPK-mediated Hsp27 phosphorylation might contribute to ROS-induced 
cell death. In support of this view, MK-2-/- mice are protected from ischemic brain injury 
(Wang et al. 2002), indicating that the p38 MAPK pathway is involved in ROS-induced 
cell death. Although Hsp27 overexpression or induction is associated with cytoprotection, 
the role of Hsp27 phosphorylation in ROS-induced renal cell death is unclear. Hsp27 
serves as a molecular chaperone that associates with certain proteins, such as actin, Akt 
(Rane et al. 2003), and IκBα (Parcellier et al. 2003a), to stabilize and regulate their 
activation/deactivation. Inappropriate phosphorylation of Hsp27 might therefore convert 
Hsp27 from a cytoprotective to a death-inducing protein (Huot et al. 1998). TGHQ-
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induced phosphorylation of MK-2 and Hsp27 is totally blocked by the p38 MAPK 
pathway inhibitors, SB202190 or SB203580 (Figure 3.9), or by transfection of LLC-PK1 
cells with dominant negative mutant p38 MAPK expressing vectors (Figure 3.11). Thus, 
TGHQ-induced p38 MAPK pathway activation mediates Hsp27 phosphorylation. The 
potential significance of Hsp27 phosphorylation was examined by immunostaining of 
phospho-Hsp27, which was only observed within damaged or dying cells (data shown in 
Chapter 5, Figure 4.8). Moreover, in post-confluent LLC-PK1 cells lacking Grp78, 
TGHQ failed to induce Hsp27 phosphorylation, indicating a link between ER stress and 
the p38 MAPK pathway, and subsequent Hsp27 phosphorylation (Jia et al. 2004). We 
therefore conclude that in preconfluent cells that are actively dividing, Hsp27, another 
downstream effector of the MAPKs, is phosphorylated by TGHQ through the p38 MAPK 
pathway, and that this modification is associated with TGHQ-induced oncotic cell death. 
In summary, our data indicate that TGHQ induces selective EGFR 
phosphorylation, leading to the activation of the ERK pathway, and induces EGFR-
independent p38 MAPK pathway activation. Both the ERK and p38 MAPK pathways 
contribute to histone H3 phosphorylation and oncotic cell death. In addition, TGHQ 
induces Hsp27 phosphorylation via the p38 MAPK pathway. Both histone H3 and Hsp27 
phosphorylation have the potential ability to remodel chromatin. Because inappropriate 
chromatin condensation has been linked to TGHQ-induced cell death, the activation of 
both p38 MAPK and ERK1/2, and subsequent downstream signaling factors, likely play a 
key role in ROS-mediated oncotic cell death in renal epithelial cells. The mechanisms of 
TGHQ induced oncotic cell death are summarized in the cartoon (Scheme 2). The role of 
p38 MAPK in histone H3 phosphorylation remains to be resolved, as does the functional 
role of Hsp27 phosphorylation in TGHQ-induced oncotic cell death. Ongoing 
experiments are addressing these questions. Finally, immunoprecipitation of the EGFR 
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coupled to western blotting analysis or MALDI-TOF protein sequencing may identify 





Figure 3.12 Profiles of EGFR tyrosine phosphorylation by TGHQ, EGF, and H2O2. 
LLC-PK1 cells were treated with TGHQ (200 µM), EGF (50 ng/ml), or H2O2 (88.2 µM) 
for different periods of time (0, 0.25. 0.5, 1, 2, 4 h). Western blot analysis revealed the 
levels of specific phospho-EGFR at Y992, Y1068, Y1086, Y1148, and Y1173. EGFR 
tyrosine phosphorylation was determined semi-quantitively by densitometric scanning of 















Figure 3.13 Possible signaling pathways that contribute to TGHQ-induced oncotic cell 
death in LLC-PK1 cells.  
TGHQ-generated ROS phosphorylate EGFR tyrosine residues, mainly at Y992 and 
Y1068, and induce the activation of ERK pathway. ERK1/2 activation leads to histone 
H3 phosphorylation. TGHQ-generated ROS also induce the activation of p38 MAPK, 
which phosphorylates MK-2 and Hsp27. p38 MAPK also leads to histone H3 
phosphorylation. Inappropriate histone H3 phosphorylation leads to premature chromatin 
condensation and oncotic cell death. Meanwhile, Hsp27 phosphorylation induced by p38 
MAPK activation might also be associated with TGHQ-induced chromatin remodeling, 
and oncotic cell death. Thus multiple rather than a single pathways contribute to TGHQ-




















































Chapter 4: PROTEOMIC STUDIES ON PROTEIN REGULATIONS 
BY TGHQ IN RENAL EPITHELIAL CELLS 
 
I. INTRODUCITON AND RATIONALE 
ROS, including superoxide anion (O2. -), hydrogen peroxide (H2O2) and hydroxyl 
radical (HO.-) are generated either endogenously as by-products during mitochondrial 
electron transport or by several oxidoreductases and by the metal-catalyzed oxidation of 
metabolites, or exogenously by redox-active chemicals. ROS are associated with a 
variety of human diseases and chemical-induced toxicities (Bolton et al. 2000). An 
increasing number of studies are implicating ROS in key roles in cell signaling (Arnold et 
al. 2001; Irani et al. 1997; Rhee 1999). In contrast, ROS may cause direct damage to 
cellular macromolecules such as lipids, proteins, or nucleic acids, which subsequently 
induces activation of various stress-response signaling pathways. Renal proximal tubule 
epithelial cells are particularly susceptible to oxidative stress-induced damage. TGHQ-
induced nephrotoxicity in renal epithelial cells is therefore considered a good model for 
the study of ROS-generating chemical-induced toxicity.  
TGHQ is a potent nephrotoxic metabolite of HQ (Lau et al. 1988), causes oncotic 
cell death of renal proximal epithelial cells in a ROS-dependent manner (Ramachandiran 
et al. 2002), and contributes to HQ-mediated nephrotoxicity and nephrocarcinogenicity 
(Lau et al. 1988; Lau et al. 2001a; Peters et al. 1997). TGHQ induced cell death is ROS-
dependent, because catalase is able to completely block TGHQ-mediated cell death. 
Moreover, TGHQ likely enters renal epithelial cells through the L-amino acid transporter 
as the corresponding cysteine conjugate, thus providing an intracellular ROS generating 
source. The one-electron reduced form of a quinol-thioether may react with O2, yielding 
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superoxide anion radical, which finally gives rise to hydrogen peroxide and hydroxyl 
radical (Monks and Lau 1998). These ROS cause extensive DNA damage, as evidenced 
by the formation of DNA single strand breaks and a rapid growth arrest response (Jeong 
et al. 1996). In the preceding chapter, I discussed the potential signaling pathways that 
contribute to TGHQ-mediated renal cell death, focusing on the MAPK pathways and 
histone H3 phosphorylation. Since none of the three inhibitors, or the combination of the 
inhibitors for the MAPKs, is able to completely block TGHQ-induced renal cell death, 
activation of some other pathways must also contribute partially to TGHQ-mediated renal 
cell death. Therefore, using a proteomics approach I intended to reveal additional 
potential signaling pathways that may play a role in TGHQ-mediated cell death. 
The signaling pathways engaged in TGHQ induced oncotic renal cell death are 
complex. TGHQ induces changes in a complex network of signaling pathways, some of 
which are initiated as a defensive/buffering response against oxidative stress. Such cell 
stress responses include initial sacrifice of antioxidants (GSH, Trx, Prx, etc.) and 
reorganization of the cytoskeleton (actin, etc.), followed by post-translational 
modification of cell signaling components (MAPK cascades, cell cycle, etc.), and finally, 
activation of transcriptional factors (AP-1, NF-κB, etc). In our studies using 2-
dimensional gel electrophoresis and mass spectrometry, we identified changes in several 
proteins, either in their overall expression, or as post-translational modifications. Among 
these proteins, changes to Prxs and Hsp27 were the most significant. Indeed, Prxs are a 
family of thioredoxin dependent peroxidases, which are believed to be gatekeepers for 
cell signaling in response to ROS (Wood et al. 2003). The 2-Cys Prxs behave as 
antioxidant enzymes (Hofmann et al. 2002), as a peroxynitrite reductase (Bryk et al. 
2000), and as signaling factors (Fujii and Ikeda 2002). Prxs require two redox-active 
cysteines to be active as an antioxidant enzyme. Thus, when cells are exposed to very 
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high levels of ROS, Prxs are oxidized (to sulfenic acid and/or sulfinic acid) (Wagner et 
al. 2002) and consequently lose their antioxidant function. Prxs are also associated with 
the mitogen activated protein kinases (MAPKs) signaling pathways (Hess et al. 2003; 
Kang et al. 2004; Romashko et al. 2003; Veal et al. 2004), which are all activated by 
TGHQ very rapidly in LLC-PK1 cells (Ramachandiran et al. 2002). Both ERK1/2 and 
p38 MAPK activation contribute to histone H3 phosphorylation and oncotic cell death. 
Inappropriate phosphorylation of histone H3 leads to premature chromatin condensation 
and oncotic cell death in LLC-PK1 cells (Tikoo et al. 2001). One downstream substrate 
of p38 MAPK is the mitogen activated protein kinase activated protein kinase-2, which, 
upon phosphorylation, phosphorylates its substrate heat shock protein 27 (Hsp27). Hsp27 
is a chaperone protein (Rogalla et al. 1999), and is associated with actin stabilization 
(Lavoie et al. 1993b; Lavoie et al. 1995), and with cell signaling, such as Akt (Rane et al. 
2003) and IKK (Park et al. 2003). Overexpression of Hsp27 in cells provides 
cytoprotective effects (Kampinga et al. 1994; Landry et al. 1989; Lee et al. 2004; Lewis 
et al. 1999; Park et al. 1998), whereas the roles of Hsp27 phosphorylation in ROS-
induced cell death remain debatable. On one hand, Hsp27 phosphorylation facilitates 
actin reorganization and provides a cytoprotective effects (Huot et al. 1997; Landry and 
Huot 1995; Mounier and Arrigo 2002). On the other hand, phosphorylation of Hsp27 
could lead to loss in chaperone function, activate/inactivate signaling pathways, or induce 
actin polymerization and cell blebbing, a typical morphological alteration observed 
during apoptosis (Huot et al. 1996). Unphosphorylated Hsp27, but not phosphorylated 
Hsp27, also increases cellular GSH levels and protects cells from oxidative stress (Arrigo 
1998). 
As discussed above, multiple signaling pathways are likely associated with 
TGHQ-induced renal cell death, each of which may either play a role in cytoprotection or 
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cell death. Using pharmacological inhibitors or molecular manipulation, we have not 
been able to identify a single signaling pathway that is solely responsible for TGHQ-
induced oncotic cell death. It is likely that the balance of a network of signaling pathways 
determines the fate of renal epithelial cells. To obtain a more global view of the signaling 
factors involved in TGHQ-mediated cell signaling at the protein level, we used a high 
throughput proteomics approach. 
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II. RESULTS 
A. Changes of cellular proteins in TGHQ treated LLC-PK1 cells 
After TGHQ (200 µM) treatment for 1, 2, or 4 h, the intensity of eleven spots on 
the 2-D gel changed compared to that in the untreated cells (Figure 4.1). The changes in 
spot intensity were first identified manually by two individuals, and then subject to 
PDQUEST program for analysis and quantitation. Spots with altered intensities after 
TGHQ treatment were excised out, subject to in-gel digestion, and the proteins in the 
spots were identified by MALDI-TOF mass spectrometry. Identities of these proteins are 
listed in Table 4.1, with the percentage of peptide masses matched, key functions of the 
proteins, and their approximate pIs on the 2-D gel. Among the eleven proteins identified 
that changed intensity after TGHQ treatment, two pairs of three spots were each 
recognized as either Prx3 or Hsp27. After TGHQ treatment, the intensity of the spot with 
more acidic pIs increased, but the intensity of the spot with more basic pI decreased 
compared to untreated cells (Figure 4.1). Other proteins regulated by TGHQ in LLC-PK1 
cells included a rapid increase in the overall expression of annexin I, calreticulin, and an 
increase followed by a decrease in PDI precursor and nucleophosmin/B23 (Figure 4.1). 
These proteins are associated with a number of cellular functions such as carcinogenesis, 
ER stress, calcium regulation, and nuclear shuttling. The changes were quantified by the 
PDQEST program and summarized (Figure 4.2). Folds of increase in the spot intensity 
after treatment compared to controls at each time point are illustrated as bars (Figure 4.2). 
Bars to the left represent decreases in the spot intensity, and bars to the right with 
increased spot intensity. Annexin I levels increased after TGHQ treatment, as evidenced 
on the 2-D gel, and confirmed by western blot analysis using a specific antibody for 
Annexin I (Figure 4.3). The folds of increase after TGHQ treatment compared to controls 
were quantified by spot-densotometry (Figure 4.3). 
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Figure 4.1. 2-D gel analysis of TGHQ induced protein changes in LLC-PK1 cells.  
The spots with increased or decreased intensity in TGHQ treated cells compared to 
controls are circled in red and highlighted with arrows and numbers. The identities of the 
spots are summarized in Table 4.1. Cells were treated with TGHQ (200 µM)  for 1, 2, or 4 
h, and were compared to untreated cells at each time point. Changes in the spot intensity 
were initially identified by at least two individuals, and were subsequently analyzed and 
quantified by PDQUEST. 1. Calreticulin, 2. Protein disulfide isomerase precursor (PDI), 
3. Nucleophosmin/B23, 4. Peroxiredoxin 2, 5 & 9 & 10. Heat shock protein 27 (HSP27), 
6 & 7 & 8. Peroxiredoxin 3, 11. Annexin I.
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Table 4.1. A summary of the proteins altered by TGHQ. 
 
Identity #/% Masses 
Matched 
Key Functions ~pI 
Calreticulin 8/20 (40%) Calcium binding protein, 
protein assembly 
4 
Protein disulfide isomerase 
precursor (PDI) 
6/20 (30%) Chaperone, protein folding, 
regulating cell adhesion 
5 
Nucleophosmin/B23 2/3 (66%) Ribosomal assembly/rRNA 
transport, phophorylated by 
cdc2 during mitosis 
4 
Peroxiredoxin 2 5/6 (83%) Reduce peroxides 5 
Heat shock protein 27 5=9=10 Stress resistance 
actin organization 
7 
Peroxiredoxin 3 3/5 (60%) Reduce peroxides 7.5 
Peroxiredoxin 3 4/5 (80%) Reduce peroxides 8 
Peroxiredoxin 3 8=6 Reduce peroxides 8.5 
Heat shock protein 27 5/11 (45%) Stress resistance 
actin organization 
9 
Heat shock protein 27 10=5=9 Stress resistance 
actin reorganization 
8 






















Figure 4.2. Quantification of protein changes in TGHQ-treated LLC-PK1 cells. 
Spots with altered densities were analyzed using the PDQUEST software package (Bio-
Red). Increases or decreases in the intensity of the spots in treated cells compared to 
controls are illustrated by black bars, along with the fold-increase or decrease. Note: ‘∞’ 
means one of the spots (either in control or in treated) was undetectable on the 2D gel, 











Figure 4.3. Annexin I expression levels increased after TGHQ treatment.  
LLC-PK1 cells were treated with TGHQ (200 mM) for 0 to 4 h, and total cellular 
proteins were extracted and subject to western blot analysis using specific antibody for 
Annexin I. The intensity of the western bands was quantified by spot-densotometing and 
shown in the figure (n=1). 
Annexin I


















B. Prx3 is modified by TGHQ 
Three spots on the 2-D gels were identified as Prx3, and the intensity of the spots 
changed after TGHQ treatment, shifting to a more acidic pI (Figure 4.4). This mode of 
change is likely due to post-translational modification, for example, oxidation and/or 
phosphorylation. We used a specific antibody (provided by Dr. Garth Powis, Univ. of 
Arizona Cancer Center) to examine the total levels of Prx3 before and after TGHQ 
treatment, and which revealed a decrease in intensity of the Prx3 band  (Figure 4.5). A 
nonspecific staining band serves as an equal loading control for the total proteins. The 
observed decrease in the Prx3 band intensity is likely due to either a decrease in Prx3 
expression levels, or due to a shift of mobility of the protein after TGHQ treatment. 
Because the western blot analysis was performed under denaturing conditions, which 
could lead to a reduction of Prx3, we examined the mobility of Prx3 on a native gel under 
non-denaturing conditions. Native western blot analysis revealed a significant band shift 
after TGHQ treatment (200 µM, 2 h) (Figure 4.6). Before treatment, a single band was 
identified as Prx3 and represents the native Prx3 within LLC-PK1 cells. After TGHQ 
treatment, the intensity of the native Prx3 band decreased significantly, with the 
concomitant appearance of another band below the native Prx3 band, with a higher 
mobility on the gel (Figure 4.6). H2O2 (88.2 µM, 2 h) was compared with the TGHQ-
mediated effects on Prx3, and it produced similar effects as TGHQ, but to a lesser extent 
(Figure 4.6). This mobility shift is most likely due to oxidation, as reported by others 
(Rabilloud et al. 2002; Woo et al. 2003a). To identify the modification of Prx3 after 
TGHQ treatment, we excised the corresponding band revealed by western blot analysis 
from the native gel, and digested it with trypsin or chymotrypsin. The peptides, after 
digestion, were analyzed by LC-MS/MS to identify the modification on Prx3. The band 
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in the control sample representing the native Prx3 was identified without modification 
(data not shown), whereas in the TGHQ treated sample we were unable to identify the 
second band as either Prx3, or the nature of the modification. One spot on the 2-D gel 
was identified as Prx2 (spot V) (Figure 4.4). The intensity of spot IV increased after 
TGHQ treatment, which is likely the ROS-modified Prx2, again as supported by the 
others (Rabilloud et al. 2002). Interestingly, Rabilloud et al. reported only two spots on 
2-D gels as Prx3, including one as the reduced and one as oxidized Prx3 by H2O2. 
However, we identified a third spot as Prx3 (spot III), which has decreased intensity after 
TGHQ treatment (Figure 4.4). Whether this spot is another modified form of Prx3 or 












Figure 4.4. TGHQ induced modification of peroxiredoins (Prx) revealed by 2-D gel 
analysis. 
LLC-PK1 cells were treated with TGHQ (200 µM) for 2 h, and the cells were lysed and 
total proteins were subject to 2-D gel for separation, and finally visualized by fluorescent 
staining. There are three spots (i, II, III) on the 2-D gel that are all identified as Prx3, one 
spot (V) identified as Prx2, and one postulated as oxidized Prx2 iv). The corresponding 
spots on the control or treated samples are marked with the same numbers (capitalized or 
uncapitalized). Approximate pIs for these spots are listed in Table 4.1. 
I II III i ii iii
IV ivV v
pI pI







Figure 4.5. TGHQ induced changes in Prx3 revealed by western blot analysis. 
LLC-PK1 cells were lysed and subject to western blot analysis under denaturing 
conditions using a specific antibody for Prx3. Proteins (5-30 µg) were loaded onto SDS-
PAGE from either control (C) or TGHQ (200 µM, 2 h) treated samples (T). Nonspecific 
















Figure 4.6. TGHQ and H2O2 induced a mobility shift of Prx3 revealed by native western 
blot analysis. 
LLC-PK1 cells were treated with TGHQ (200 µM, 2 h), or H2O2 (88.2 µM, 2 h), and then 
lysed and subject to native western blot analysis under non-denaturing conditions. Total 











C.  Hsp27 revealed to be modified by TGHQ by 2-D gel analysis 
Similar to Prx3, Hsp27 was identified in three spots on 2-D gels that changed 
intensity after TGHQ treatment (Figure 4.7). The intensity of the spots with more acidic 
pI increased after TGHQ treatment, whereas the intensity of the spot with a more basic pI 
decreased after treatment (Figure 4.7). This again implies a post-translational 
modification of Hsp27 after TGHQ treatment. This was the first time a Hsp27 
modification was revealed by 2-D gel analysis. One known modification for Hsp27 is 
phosphorylation, and there are multiple residues on Hsp27 that may be phosphorylated 
(Gaestel et al. 1991; Landry et al. 1992). Using phosho-specific antibodies, we were able 
to reveal increases in phosphorylation of Hsp27 at S15, S78 and S82 (Figure 3.9). 
Therefore, the observations on the 2-D gel analysis are most likely due to the 
phosphorylation of Hsp27 at multiple serine residues. Phosphorylation and 
oligomerization of Hsp27 are important for its function, as discussed in Chapter 3. 
Immunocytochemical staining revealed constitutive phospho-Hsp27 (S15) in the 
untreated cells (Figure 4.8), and an increase in phospho-Hsp27 (S15) after TGHQ 
treatment (200 µM, 2 h). This observation is consistent with our western blot data on the 
levels of phospho-Hsp27 (S15) (Figure 3.9). Higher magnification revealed that cells 










Figure 4.7. TGHQ induced changes of intensity of three spots on 2-D gel, all identified 
as Hsp27. 
LLC-PK1 cells were treated with TGHQ (200 µM, 2 h), lysed, and total protein was 
subject to 2-D gel separation. Proteins were visualized by fluorescent staining. There are 
three spots (1’, 2’, 3) on the 2-D gel that were all identified as Hsp27. The corresponding 
spots on the control or treated samples are marked with same numbers (capitalized or 
uncapitalized). Approximate pIs for these spots are listed in Table 4.1. 
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Figure 4.8. Localization of phosphorylated Hsp27 within LLC-PK1 cells after TGHQ 
treatment. 
Untreated or treated LLC-PK1 cells were subject to immunocytochemical staining using 
phospho-specific antibody for phospho-Hsp27 (Ser15). Cells expressing phospho-Hsp27 
(Ser15) stain brown, otherwise, cells stain purple. A. untreated; B. IgG control; C&D. 
TGHQ treated (200 µM, 2 h). A&B&C. ×40; D. ×400. 
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III. DISCUSSION 
These experiments were designed to identify additional proteins that modulate 
ROS-mediated oncotic renal cell death. TGHQ caused consistent changes in the mobility 
of several proteins upon 2-D gel analysis cells, each with various functions associated 
with antioxidants, the cytoskeleton, carcinogenesis, ER stress, calcium regulation, and 
nuclear shuttling. In general, when cells are exposed to ROS, they possess a first line of 
defensive barrieres to protect themselves against oxidative stress. At the same time, ROS 
also induce activation of signaling pathways that could either contribute to or protect 
from cell death. The balance of these two opposing types of signaling pathways 
determines whether cells survive or die. This balance is dependent on the intensity of the 
stress that the cells are exposed to. If the amount of stress exceeds the defensive capacity, 
cell death prevails. 
One of the first lines of defense against oxidative stress are the Prxs. Prxs 
(Hofmann et al. 2002) are a family of abundantly expressed peroxidases that provide an 
initial defense against ROS-mediated cell damage. Other anti-oxidants include GSH, 
catalase, and SOD. In the presence of a small amount of intracellular ROS, Prxs reduce 
H2O2 and oxidized lipids by the concomitant oxidation of the active cysteine sulfhydryl 
group to a sulfenic acid (SOH), and subsequently disulfide bond formation with a second 
active cysteine residue (S-S) (Rhee et al. 2001). Oxidation of the cysteine residue is 
quickly reversed by thioredoxin reductase, and Prxs regain their antioxidant function 
(Rhee et al. 2001). In contrast, in the presence of an overwhelming amount of ROS, 
additional oxidation of the Prxs cysteine residues to sulfinic (SO2H) and sulfonic acid 
(SO3H) occurs (Rabilloud et al. 2002). These oxidation products are not easily reversed 
and the process of reduction is slow and requires specialized enzymes (Chang et al. 2004; 
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Woo et al. 2003a). This super-oxidation of Prxs allows ROS to interact with other 
cellular constituents and to activate an oxidative stress response. In this respect, 
superoxidation of Prxs is probably the gateway for ROS-mediated stress signaling 
activation in cells. We found that Prx3 is modified by TGHQ, as well as by H2O2, 
evidenced by western blot analysis. Others have reported the identification of two spots 
on a 2-D gel as Prx3, and observed similar phenomenon of spot intensity changes after 
H2O2 treatment (Rabilloud et al. 2002). Mass spectrometric analysis of the spots revealed 
that the spot with a more acidic pI had one cysteine oxidized to sulfonic acid (Rabilloud 
et al. 2002). Therefore, TGHQ-induced Prx3 modification very likely involves oxidation 
of cysteine residues to sulfinic or sulfonic acid. 
Interestingly, Prxs also regulate MAPK activity (Kang et al. 2004; Veal et al. 
2004), and overexpression of Prxs protects cells against oxidative stress induced cell 
death (Butterfield et al. 1999; Nonn et al. 2003). Both ERK1/2 and p38 MAPK pathways 
are activated by TGHQ, and are associated with TGHQ-induced renal cell death. We also 
know that the activation of ERK1/2 occurs through EGFR activation, whereas p38 
MAPK activation is EGFR-independent (Chapter 3). One mechanism by which the stress 
activated protein kinases (SAPK, p38 MAPK & JNK) are activated is through the 
dissociation and activation of SAPK, or its upstream kinases, from their binding partners. 
For example, 14-3-3, a scaffold protein is found to interact with MKK1, 2, or 3 (Fanger et 
al. 1998). Trx binds to Ask1, an upstream kinase of p38 MAPK, and prevents the 
activation of the p38 MAPK and JNK cascades (Saitoh et al. 1998). Trxs have much 
similarity with Prxs, both functioning as antioxidants, both are activated/inactivated by 
oxidation, and both are associated with the MAPK pathways. Therefore, oxidation of 
Prxs by TGHQ may contribute to the activation or inactivation of a number of signaling 
pathways, especially the MAPK pathways. Native western blot analysis on Prx3 revealed 
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a band shift after TGHQ and H2O2 treatment, most likely due to oxidation. Dithiothreitol 
treatment was not able to reverse the oxidation (data not shown), indicating that the 
oxidation of the cysteine residues results in sulfinic or sulfonic acid formation. The bands 
were excised and analyzed for post-translational modification by LC-MS/MS mass 
spectrometry. However, the identification of the modification was technically difficult, 
given that more than one protein were likely present in an excised single band. Further 
attempts on 2-D gel analysis followed by mass spectrometry has better separation of the 
proteins but could still not detect the modification. This is probably due to insufficient 
amount of Prx3 after sample preparation. One way to obtain sufficient sample for mass 
spectrometric analysis of Prx3 modification would be to pool the samples from several 
parallel-run 2-D gels. Future functional analysis would probe the cytoprotective effects of 
Prxs against ROS by overexpressing Prxs in LLC-PK1 cells, and reveal the potential 
binding partners of Prxs. In contrast to findings from the others, we identified a third spot 
on the 2-D gel as Prx3, the intensity of which decreased after TGHQ treatment. This spot 
also had a slower mobility shift on the 2-D gel, either due to a different molecular weight 
or due to different charges. We have not yet been able to determine the nature of the 
difference between the spots on the 2-D gels, all identified as Prx3. Because Prxs are 
abundant and highly conserved proteins, and because MALDI-TOF identification of Prxs 
relies on only partial peptide sequence match with the theoretical proteins, it is likely that 
the third spot is an isoform of Prx3. Notably, this spot was also modified by TGHQ. 
TGHQ induced a similar pattern of Hsp27 modification upon 2-D gel analysis. 
The phosphorylation of Hsp27 by TGHQ was confirmed by western blot analysis and 
was found to be very rapid and intensive. Microscopic analysis revealed an increase in 
phospho-Hsp27 staining mainly in those cells displaying signs of cellular damage after 
treatment with toxic doses of TGHQ. Hsp27 lies downstream of the p38 MAPK pathway 
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(Chapter 3), and has multiple functions. Usually, heat shock proteins are well known for 
their cytoprotective effects, which are the subject of many studies. However, the 
consequences of Hsp27 phosphorylation under oxidative stress appear complicated, as 
evidenced by opposing observations in different systems by different approaches and by 
investigators (Arrigo 1998; Benndorf et al. 1994; Dalle-Donne et al. 2001; Ehrnsperger et 
al. 1997; Garrido 2002; Guay et al. 1997; Huot et al. 1998; Huot et al. 1996; Jakob et al. 
1993; Kato et al. 1994; Lavoie et al. 1995; Mehlen et al. 1996a; Parcellier et al. 2003a; 
Preville et al. 1998; Rogalla et al. 1999). In summary, unphosphorylated Hsp27 forms 
large oligomers and functions as a chaperone protein to bind and regulate Hsp27-
interacting proteins. Therefore, overexpression of total Hsp27 increases cell viability 
against ROS challenge. Upon phosphorylation, Hsp27 disaggregates and forms small 
oligomers or monomers, which lose their chaperoning function. However, 
phosphorylated Hsp27 can assist in stabilizing cytoskeleton by interacting with actin, 
providing a cytoprotective effect against ROS. Moreover, only unphosphorylated Hsp27 
can increase cellular GSH levels, thereby protecting the cells from oxidative stress. 
Interestingly, in neutrophils, Akt, p38 MAPK, MK-2, and Hsp27 form a signaling 
module (Rane et al. 2001). Upon activation of p38 MAPK by transient transfection of 
MKK3 or MKK6 in HEK293 cells, Hsp27 is phosphorylated and dissociates from the 
module (Rane et al. 2001). The association of Hsp27 with Akt is required for the activity 
of Akt, which is lost due to the dissociation of Hsp27 from Akt (Rane et al. 2003). 
Pivotal experiments showed that LLC-PK1 cells transfected with plasmid expressing 
mutated Hsp27 (3A), which mimics the fully phosphorylated form of Hsp27 (S15, S78, 
S82) demonstrated no change in viability compared to the mock-transfected cells (data 
not shown). Additionally, pretreatment of LLC-PK1 cells with DDM-PGE2 provides 
protection against TGHQ-induced cytoxicity. However, TGHQ failed to induce Hsp27 
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phosphorylation and the cytoprotective effects of DDM-PGE2 against TGHQ were lost in 
post-confluent Grp78 non-inducible LLC-PK1 cells (Jia et al. 2004). These data indicate 
that Hsp27 phosphorylation likely exhibits dual roles in response to TGHQ-induced 
oxidative stress. 
Other proteins that were altered by TGHQ treatment in LLC-PK1 cells could also 
be associated with TGHQ-induced renal cell death or carcinogenesis. For example, 
annexin I is a protein typically associated with carcinogenesis, and promotes membrane 
fusion and is involved in exocytosis (Parente and Solito 2004). Annexin I was induced by 
TGHQ treatment (Figure 4.1 to 4.3), and is likely involved in TGHQ-mediated signaling 
activation (PLA2 regulation). PDI and calreticulin are both localized within the 
endoplasmic reticulum and are closely related to protein refolding and stabilization under 
stresses (Wilkinson and Gilbert 2004). Nucleophosmin/B23 is a ubiquitously expressed 
phosphorylatable chaperone protein involved in ribosome assembly/transport, 
cytoplasmic/nuclear trafficking, regulation of DNA polymerase alpha activity, 
centrosome duplication, and regulation of p53. NPM continuously shuttles between the 
nucleus and cytoplasm, and is associated with centrosome and cell division (Okuda 
2002). However, changes to these proteins after TGHQ treatment were less apparent than 
the changes to Prxs and Hsp27. Further studies examining the functional consequences of 
changes in these proteins would be of a value to our understanding cell response to 
oxidative stress. Because the pattern of changes in Prxs and Hsp27 on 2-D gels after 
TGHQ treatment are rapid, significant and highly reproducible, they could also be used 
as a biomarker for ROS-induced cellular damage. 
In summary, I found that TGHQ induced changes in several proteins identified by 
2-D gel analysis followed by MALDI-TOF protein identification. These proteins are 
associated with protection against oxidative stress, carcinogenesis, ER stress response, 
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calcium regulation, and nuclear shuttling. In particular, Prxs are antioxidants that are 
oxidized by ROS, and Hsp27 is phosphorylated in response to TGHQ, the consequences 
of which appear to be context-dependent. 
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Chapter 5: TGHQ INDUCED ERK & HISTONE H3 
PHOSPHORYLATION IN THE KIDNEYS OF TGHQ-TREATED 
EKER RATS 
I. INTRODUCITON AND RATIONALE 
Reactive oxygen species (ROS) are associated with a variety of human diseases 
and toxicity (Bolton et al. 2000). Renal proximal tubule epithelial cells are particularly 
sensitive to oxidative stress-induced damage. However, the molecular mechanisms by 
which ROS cause injury in renal epithelial cells remain unclear. 2,3,5-Tris-(glutathion-S-
yl)hydroquinone (TGHQ) is a potent nephrotoxic metabolite of hydroquinone (HQ). 
TGHQ causes oncotic/necrotic cell death of renal proximal tubule epithelial cells, and 
likely mediates HQ-induced nephrotoxicity and nephrocarcinogenicity (Lau et al. 1988; 
Lau et al. 2001a; Peters et al. 1997). TGHQ maintains the ability to redox-cycle and 
generate ROS (Towndrow et al. 2000; Weber et al. 2001), and covalently binds to 
cellular macromolecules (Kleiner et al. 1998a; Kleiner et al. 1998b). The one-electron 
reduced form of TGHQ may react with O2, yielding superoxide anion radical, which 
ultimately gives rise to hydroxyl radical and hydrogen peroxide (Monks and Lau 1998). 
Quinone-thioethers induce rapid ROS-dependent DNA damage, growth arrest, and cell 
death in a well-established in vitro model of porcine renal proximal tubule epithelial cells 
(LLC-PK1) (Jeong et al. 1997a; Jeong et al. 1997b; Jeong et al. 1996; Mertens et al. 
1995).  
The nephrotoxicity of polyphenolic glutathione (GSH) conjugates is dependent on 
the high activity of γ-glutamyl transpeptidase (γ-GT) within the brush border membrane 
of the proximal tubule epithelial cells (Lau et al. 1988; Monks and Lau 1998). The 
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activity of γ-GT is required for the generation of the corresponding cysteine conjugates, 
which are subsequently transported into cells via the system L-amino acid transport 
system. ROS generation and covalent binding by the cysteine conjugates and the 
subsequent activation or inactivation of signaling pathways likely contribute to TGHQ-
induced nephrotoxicity. A major signaling pathway that responds to various external 
stress, including oxidative stress, is the mitogen-activated protein kinase (MAPK) 
pathway (Martindale and Holbrook 2002). The MAPK family is comprised of three 
major subfamilies, the extracellular signal-regulated protein kinase (ERK), the c-Jun N-
terminal kinases/stress-activated protein kinase (JNK/SAPK), and the p38 MAPK (Cobb 
1999). Upon activation, following phosphorylation of the tyrosine and threonine residues, 
MAPKs subsequently activate a variety of substrates, the majority of which are 
transcription factors. One indirect downstream substrate of MAPKs is histone H3, which 
is phosphorylated subsequent to ERK activation, probably through the activation of either 
90 kDa ribosomal S6 kinase 2 (RSK2) or mitogen and stress activated protein kinase 1 
(MSK1) (Tikoo et al. 2001). TGHQ induces the activation of all three major subfamilies 
of MAPK (Ramachandiran et al. 2002) and histone H3 phosphorylation (Tikoo et al. 
2001) in LLC-PK1 cells.  The inappropriate phosphorylation of histone H3 leads to 
premature chromatin condensation (PCC) and oncotic cell death in LLC-PK1 cells 
(Tikoo et al. 2001). Inhibition of ERK phosphorylation by PD098059, a MAPK kinase 
(MEK1/2) inhibitor, decreases TGHQ-induced histone H3 phosphorylation (Tikoo et al. 
2001) and cell death (Ramachandiran et al. 2002) in LLC-PK1 cells. Whether similar 
signaling cascades contribute to the acute nephrotoxicity of TGHQ in vivo is not known 
and was the focus of the current studies. 
We utilized the Eker rat (Tsc-2EK/+) as our animal model with the intent of 
coupling TGHQ-induced acute nephrotoxicity to the subsequent development of renal 
 127
tumors by identifying the early molecular changes that support renal tumor formation. 
Eker rats carry a germ-line insertion in the tuberous sclerosis tumor suppressor gene (Tsc-
2), which predisposes the animals to renal tumors (Lau et al. 2001a; Walker et al. 1992; 
Walker 2002; Yoon et al. 2002; Yoon et al. 2001). Overexpression of ERK1/2 is often 
found in human neoplasia and tumors. For example, constitutive ERK activation was 
found in 48% of renal carcinomas examined (Oka et al. 1995). Moreover, PD184352, an 
inhibitor of ERK activation, suppressed tumor growth in vivo (Duesbery et al. 1999; 
Sebolt-Leopold et al. 1999). TGHQ induces an intensive increase in phospho-ERK1/2 
expression in LLC-PK1 cells. In addition, both p38 MAPK and JNK/SAPK, which play 
important roles in inflammation, tummorigenensis and apoptosis (Tian et al. 2000), are 
activated by TGHQ, rapidly and intensively in LLC-PK1 cells (Ramachandiran et al. 
2002). In the present study I investigated the effects of TGHQ on MAPK activation and 
histone H3 phosphorylation in Eker rats to identify early molecular changes that may 
contribute to HQ- and TGHQ-mediated carcinogenicity in vivo, and to determine the 
extent to which the in vitro model is predictive of molecular responses in vivo. 
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II. RESULTS 
A. Nephrotoxicity of TGHQ  
TGHQ (7.5 µmol/kg, i.v.) induced nephrotoxicity in the kidneys of Eker rats was 
confirmed by microscopic examination. By 4 hours after TGHQ administration, 
morphological damage within proximal tubules located in the OSOM was observed. The 
brush border became diffuse and the tubular lumen became filled with cellular debris 
(Figure 5.1). Kidneys of untreated Eker rats appeared unaffected. 
B. TGHQ induces ERK1/2 phosphorylation within the outer stripe of outer 
medulla of Eker rats 
ERK1/2 phosphorylation was absent in the proximal tubule of control rat kidneys 
(Figure 5.1). TGHQ-induced ERK1/2 phosphorylation was time-dependent, appearing as 
early as 1 h following TGHQ treatment and reaching maximal levels between 4 and 8 h 
after TGHQ treatment. Levels of phospho-ERK1/2 returned to control levels by 24 h. The 
staining of phospho-ERK1/2 was found to be specifically localized within the OSOM. 
Phospho-ERK1/2 was primarily located within the cytoplasm of the proximal tubule 
epithelial cells at earlier time points after TGHQ administration, although some nuclear 
staining was also present. Nuclear staining of phospho-ERK1/2 became more intense and 
prominent at later time points following TGHQ treatment. Additional immunoreactivity 
was also found in the lumen of the proximal tubules in lesional regions, probably due to 
the release of the cytoplasmic contents after cell membrane damage. Constitutive staining 
for phospho-p42/44 MAPK was present in the distal tubules, in both controls and the 
treated animal kidneys, but did not increase upon TGHQ treatment. The findings suggest 
that phospho-ERK1/2 translocates from cytoplasm to nucleus, but this initial 
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interpretation will require confirmation of immunolocalization using confocal 
microscopy. Western blot analysis, specifically on dissected OSOM tissue, revealed that 
ERK1/2 phosphorylation changed in a similar pattern to that found with 
immunohistochemical staining (Figure 5.2). 
C. TGHQ induces histone H3 phosphorylation within the outer stripe of outer 
medulla of Eker rats 
Immunohistochemistry revealed increases in phospho-histone H3 (Ser10) 8h 
following TGHQ treatment, reaching maximal levels between 12h and 24h (Figure 5.3), 
and returning to control levels by 72h. Western blot analysis was performed on pooled 
samples from 2-4 animals at each time point, and results confirmed the 
immunohistochemical findings (Figure 5.4). The presence of phospho-histone H3 within 
glomeruli likely contributes to the high expression levels in the control western blot 
analyses, consistent with the immunohistochemical findings. However, the significant 
increases in phospho-histone H3 levels revealed by western blot analyses, which exhibit 
the same kinetics as observed by immunohistochemistry, reflects changes occurring 
specifically within the OSOM, the target of TGHQ-induced toxicity. Thus, increases in 
phospho-histone H3 (Ser10) were found mostly within the OSOM and were associated 
with tubules exhibiting pathologic features. We also observed that phospho-histone H3 
appeared in both nuclei and cytoplasm of the proximal tubule epithelial cells, but most 
prominently in the nuclei at earlier time points (8 h), with increased intensity of 





Figure 5.1 Increased ERK1/2 
phosphorylation within 
the OSOM of TGHQ-
treated Eker rat kidney:  
Cells expressing phospho-ERK1/2 
stain brown, phospho-ERK1/2 
negative cells stain blue with 
hematoxylin counterstain. 
Representative treatment times (0, 
4, 8, 24 h) are shown under the 
photomicrographs, taken under 400 
× (Bar = 20 µm) or 40 × (Bar = 200 
µm) total magnification. CS, 
cytosolic staining; NS, nuclear 


















Figure 5.2 Western blot analysis confirms increases in ERK1/2 phosphorylation in 
OSOM tissue of Eker rat kidneys after TGHQ treatment. 
Frozen OSOM tissues of Eker rats (0-72 h) were homogenized, lysed and analyzed by 
western blot analysis using a phospho-specific antibody for p-ERK1/2. (A) ERK1/2 
phosphorylation upon TGHQ treatment. p-ERK1/2 (upper two bands), and total ERK1/2 
(lower two bands) are shown, and the illustrated blot is typical of at least three 
independent experiments. (B).  Statistical analysis on the changes of p-ERK1/2. p-
ERK1/2 are compared and normalized to total ERK1/2, at each TGHQ treatment time 
point, and data are shown as fold-increase compared to untreated controls. Statisticaly 





Figure 5.3 TGHQ increases histone 
H3 phosphorylation at 
Ser10 within the OSOM 
of TGHQ treated Eker 
rat kidneys:  
p-Histone H3 (Ser10) expressing 
cells are stained brown, whereas 
cells staining negative for p-histone 
H3 (Ser10) are counter-stained blue 
with hematoxylin. Time of 
treatment is shown below the 
photomicrographs, with meter bar of 
200 µm or 20 µm for lower or 
higher total magnification (40 × or 
400 ×). CS, cytosolic staining; NS, 













Figure 5.4 Western blot analysis confirms an increase in histone H3 phosphorylation 
after TGHQ treatment: 
Frozen OSOM tissue from untreated or TGHQ-treated Eker rats were homogenized, 
lysed, sonicated, and analyzed by western blot analysis using a phospho-specific antibody 
for phospho-histone H3 (Ser10). Lysates from 2-4 animals from each time point (0-72 h) 
were pooled for analysis. The upper band represents the phospho-histone H3 (Ser10), and 




D. TGHQ induces no increase in phospho-p38 MAPK or JNK1/2 in Eker rats 
The phosphorylation status of p38 MAPK (Figure 5.5) and JNK1/2 (Figure 5.6) 
within the OSOM changed little following TGHQ treatment, compared with the 
phosphorylation of ERK1/2, as determined by immunohistochemistry. Constitutive 
staining was observed throughout the kidney, mainly in glomeruli, the outer medulla, the 
inner medulla, and endothelial cells. We observed a slight increase in phospho-p38 
MAPK (Figure 5.5) and phospho-JNK1/2 (Figure 5.6) within the OSOM 12 h after 
TGHQ administration, but this was observed only within limited loci with much less 
intensity than that observed for phospho-ERK1/2. Western blot analysis on the OSOM 
tissues using phospho-specific antibodies confirmed the constitutive phosphorylation of 
p38 MAPK (Figure 5.7) and JNK1/2 (Figure 5.8) in both untreated and treated animal 
kidneys, and failed to detect any changes following TGHQ treatment. Preferential 
phosphorylation of JNK2 compared to JNK1 within OSOM tissue of both untreated and 
TGHQ-treated Eker rats was observed with a phospho-specific antibody for phospho-
JNK1/2. However, the mechanism for the preferential phosphorylation of JNK2 is 





Figure 5.5 TGHQ has little effect 
on p38 MAPK 
phosphorylation within 
the OSOM of Eker rat 
kidney: 
p-p38 MAPK expressing cells are 
stained brown with DAB, whereas 
p-p38 MAPK negative cells are 
counter-stained blue with 
hematoxylin. Selected treatment 
times are shown below the pictures. 
Bar = 200 µm for lower 
magnification (40 ×); bar = 20 µm 






Figure 5.6 TGHQ does not induce 
significant JNK1/2 
phosphorylation within 
the OSOM of Eker rat 
kidneys: 
In the photomicrographs, p-
JNK1/2 expressing cells are 
stained brown, whereas p-JNK1/2 
negative cells are counter-stained 
blue with hematoxylin. Treatment 
times are shown below the 
pictures. Bar = 200 µm for lower 
magnification (40 ×); bar = 20 µm 












Figure 5.7 Western blot analysis confirms the lack of induction of p38 MAPK 
phosphorylation after TGHQ treatment: 
Frozen OSOM tissue from Eker rats (0-72 h) were homogenized, lysed and analyzed by 
western blot using a phospho-specific antibody for p-p38 MAPK. The upper band shows 
unchanged p-p38 MAPK, and the lower band shows unchanged total p38 MAPK. The 













Figure 5.8 Western blot analysis confirms the lack of induction of JNK1/2 
phosphorylation after TGHQ treatment:  
Frozen OSOM tissue from Eker rat (0-72 h) were homogenized, lysed and analyzed by 
western blot using a phospho-specific antibody for p-JNK1/2. The upper two bands 
represent the p-JNK1/2, and the lower two bands represent the total JNK1/2. The blot is a 
representative of at least 3 independent results. 
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III. DISCUSSION 
In the present study I have shown that TGHQ induces the time-dependent 
phosphorylation of ERK1/2, followed by the subsequent phosphorylation of histone H3, 
within the OSOM of Eker rats. More importantly, increases in ERK1/2 phosphorylation 
precede the morphological findings of acute toxicity, consistent with a role for these 
phosphorylation events in the toxicity. TGHQ-induced DNA damage precedes 
nephrotoxicity as determined by immunostaining for 8-oxo-dG, and is maximal 8 h after 
TGHQ treatment of Eker rats (Habib et al. 2003). The acute toxicity of TGHQ is mainly 
localized to proximal tubule epithelial cells within the OSOM, due to the high 
concentrations of γ-GT on these cells. Urinary γ-GT levels increase rapidly after 
administration of renal toxicants, followed by increases in the urinary excretion of 
cytosolic components, such as glutathione S-transferase (GST). Thus, urinary γ-GT and 
GST activity serve as predictive indeces of renal toxicity in vivo. After TGHQ treatment, 
urinary γ-GT activity in Eker rats increases as early as 4 h, and rapidly reaches maximum 
levels at 8 h, and which are sustained for at least 48 h (Habib et al. 2003). In contrast, 
urinary GST activity, an indicator of renal cell shedding into the tubular lumen, increases 
progressively, and reaches peak levels 24 h after TGHQ treatment (Habib et al. 2003). 
Thus, initial increases in GST occur coincident with increases in histone H3 
phosphorylation.  
We subsequently performed immunohistochemical experiments to compare Eker 
rats (possessing a mutation in one allele of the Tsc-2 tumor suppressor gene) with their 
wild-type equivalents (Long-Evans), but did not observe any differences in the 
expression of phospho-ERK1/2 and phospho-histone H3 between the wild type and the 
mutant Eker rats (data not shown). Consistent with these findings, TGHQ induces 
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markedly increased cell proliferation and increased ERK activity within the OSOM of the 
kidneys in both wild type and mutant Eker rats (Yoon et al. 2002). Loss of the remaining 
wild type allele of the Tsc-2 gene is required for TGHQ induced nephrocarcinogenicity. 
The Eker rat therefore represents an excellent model with which to examine chemical-
induced nephrotoxicity and nephrocarcinogenicity.  
Two downstream substrates of ERK1/2 are MSK1 and RSK2, both of which 
exhibit histone H3 kinase activity (Thomson et al. 1999). Consistent with the in vitro 
findings, ERK1/2 phosphorylation preceded histone H3 phosphorylation in vivo, 
suggesting that histone H3 may also be a downstream substrate of phospho-ERK1/2 in 
vivo. However, in contrast to TGHQ-mediated activation of p38 MAPK and JNK1/2 in 
LLC-PK1 cells, neither of these kinases were significantly altered within the OSOM of 
Eker rats. Thus, the contribution of p38 MAPK and JNK1/2 to TGHQ-induced 
nephrotoxicity in vivo remains unclear. Western blot analysis of OSOM tissue from 
TGHQ treated Eker rats confirmed the immunohistochemical findings, and revealed little 
change in phospho-p38 MAPK and phospho-JNK/1/2 throughout the observed time 
points. Our data are consistent with the constitutive expression of JNK1/2 and of 
corresponding JNK1/2 phosphorylation reported in proximal tubules of adult rats (Omori 
et al. 2000). 
The roles of the MAPKs in hypertrophy, ischemia/reperfusion-induced injury, 
chronic renal disease, angiotensinogen gene expression, and in the endoplasmic reticulum 
stress response have been the subject of many investigations (Hannken et al. 2000; Hsieh 
et al. 2002; Hung et al. 2003; Khan et al. 2001; Park et al. 2002). However, relatively 
less is known with respect to the pattern of activation of the MAPK pathways in kidneys 
in response to ROS-generating chemicals in vivo. The effects of ERK1/2 activation, and 
the subsequent changes in the phosphorylation status of their substrates are controversial. 
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Thus, ERK1/2 activation may contribute to both cell proliferation and differentiation. The 
duration of ERK1/2 activation is also critical for cell signaling decisions in PC12 cells 
(Marshall 1995); short-term ERK activation leads to proliferation whereas sustained ERK 
activation leads to differentiation. In the present model, ERK1/2 phosphorylation was 
maximal 4 h after TGHQ treatment, and returned to control levels by 24 h. The 
phosphorylation of ERK1/2 and subsequent histone H3 phosphorylation may constitute 
signals to the proximal tubule epithelial cells to activate the necessary machinery for cell 
division and proliferation. However, these same cells are simultaneously experiencing 
extensive DNA damage, with the concomitant activation of growth arrest and DNA 
damage inducible signals (gadd153 mRNA upregulation, and downregulation of histone 
mRNA, (Jeong et al. 1996). These two conflicting signaling pathways may contribute to 
premature chromatin condensation and mitotic catastrophe. Moreover, cells that survive 
the TGHQ-induced ROS-dependent stress by activating specific characteristics/signaling 
pathways, or by excessive proliferation after tissue damage, may acquire the potential to 
develop into tumors.  
The relationship between TGHQ induced cell proliferation and TGHQ-induced 
nephrotoxicity and nephrocarcinogenicity has been previously established (Lau et al. 
2001a; Peters et al. 1997; Yoon et al. 2002). The mechanism likely involves cytotoxicity 
and compensatory cell proliferation, accompanied by, in Eker rats, loss of tuberin 
expression. ERK activation is associated with mitogenesis, and histone H3 (S10/S28) 
phosphorylation is a marker of cell proliferation. We hypothesize that TGHQ induced 
DNA damage (Habib et al. 2003) increases the frequency of mutations, and perhaps loss 
of heterozygosity at the Tsc-2 locus, in the highly proliferate environment that exists in 
renal proximal tubules in response to tissue injury. In addition, the constitutive 
phosphorylation of JNK1/2 and p38 MAPK (Figure 5.5 to 5.8) may indicate that Eker 
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rats, even in the absence of stress, exhibit a unique spectrum of signaling pathways that 
predispose these animals to the development of spontaneous renal tumors.  
The shuttling of MAPKs between the cytoplasm and nucleus plays an important 
role in regulating MAPKs function (Adachi et al. 2000). Activated ERK1/2 usually 
translocates from the cytoplasm to the nucleus, and inactivated ERK1/2 binds to 
MEK1/2, and relocalizes to the cytoplasm, assisted by the nuclear export signal on 
MEK1/2 (Adachi et al. 2000). The nuclear export of ERK1/2 is inhibited by leptomycin 
B, which binds to a component of the nuclear export complex, CRM1, and blocks nuclear 
export (Adachi et al. 2000). Nuclear translocation of activated ERK1/2 may participate in 
the activation of several targets, mainly transcription factors, and culminate in nuclear 
histone H3 phosphorylation. Following nuclear export of ERK1/2 to the cytoplasm, or 
breakdown of the nuclear and/or plasma membranes, phospho-ERK1/2 and phospho-
histone H3 are detectable in the cytoplasm and/or within the lumen of the proximal 
tubules (Figure 5.1), indicating necrotic cell death. With the development of new 
biological tools, such as leptomycin B, importin antisense, and confocal microscopy, it 
will be possible to monitor the localization of MAPKs following TGHQ treatment. 
In summary, we have shown that TGHQ induces time-dependent phosphorylation 
of ERK1/2 within the OSOM of Eker rats. Phosphorylation of ERK1/2 and histone H3 
are associated with oncotic/necrotic cells. In addition, the nuclear shuttling of both 
ERK1/2 and histone H3 was observed in response to TGHQ treatment. In contrast, the 
phosphorylation of p38 MAPK and JNK1/2 remained unchanged after TGHQ treatment.  
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Chapter 6: CONCLUSIONS AND FUTURE DIRECTIONS 
ROS are associated with a number of diseases and toxicities, but also behave as 
signaling factors in a variety of cellular processes. The roles of ROS in cell signaling 
have been the subject of many studies, and ROS have been associated with both cell 
death and cell survival signaling pathways. Although a number of studies have linked 
ROS-induced signaling pathways to apoptotic cell death, relatively less information is 
available on the association between ROS-mediated signaling pathways and oncotic cell 
death. To determine the molecular mechanisms of ROS-mediated cell death, we used a 
model compound, TGHQ, as a source for ROS generation in cells. TGHQ targets renal 
proximal tubule epithelial cells, due to the ability of these cells to metabolize TGHQ and 
to subsequently transport the metabolites into cells. Therefore, TGHQ generates ROS 
within renal epithelial cells that may activate or inactivate a number of signaling 
pathways associated with cell fate determination. In addition, TGHQ possesses the ability 
to alkylate macromolecules and to cause damage to the cells. The ability of TGHQ to 
generate ROS and to alkylate macromolecules are coupled. Thus, even when TGHQ 
alkylates macromolecules, it can still generate ROS (Monks and Lau 1998). Therefore, 
alkylation and ROS generation can be inter-dependent. TGHQ induces oncotic rather 
than apoptotic renal epithelial cell death. Oncotic cell death and the resulting tissue 
necrosis frequently elicits an inflammatory response that exacerbates the damage to 
neighboring cells. During oncotic cell death a number of signaling pathways are also 
activatied. Studies in this dissertation focused on deciphering the signaling pathways 
involved in ROS-induced oncotic cell death, with the intent of uncovering ways in which 
to manipulate this process. 
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TGHQ induces DNA damage, growth arrest, MAPKs activation, and histone H3 
phosphorylation in porcine renal proximal tubule epithelial cells (LLC-PK1). DNA 
damage inducible histone H3 phosphorylation during oxidative stress likely contributes to 
premature chromatin condensation, mitotic catastrophe and ultimately cell death. 
Inhibition of either the ERK or p38 MAPK pathway attenuates TGHQ-induced renal cell 
death. Activation of the ERK pathway has been coupled to histone H3 phosphorylation. I 
thereby investigated the molecular mechanisms by which TGHQ induces renal cell death, 
with the intent of uncovering detailed information on ROS-mediated signaling pathways.  
The first question I asked was how ROS generation activates MAPK cascades. 
TGHQ induces EGFR phosphorylation leading to EGFR-dependent activation of the 
ERK cascade. In contrast, TGHQ-induced p38 MAPK activation does not occur through 
EGFR phosphorylation. Instead, at least one of the factors in the p38 MAPK cascade is 
associated with inhibitory chaperone proteins, the post-translational modification of 
which leads to the dissociation and activation of the p38 MAPK cascade. The effects of 
EGF and H2O2 on EGFR were compared to TGHQ. Phosphorylation of five tyrosine 
residues on EGFR was examined, all of which are associated with ERK pathway 
activation. EGF induced rapid (Max = 15 min) EGFR activation by promoting the 
phosphorylation of all the tyrosine residues examined (Y992, Y1068, Y1086, Y1148, 
Y1173), each of which provide binding sites for a variety of signaling factors to initiate 
disparate signaling cascades. TGHQ induced subtantial EGFR tyrosine phosphorylation 
at Y992 and Y1068, weak phosphorylation at Y1086 and Y1148, but not at Y1173 (Max 
= 1 h). H2O2, surprisingly, only induced significant increases in tyrosine phosphorylation 
at Y992, but not Y1068, and weak phosphorylation at Y1086 and Y1148 (Max = 1 h). 
These observations indicate that the mechanisms of TGHQ-mediated EGFR activation 
are somehow different from H2O2-mediated EGFR activation. EGFR has an excessive 
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number of tyrosine residues, because many of them may lead to similar responses. 
However, the different combinatorial and kinetic activation of EGFR tyrosine residues 
provides a basis for selectivity and differential kinetics of downstream signaling pathway 
activation. Indeed, the kinetics of ERK1/2 activation by TGHQ and H2O2 differed. Total 
EGFR levels were also different in cells treated with the three agents, with EGF-treated 
cells exhibiting the most rapid decrease in EGFR expression levels. TGHQ-treated cells 
responded with less substantial decreases in EGFR expression levels, with no decreases 
in total EGFR levels in H2O2 treated cells. The decrease in total EGFR is probably due to 
inactivation, or internalization/degradation of EGFR upon phosphorylation of certain 
EGFR tyrosine residue(s). H2O2, however, inhibits EGFR internalization and 
degradation. It would be interesting to differentiate the recruitments of various binding 
partners for EGFR tyrosine residues phosphorylated in response to TGHQ, EGF or H2O2. 
Current studies using immunoprecipitation techniques to pull down EGFR and its 
associated proteins, and analysis of different patterns of recruitment of EGFR binding 
partners to the EGFR before and after treatment with EGF, TGHQ and H2O2 will assist in 
understanding the mechanisms of EGFR activation and downstream signaling regulation 
in response to the different agents. 
We subsequently endeavored to discover the mechanisms of histone H3 
phosphorylation in TGHQ challenged renal cells. Since MAPKs activation has been 
linked to histone H3 kinase activation, our aim was to determine whether TGHQ-
mediated histone H3 phosphorylation results from the activation of MAPKs. Among the 
MAPKs, both the ERK1/2 and p38 MAPK pathways may lead to histone H3 
phosphorylation. Using pharmacological manipulation, we found that both the ERK and 
p38 MAPK pathways contribute to TGHQ-induced histone H3 phosphorylation. Msk1 
and Rsk2 are two histone H3 kinases downstream of ERK1/2 or p38 MAPK. However, 
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our laboratory has shown that dominant negative Msk1 or pharmacological inhibition of 
Rsk2 failed to affect TGHQ-induced histone H3 phosphorylation. Therefore, there must 
be other histone kinases downstream of ERK and p38 MAPK pathways, which contribute 
to TGHQ-induced histone H3 phosphorylation in LLC-PK1 cells (Cox and Palmer, 
unpublished data). Future studies will be designed to reveal the kinase(s) responsible for 
histone H3 phosphorylation induced by TGHQ in renal cells. Moreover, recent finding in 
the laboratory have revealed that phosphorylation of the conventional phospho-histone 
H3 residues (S10 and S28) actually decreases after TGHQ treatment, despite overall 
increase in [32P]-incorparation into histone H3. Therefore, a novel phosphorylation 
residue(s) on histone H3 must be responsible for the overall increase of histone H3 
phosphorylation after TGHQ treatment. One possibility is S31 in histone H3.3. Increases 
in histone H3 phosphorylation occurs specifically on serine residues, and the increases 
are limited to the H3.3 isoform, which possesses a serine rather than an alanine residue at 
position 31, and which is the likely putative phosphoryaltion residue. Current studies 
involve the construction of vectors containing single or multiple mutations in histone H3, 
with S10, S28 and S31 being mutated to A10, A28 and A31, which cannot be 
phosphorylated. These vectors are then transfected into LLC-PK1 cells to study whether 
S31 phosphorylation is important in TGHQ-mediated cell death.  
I further examined roles of the p38 MAPK pathway in TGHQ-mediated renal cell 
death. p38 MAPK activation leads to the phosphorylation of Hsp27, which acts as a 
chaperone, and stabilizes the cytoskeleton. TGHQ induces phosphorylation of Hsp27 at 
S15, S78 and S82 residues (Figure 3.9). Phosphorylation of Hsp27 leads to the break 
down of large Hsp27 oligomers into smaller oligomers or monomers, which lose their 
chaperoning functions and their ability to bind to unfolded proteins and to facilitate the 
efficient refolding of these proteins. Hsp27 also regulates intracellular antioxidant GSH 
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levels in a manner that protects against oxidative stress. However, this property of Hsp27 
is lost upon phosphorylation. In contrast, smaller oligomers or monomers of Hsp27 that 
form subsequent to phosphorylation assist in stabilizing actin and in protecting cells from 
oxidative stress induced damage. The roles of Hsp27 phosphorylation in oxidant-induced 
cell death remain controversial. We speculate that Hsp27 likely acts in both a protective 
and in a cell death inducing fashion. Total Hsp27 levels provide a cytoprotective effect 
by providing a larger pool of Hsp27 that function in both a chaperoning function and 
antioxidant (increases intracellular GSH levels) manner. Once phosphorylated, Hsp27 
loses its ability to stabilize damaged proteins (loses its chaperoning properties), and its 
ability to maintain GSH levels, but it simultaneously acquires the ability to stabilize the 
actin cytoskeletal network and to maitain cell structure. Moreover, in LLC-PK1 cells that 
lack the ability for Grp78 induction, the activation of the p38 MAPK pathway and Hsp27 
phosphorylation is disrupted, and likely contributes to the loss of DDM-PGE2-mediated 
cytoprotection against TGHQ-mediated oncotic cell death. The role of Hsp27 
phosphorylation in TGHQ-mediated renal cell death clearly requires further investigation. 
The fraction of unphosphorylated and phosphorylated Hsp27, and the subsequent balance 
in chaperoning functions, maintainance of GSH levels, and the ability to stabilize the 
actin cytoskeleton all combined are to determine the overall effect of Hsp27 in ROS 
stressed cells. I suspect that in the acute toxicity studies (2 h) in preconfluent renal cells, 
the loss of the chaperoning function and the ability to maintain GSH levels are the key 
features linking Hsp27 to cell death. In contrast, in DDM-PGE2 pretreated (24 h) or in 
genetically manipulated post-confluent renal cells (Grp78 antisense), changes in total 
Hsp27 protein expression and the subsequent phosphorylation are important in stabilizing 
actin to provide a cytoprotective effects. One approach to further study the roles of Hsp27 
would be to overexpress the unphosphorylatable mutants of Hsp27 in renal cells, and to 
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examine whether blocking of Hsp27 phosphorylation protects or enhances TGHQ-
induced renal cell death. More studies using this mutant will help to understand how 
Hsp27 phosphorylation influences (i) the chaperoning function of large 
unphosphorylatable oligomers (ii) GSH levels, and (iii) how phosphorylated Hsp27 
tetramers and monomers interact with cytoskeletal proteins and their function in 
cytoprotection. However, as previously discussed, the dual roles of Hsp27 
phosphorylation add complexity to this approach, and we should be cautious in 
interpreting the data acquired. 
Because no single or combination of inhibition of TGHQ-induced cell-death-
associated signaling pathways can completely block cell death, I hypothesized that there 
are multiple signaling pathways involved in this process. I therefore investigated global 
cellular responses to TGHQ in renal epithelial cells using a proteomics approach 2-D gel 
analysis revealed three spots that were altered in response to TGHQ, all of which were 
identified by MALDI-TOF as Prx3, and two spots indentified as Prx2 (Figure 4.1, 4.2). 
After TGHQ treatment, spots with a more acidic pI became more intense. Two spots 
exhibiting a similar phenomenon of spot intensity shifts on a 2-D gel identified as Prx3 
have been similarly observed (Rabilloud et al. 2002). Mass spectrometric analysis of the 
spots revealed that the one with more acidic pI possessed a cysteine residue oxidized to 
the sulfinic and sulfonic acid. However, no one has yet to report the third spot, identified 
by us as Prx3, which exhibits a decrease in intensity after TGHQ treatment. 
Determinating the post-translational modifications of Prxs, and the identity of the third 
spot found on the 2-D gel is therefore a current priority. We suspect that the third spot, 
identified as Prx3, is likely a subisoform of Prx3, which shares homology with the 
peptides altering matched. 
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Prxs are a family of abundantly expressed peroxidases that provide the first 
defense barrier against ROS-mediated cellular damage. Other anti-oxidants include GSH, 
catalse, and SOD. In the presence of small amounts of intracellular ROS, Prxs reduce 
H2O2 and oxidized lipids with the accompanying oxidation of the sulfhydryl group in the 
active site cysteine residues to the sulfenic acid. Oxidation of the cysteine residue is 
quickly reversed by thioredoxin reductase and Prxs regain their antioxidant functions. 
However, in response to excessive amounts of ROS, additional oxidation of Prxs cysteine 
residues into sulfinic and sulfonic acid, and these oxidative modifications are not readily 
reversed, the process of reduction being slow. This hyperoxidation of Prxs allows excess 
ROS to react with additional cellular constituents and yields an oxidative stress response. 
In this respect, oxidation of Prxs probably represents a gateway for ROS-mediated 
signaling in cells. Prxs also regulate MAPK activities, and overexpression of Prxs 
protects cells against oxidative stress induced cell death. Therefore, oxidation of Prxs by 
TGHQ may contribute to the activation or inactivation of a number of signaling 
pathways. Native western blot analysis of Prx3 revealed a band shift after TGHQ and 
H2O2 treatment, most likely due to oxidation. The bands were excised and analyzed for 
post-translational modification by LC-MS/MS mass spectrometry. However, 
identification of the modification is technically difficult. Although 2-D gel analysis 
provides improved separation of the proteins, the yield of Prx3 after sample preparation is 
low. These technical difficulties have limited our ability to study the modification of Prx3 
in greater detail. Future studies will attempt to pool the samples to obtain larger amounts 
of protein for analyses. Studies on the cytoprotective effects of Prxs against ROS can be 
performed by overexpressing Prxs in renal cells. Current studies are designed to identify 
potential signaling factors (especially p38 MAPK cascade) associated with Prxs by 
immunoprecipitation followed by MALDI-TOF protein identification, which will be 
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confirmed by western blot analysis. Such studies will assist in better understanding the 
roles of Prxs in ROS induced oncotic renal cell death. Other proteins regulated by TGHQ 
in LLC-PK1 cells include a rapid increase in the overall expression of annexin I, PDI 
precursor, calreticulin, and changes in nucleophosmin. These proteins are associated with 
a number of cellular functions, including carcinogenesis, ER stress, calcium regulation, 
and nuclear shuttling. We further confirmed increases in annexin I expression levels after 
TGHQ treatment by western blot analysis. Whether induction of annexin I by TGHQ is 
associated with nephrotoxicity and nephrocarcinogenicity requires further investigation. 
We now have identified a network of signaling pathways that are engaged during 
TGHQ-induced renal cell death in LLC-PK1 cells (Figure 6.1). Whether these signaling 
pathways are also activated in vivo remains to be examined. Pivotal studies were 
performed in TGHQ-treated Eker rats in search of the activation of the MAPKs and 
histone H3 phosphorylation. As shown in Chapter 5, TGHQ induced substantial time-
dependent ERK1/2 and histone H3 phosphorylation within the OSOM, the target of 
TGHQ-mediated nephrotoxicity. Increases in ERK phosphorylation precede indeces of 
nephrotoxicity, urinary γ-GT and GST excretion. However, constitutive phosphorylation 
of p38 MAPK within the OSOM of Eker rat kidney obscured any changes that might 
occur in response to TGHQ. Constitutive p38 MAPK activation might also contribute to 
the predisposition of these rats to spontaneous renal tumors. In vivo mechanistic studies 
on signaling pathways are much harder to conduct than in vitro studies, due to the 
complexity of the in vivo systems in comparison to in vitro cell culture. However, in vivo 
evidence is very valuable in predicting human responses and should always be used to 
confirm the in vitro phenomena. Future studies in our laboratory may involve in vivo 
mechanistic studies using TGHQ-sensitive animals. A pharmacological inhibitor of the 
p38 MAPK pathway (SB202190) is commercially available for in vivo studies. 
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Unfortunately, a similar in vivo inhibitor of the ERK pathway is not commercially 
available because it is patented and in development as an anti-cancer drug. Other in vivo 
mechanistic studies are also possible, such as genetic manipulation of key signaling 
factors by generating transgenic or knockout animals. 
This dissertation describes and discusses my research findings that contribute to 
an increased understanding of the molecular mechanisms of ROS-induced oncotic renal 
cell death. It is my wish that these studies and findings would contribute to our overall 
understanding of quinone-thioethers-mediated toxicities, of signaling pathways involved 
in ROS-mediated cell death, and assist in identifying potential solutions to manipulate 





















Figure 6.1 Summary of the cell signaling in TGHQ treated renal proximal tubule 
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